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S~THESIS AND BIOCHEMICAL PHARMACOLOGY OF OXOAZOPUR!NES 
This study was undertaken to investigate the synthesis 
and chemical and biological properties of a new class of 
compounds, the oxoazopurines. 8,8'-Dioxo-6,6'-azopurine 
monohydrate (DOAP), the parent member of this new class, was 
synthesized from adenine using sulfuric acid, potassium bro-
mide, potassium permangnate, and hydrogen peroxide. A hy-
drazo derivative of DOAP, 8,8'-dioxo-6,6'-hydrazopurine 
monohydrate (DOHP), was synthesized by a partial reduction 
of DOAP using SnC12/HCl at 70°C, and an azoxy derivative of 
DOAP, 8,8'-dioxo-6,6'-azoxypurine hexahydrate trisodium salt 
(NaDOAXP), was synthesized from the air oxidation of DOAP in 
0. 00 5 N NaOH. Reductive cleavage of DOAP using sodium hy-
dro sulfite and NaOH resulted in 8-hydroxyadenine indicating 
· that DOAP was a purine dimer joined through an azo bond be-
tween the c6 and c6 , positions. The structure of DOAP was 
further confirmed by enzymatic synthesis of DOAP from the 
oxidation of 6,6'-azopurine disodium salt (NaAP) by rabbit 
liver aldehyde oxidase. Since rabbit liver aldehyde oxi-
dase is known to oxidize purines selectively at the c8 posi-
tion, the enzymatic synthesis of DOAP confirmed that the oxo 
groups of DOAP are at the c8 and c8 , positions. DOAP has 
also been shown to be a potent inhibitor of xanthine oxidase 
During this investigation it was also observed that 
6,6'-azopurine disodium salt (NaAP) was a potent competi-
tive inhibitor of rabbit liver aldehyde oxidase. A 50% 
inhibition of rabbit liver aldehyde oxidase activity was 
found to occur at a final concentration of 2.6 X 10-6 M 
NaAP in the in vitro reaction mixture. Results of both a 
Lineweaver and Burk plot as well as a Dixon plot revealed 
a mean K. of J.J X 10-6 M for NaAP while indicating that 
. 1 
the.nature of the inhibition of rabbit liver aldehyde ox-
idase by NaAP was competitive. The present finding of 
such competitive inhibition of rabbit liver aldehyde oxi-
dase suggests that further investigations of substituted 
azopurines may elucidate their physiologic function. 
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ABBREVIATIONS 
A = Absorbance. 
DOAP = 8,8'-Dioxo-6,6'-azopurine monohydrate. 
DOHP = 8,8'-Dioxo-6,6'-hydrazopurine monohydrate. 
HP= 6,6'-Bisadenine monohydrate (6,6'-hydrazopurine, HP). 
int. area = integrated area. 
ir, IR = Infrared. 
M = Molar. 
NaAP = 6,6'-azopurine hemihydrate disodium salt • 
. NaDOAXP = 8,8'-Dioxo-6,6'-azoxypurine hexahydrate trisodium 
salt. 
NaAXP = 6,6'-Azoxypurine dihydrate disodium salt. 
N1MN = N1-methylnicotinamide. 
nmr, NMR = Nuclear magnetic resonance. 
0. D. = Optical density. 
ppm = parts per million. 
Rf = Rate of flow. 
uv, UV = Ultraviolet. 
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CHAPTER I 
INTRODUCTION 
The ongoing search for new biologically-active ·purines 
has led to .numerous significant compounds such as 6-mer-
captopurine, apurine analogue; methotrexate, a folic acid 
analogue; azathioprine, an immunosuppressive agent, etc. 
This study was undertaken to investigate anew class 
of purines, the oxoazopurlnes. The parent member of this 
new class, an Orange Adenine Chromophore, was first synthe-
sized and isolated by P!.ofessor Joseph ·R. Davis in 19.56 dur-
ing the development of a colorimetric analysis of adenine 
compounds (Davis and Morris, 1963). 
Chemical characterization of the members of this new 
class of compounds was the first essential step in this in-
vestigation. These studies included establishing the mo-
lecular structure of the Orange Adenine Chromophore (8,8'- . 
Dioxo-6, 6 '-azopurine monohydrate, . abbreviated as DOAP), 
preparation of: its derivatives, along with studying their 
physico-chemical characteristics by using various spectro- · 
scopic techniques. DOAP is an oxidized purine dimer result-
ing from the oxidation of a brown adenine chromophore (BAC) 
2 
with JO ' per cent H2o2 in the reaction medium. The struc-
tures of these chromophores were established in light of 
the mechanism of this unique reaction. Physical proper-
ties such as molar extinction coefficients, characteristic 
3 
absorptions of functional groups in the infrared region, 
chemical shifts of various protons in nuclear magnetic res-
onance spectra, .and Rf values are discussed in light of the 
structures of these compounds, and compounds whose struc-
tures have already been characterized. 
From a mechanistic point of view, the reaction through 
which these various chromophores are formed is unique, . 
since it involves an entirely new method of synthesizing 
biologically-active oxopurines. 
Previous reports from this laboratory showed that DOAP 
is a non-competitive inhibitor of bovine milk xanthine ox-
idase in vitro (Davis et al., 1974). This finding has also 
been confirmed in vivo. 
Many purines act as a substrate for the enzyme alde-
hyde oxidase (aldehydeao2 oxidoreductase, EC 1.2 • .3.1). This 
enzyme is particularly known to oxidize purines at 8-posi-
tion. Thus, Bradshaw and Baker showed that, while xanthine 
oxidase oxidized purine initially to hypoxanthine, purine 
is converted to 8-hydroxypurine by aldehyde oxidase (Brad-
shaw and Baker, 1960). Azathioprine is oxidized to 8-hy-
droxyazathioprine by aldehyde oxidase from rabbit and hu-
man liver (Chalmer et al., 1969). These findings led us 
· to the enzymatic synthesis of 8,8'-dioxo-6,6'-azopurine 
(DOAP) from 6,6'-azopurine disodium salt by rabbit liver· 
aldehyde oxidase. 
4 
Investigation of the interaction between rabbit liver · 
aldehyde oxidase and 6.6'-azopurine disodium salt showed 
that this compound is a very potent competitive inhibitor 
of this enzyme. 
CHAPTER II 
REVIEW OF THE RELATED L!TERATURE 
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I CHAPTER II 
REVIEW OF THE RELATED LITERATURE 
A. HISTORY OF THE DEVELOPMENT OF 
SYNTHETIC METHODS FOR PURINES 
Although Emil Fisc.her introduced the term "purine" in 
1898 (Fischer, E., 1898), the history of purine chemistry 
is 200 years old. It ~tarted when the pioneering chemists 
began characterizing the naturally occurring purines. Na-
ture contains a wide variety of purines and their deriva- . 
tives. Uric acid was the first purine to be recognized in 
~ · nature. It was discovered and obtained in a pure state 
J from gallstones by Scheele and Bergmann in 1776 (Scheele, 
c. w., 1776 and Bergmann, T., 1776). Liebig and Wohler 
~ 
carried out the pioneering studies on uric acid (Liebig, 
J., 18:34 and Wohler, F. and Liebig, J., 18)8a). Mitscher-
lich and Baeyer established its correct empirical formula 
(Mitscherlich, 18)4 and Baeyer, A., 1864). Various struc-
~- · tural formulae were proposed based on these results. The 
I 
structural formula of uric acid proposed by Fittig had two 
.5-membered rings with one carbonyl and two imidazole -NH . 
groups and these two rings were linked through a )-membered 
6 
... , 
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ring with · one carbonyl group (Fittig, 1877). Medicus pro-
posed a formula in which a 6-membered ring containing two 
carbonyl groups is attached through -C=C- to a 5-membered 
ring containing two imidazole. (-NH) groups and one carbonyl 
group; which is the currently accepted formula of uric acid 
(Medicus, · L., 1875). The final proof for the structure of 
uric acid was furnished by the' long · and ingenious work of 
Fischer in · l895· · Fischer and his school (Fischer, E., 1907) 
synthesized many of the purine bases and demonstrated the 
conversion of uric acid to a number of naturally occurring 
purines which included }tanthine (1,2,3,·6-tetrahydro-2,6-
dioxopurine), guanine (2-amino-1,6-dihydro-6-oxopurine), 
theophylline (1,3-dimethylxanthine), theobromide (3,7-di-
met}lylxanthine), .· and caffeine ( 1,3, 7-trimethylxanthine). 
Adenine and Guanine are the two important constituents 
of RNA . and DNA. Kosse! discovered and isolated adenine from 
beef pancreas by acid hydrolysis (Kosse!, A., 1885, 1886). 
He also converted adenine into hypoxanthine by treating ade-
nine with nitrous acid. Although' Medicus proposed the cor-
rect cyclic structure for hypoxanthine, the final chemical 
evidence for ·the structure of adenine was furnished by 
Fischer (Fischer, E., 1897). 
Guanine was found. in 1844 in the excreta (guano) of · 
birds (Unger, B., 1846). The cyclic . structure for guanine, 
8 
postulated by Medicus was accepted when it was shown that 
guanine can be converted by nitrous acid to xanthine and 
can also be oxidized to guanidine arid parabanic acid by the 
action of perchloric acid. 
Hypoxanthine was discoveredby Scherer in 1850 (Scher-
er, A., 1850). He found the presence of hypoxanthine in 
the spleen of many animals including human. He named it 
hypoxanth.ine because according to his analytical data, ·hy-
poxanthine contained one oxygen atom less than xanthine, 
and the name hypoxanthine indicated to him a substance in 
a lower oxidation state than xanthine. A comprehensive 
work on the structure of hypoxanthine was undertaken by 
Kruger in 1894 (Kruger, M., 1894). At this time Fischer' ·s 
work on -purines had already made important progress. Kru-
ger prepared several alkyl derivatives, the bromo deriva-
tives, and the oxidation products of hypoxanthine such as 
alloxan and urea. 
Marcet discovered xanthine in 1817 (Marcet, 1817). 
Wohler and Liebig identified the presence of xanthine in a 
surgically removed urinary stone (Wohler and Liebig, 18)8b). 
Scherer found the presence of xanthine in pancreas gland 
and showed that xanthine and hypoxanthine can be distin-
guished by their color reaction with potassium hydroxide in 
the presence of nitric acid. Xanthine gives a yellowish-red 
coloration which changes to purple on warming while hypo-
xanthine does not react (Scherer, 1859). Although correct 
formulae for the structures of xanthine and hypoxanthine 
were given by Medicus, Fischer developed the currently ac-
cepted structural formulae (Fischer, E., 1882). 
9 
Thus, Fischer's work laid the groundwork for the pu-
rine chemistry. Between the years 1882 and 1906, Fischer 
and his school published nearly fifty papers describing 150 
new purine derivatives. 
The synthetic routes devised by Fischer involved py-
rimidine precursors and hence were limited in scope. This 
limitation vanished when Traube devised versatile synthesis 
of a wide spectrum of purines (Traube, w., 1900). Follow-
ing this pioneering work, purine chemistry flourished and 
at the turn of the 19th century the literature is profilic 
with papers predominantly from the German Schools. 
In Traube's method of purine synthesis, a 4,5-diamino-
pyrimidine was condensed with a one carbon carboxylic acid 
such as formic acid; and the resulting 5-formamido deriva-
tive gave the purine when it was heated at 220°C. The first 
purine to be synthesized in _this manner was guanine which 
was formed directly by heating 2,4,5-triamino-6-hydroxy-
pyrimidine with formic acid at 220°C. 9-alkylpurines were 
also synthesized using this procedure. 2-hydroxy-6,9-di-
methylpurine was obtained by heating 5-amino-2-hydroxy~4-
methylamino-6-methylpyrimidine with formic acid (Johns, 
. 14 
1912a, 1912b). 8-C-adenine was also synthesized by this 
10 
route using 4-formylmorpholine as a solvent (Clark, · 1950). 
If a group capable of providing an alternative route 
of cyclization is present in ~he 6-position of the pyrim-
idine ring, then formic acid cannot be used in the synthe-
sis of purines as described above. For example, 4-amino-5-
forma.mido-6-mercaptopurine can cyclize to give either thi-. 
azolepyrimidine or 6-mercaptopurine according to the cycli-
zation conditions (Elion et al., 1956). ·Some substituted 
pyrimidines were also found to be unstable when treated 
with formic acid. For these reasons a substitute for for-
mic acid was sought for a long time. 
Purine nucleosides were synthesized using dithioformic 
acid . instead of formic acid ( Baddiley et al., ·194Ja). A-
queous sodium dithioforrnate or methanolic dithioformic acid 
reacts ·readily with 5-amino-4-alkylamino- or 5-a.mino-4-gly-
cosylaminopyrimidines to give the corresponding 5-thioforrn-
amido compounds which cyclize readily at their ·melting 
point or in the presence of a base such as hot pyridine or 
methanolic sodium methoxide to .give 9-substituted purines. 
Adenine, 2-methylthio-9-methyladenine were synthesized us-
ing this technique (Baddiley, Lythgoer, Todd, 194Jb). 
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Dithioformic acid does not provide complete cycli-
zation in certain cases. Use of formamide was introduced 
by Bendich and co-workers to synthesize purines unsubsti-
tuted at 8-posi tion ( Bendich et al. , 1948). Diaminopyrim-
idines also afford 8-unsubstituted purines when heated in 
' 
acetic anhydride with ethyl orthoformate, the N-acetyl de-
rivative initially formed being hydrolyzed by aqueous al-
kali (Montgomery et al., 1958a). A more unusual reagent, 
5-triazine, which reacts only with primary amino groups, 
is capable of converting 4,5-diaminopyrimidines to purines. 
Theophylline was obtained in this way in a 99 per cent yield 
(Grundenmann and Kreutzberger, 1955) .. 
Purines carrying a substituent in the 8-position were 
synthesized using carboxylic acids other than formic acid 
· to cyclize 4,5-diaminopyrimidines. ),8-dimethylxanthine 
and J-methylxanthine-8-carboxylic acid were synthesized by 
condensing the appropriate pyrimidine with acetic acid and 
oxalic acid, respectively (Traube, 192}). 1,),7,8-tetra-
m-ethylxanthine was prepared by boiling l,J-dimethyl-4, 5-di-
methylaminouracil with acetic anhydride ( Bredereek et al. , 
19 53). 
4,5-dihydroxypyrimidines were condensed with urea in 
the classical synthesis of uric acid, and Fischer in many 
of his synthesis condensed 5;..amino-4-hydroxypy!oimidines 
12 
with cyanate. Imidazoles have also been used to synthesize 
purines (Prasad and Robin, 1957). This type of synthesis 
received some attention since it was shown that 4-amino-
imidazole-5-carboxyamide accumulated in E. coli cultures 
inhibited by sulforamides (Shire et al., 1947). It is now 
known that the main biosynthetic route to purine is through 
imidazole derivatives. 
Other minor historical approaches to purine synthesis 
include those from acyclic precursors. Shaw prepared hypo-
xanthine by heating the substituted formamidomalo.namidine-
carboxyamide with forniamide (Shaw; 1950). · Taylor prepared 
2,8-dialkylpurines by the reaction of ortho esters in ace-
. 
tic anhydride or acetonitrile with aminomalonamidinecar-
boxyamide (Taylor, 1957). 6-aminopuri~es have been pre-
pared by converting silver salt of oximinomalonitrile into 
4,6-diamino-5-nitrosopyrimidines by means of amidines which, 
with formamide and formic acid in the presence of sodium 
hydrosulfite gives 6-aminopurines . (Vogl and Taylor, 1957). 
Purines have also been prep~red from imidazole precur-
sors. Workers in the field of nucleoside synthesis ap-
proached the synthesis of purine glycosides through this 
route. In alkaline potassium hypobromite solution at 0°C, 
4,5-dicarbamoylimidazole undergoes a Hofmann reaction from 
which xanthine is obtained in good yield (Baxter and Spring, 
13 
1944). · Thenucleoside, xanthosine, having the ribose moi-
ety in the furanose . form, was also obtained in the same way 
(Howard et· al., 1949). · Sarasin and Wegmann were the first 
to demonstrate a purine synthesis from an imidazole. They 
obtained 7-methylxanthine by heating 4-amino-5-carbamoyl-
1-methylimidazole with ethyl carbonate (Sarasin and Weg~ 
mann, 1924). Various agents like a mixture of formic acid 
and acetic acid, alkyl esters and trialkyl orthoesters, am-
ides, urea, isothiocyanates, chlorocarbonic esters, di-
ethyl carbonate, carbon disulphide, thiophosgenes, and thi-
oesters have been used for cyclization of imidazoles in the 
synthesis of various purine derivatives. 
B. BIOCHEMICAL EVALUATION OF PURINES 1 Il\'lPACT 
ON SYNTHETIC METHODS 
· The synthetic work has ·advanced mutually interdepend-
ant with the advances in the biochemistry of purines. This 
relationship between the chemistry and the biochemistry of 
purines started with the .pharmacological evaluation of N-
methylated purines especially with respect to their stimu-
lating and diuretic actions of N-methyla.ted purines. This 
study was then pursued by Scott and Chen and they showed 
that caffeine and theobromine stimulated the central nerv-
ous system, produced convulsions, and also stimulated the 
14 
respiratory system of mice. They .also showed that caffeine 
and theobromine inhibited weight gain of' young rats when 
fed for 2& days in O.J-0.5% of food, stimulated the motor 
activity of rats in spring-suspended cages, and had a diu-
retic ratio of 2.45 at the dosages of 0.·2 millimole/Kg body 
weight (Scott and Chen, 1944 and 1946). In another. study, 
testing of 40 xanthine derivatives revealed that these com-
pounds, at minimum effective dosages, reduced pulmonary ar-
terial pressure due to local vasodilatation, increased pul-
monary blood flow, increased force of myocardial contrac-
tion, and also produced aortic hypotension (Quimby et al., 
1958). 
The search for substances which can act as antagonists 
.for the constituents of nucleic acids started ·in the early 
fifties, and led naturally to the synthesis and study of a 
large number of purines. Studies on the specificity of the 
purine requirements of Lactobacillus casei were then under-
taken to investigate either the growth promotlng or the in-
. hibitory activities of various derivatives of purines. It 
was hoped that structural modifications of these compounds 
might lead to the discovery of new inhibitors of the growth-
promoting substances, or modify the activity of known an-
tagonists. The activity of 2,6-diaminopurine against leu-
kemia and sarcoma 180 in tissue cultures (Burchenal et S:l·• 
15 
1949 and Biesele et al., 1951) supported the view that such 
antagonists might be expected to be useful against neoplas-
tic diseases. 
Thus, 100 purines representing a variety of structural · 
changes of the physiological purine bases were tested for 
their effects on the growth of Lactobacillus casei ·in a va-
riety of media by Elion, Hitchings, and Vanderwerff (Elion 
et. al., 1951). In these studies, a diminution of the growth 
promoting or inhibitory activity of the parent compound 2,6-
diaminopurine resulted when certain structural changes, as 
the introduction of an 8-hydroxyl or 8-chloro group and 
methylation of the imidazole nucleu~ and alkylation of the 
amino groups were made. 
Many programs of purine synthesis were initiated to 
design antimetabolites capable of .interfering with .nucleic 
acid replication in malignant cells, as the role play.ed by 
nucleic acids in various cell functions became better under-
stood. This resulted in the synthesis and clinical appli-. 
cation of 6-mercaptopurine. It was synthesized by Elion and 
co-workers by treating hypoxanthine with phosphorous penta-
sulfide under specified conditions in 1952. The studies 
which began with the investigation Ofmercaptopyrimidines 
eventually led to the synthesis of 6-mercaptopurine. Thus, 
thiouracil and thiothymine were found to be competitive 
i6 
antagonists of uracil and thymine (Strardskov, 1945). 
Clinical trials of Burchenal and co-workers finally 
proved that 6-mercaptopurine produced good clinical and he-
matologic remission of .acute leukemia in children (Burchenal 
e t al. , 19 5J ) • 
This became the turning potnt in the history of purine 
chemistry; various compounds were synthesized in part be- · 
cause they bore a structural resemblance . to purines which 
had shown a particular biological effect. Thus, 6-methyl-
pur~ne was found to be extremely toxic to mice and rats by 
Philips and his co-workers ·(l954), so it was decided to pre-
pare 6..;trifluoromethylpurine. Well-known inhibitory activ- · 
ities shown by analogues of adenine as studied by Stock in 
1954, prompted the preparation of · 6-N-hydroxylaminopurine 
and azidopurine. 
Using the wealth of information available by then, at• 
tempts were made to synthesize specific biologically active 
purine derivatives; thus, purine-6-carboxaldehyde and the 
related derivatives were synthesized when they were shown 
to be the oxidation products of carcinolytic and extremely 
toxic 6-methylpurine (Giner-Sorolla et al., 1959 and Clarke 
etal., 1954). In 1954, Rutman, Cantarow, and Paschkis re-
ported an increased utilization of labeled uracil in primary 
induced rathepatoma as compared with normal liver. Similar 
~ 17 
observations ~eported with the transplanted Flexner-
Jobling carcinoma, and the mechanism of this effect was in-
vestigated by Heidelberger and co-workers in 1957· These 
studies suggested the synthesis of ablocking agent very 
closelyrelated to uracil. The profound alterations in bi-
ological effects brought about by fluorine substitution in 
various unrelated series of compounds such as the high tox-
icity of fluoroacetate, the amino acid-inhibiting proper-
ties of p-fluorophenylalanine, the increased biological 
potency of fluorinated steroids and fluorinated azo dye 
hepatocarcinogens, the nerve toxiqity of diisopropylfluoro-
phosphate, and related compounds suggested that the replace-
ment of a hydrogen atom by a fluorine atom in the pyrimidine 
ring would lead to an analogue of considerable potency. 
Thus, the activity of a series of fluorinated.pyrimidines 
was screened against several transplanted tumors. In these 
studies Heidelberger and co-workers found that 5-fluoropy-
rimidines and particularly 5-fluorouracil possessed marked 
tumor-inhibiting properties. The activity of 5-fluorouracil 
was found to be considerably greater than that of 6..;,mer-
captopurine on the Ehrlich ascites carcinoma, Novikoff hepa-
toma, and Ll210 leukemia (Heidelberger et al., 1958) •. In 
the continuing search of anticancer .agents, this finding 
prompted the synthesis· of 2-fluoropurines (Montgomery and 
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Hewson, 1960a) • 
One. aspect of the chemotherapeutic attack on malignant 
growth is the search for a means of interrupting the pro• 
duction of.certain nucleic acids which may be characteris-
tic for the tumor cell. The Watson-Crick hypothesis for . 
DNA postulated a twin helical structure · in which certain 
of the purine and pyrimidine bases in each helix are cross 
liriked by hydrogen bonds. · These bonds break momentarily at · 
the time of replication and it was suggested that one pos-
sible means of stopping further replication might be to use 
synthetic polymers for blocking the polynucleotide synthe-
sis on a template. Through this hypothesis emerged the 
synthesis of polypurines (Lister, 1960) .. Taylor, Barton, 
and Paudler (1961) synthesized 9-aminopurines, a class of 
purine derivatives potentially capable of transformation 
into interesting types of "pseudo" nucleosides, which was 
then followed by Montgomery and Temple (1960b) who obtained 
9-aminohypoxanthine ·and related compounds • . When Gierer and 
Mundry in 1958 showed that nitrous acid, when applied to 
nucleic acids, was a potent mutagen, Shapiro (1964) studied 
this reaction and isolated an interesting purine derivative, 
2.-ni tropurine. Hydrazinolysis of purine and pyrimidines 
was carried out by Hayes and Hayes-Baron (1967). 3-Hydroxy-
xanthine and 3-hydroxyguanine are carcinogens comparable in 
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potency to the oncogenic arylamines or ·hydrocarbons; but 
the isomeric 1-hydroxyxanthine induces inflammations and 
granulomas which rarely develop into tumors as was shown by 
Brown et al., in 1965, Teller et aL, in 1970, and Sugiura 
· et aL , in 1970. Thi$ distinct difference in the biolog-
--
ical responses prompted the synthesis of 7- and 9-isomers 
and thus Watson et aL (1972) obtained 9-hydroxy-8-methyl-
hypoxanthine, -xanthine, and -guanine~ 
The first attempt to diazotize a purine unit .at 8-po-
sition was that of Gomberg when in 190l .he reported the di-
azotization of ail amino group of 8-aminocaffeine . with ni-
trous acid yielding a very unstable substance which he 
called "diazocaffeine". This substance was obtained only 
in solution and was stable only at a low temperature (Gom-
berg, 1901). Woodhouse in 1950 devised a method for the 
colorimetric determination of adenine, in which he prepared 
a diazotized complex of adenine for the microderrnination of 
substituted purines in pure solutions and in hydrolyzates 
of nucleosides or .nucleic · acids; ·but the isolation and char-
acterization of the azo complex was not reported. In an-
other method of colorimetric determination of purines in 
biological fluids, the purines were reduced by zinc amalgam 
in dilute acid to a diazotizable amine, and was then diaz-
otized and coupled with N-(l..:naphthyl)-ethelenediamine to 
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give an intensely colored azo. dye (Loo and Michael, 1958). 
various purine derivatives including adenine, guanine, 
6-mercaptopurine, xanthine, and uric acid were successful-
ly diazotized and the formation of azo complexes was a-
chieved; but again, they were not isolated; nor were they 
characterized. 
Successful attempts for isolating and characterizing_ 
diazopurines were made by Jones and Robins when they iso-
lated a number of 8-diazopurines. Thus, they prepared 8-
diazoadenine, 8-diazo-6-hydroxy-2-methylaminopurine, 8-di-
azotheophylline, 8-diazohypoxanthine, 8-diazoxanthine, 8-
' 
diazoguanine, and numerous other compounds (Jones and Rob-
ins, 1960). Fel•dman (1962), condensed adenine and adeno-
sine through methylene linkage by treating them with form-
aldehyde. Alfred Giner-Sorolla, while synthesizing N-ox-
ides, first reported the formation of a purine dimer through 
an azo linkage (Giner-Sorolla, 1969 and 1970). In the light 
of this-history, the synthesis of-oxoazopurine dimers in our 
laboratory is quite novel. 
C. ANALYTICAL AND SPECTROSCOPIC STUDIES OF PURINES 
Numerous methods have been tried for the detection and 
quantitative analysis of _purines in different biological 
fluids. The early methods involved a preliminary separa-
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tion of uric acid by precipitation of its silver, magnesi-
_um, ammonium, cuprous or cupric · salts. These methods, how-
ever, lacked specificity, and the solubility of these salts 
.usually introduced large errors. The reduction of phos• 
photungst1c acid was introduced and the intensity of the · 
blue colored complex of uric acid with phosphotungstic acid 
was used as a quantitative measure of uric acid in urine 
and protein-free filtrates. Hutchings et al. (1947), de-
scribed a method for the estimation of folic acid by reduc-
tion with zinc in acid solution, diazotizing the resulting 
amine and coupling it with the reagent of Bratton .and Mar-
shall. When this reaction was applied to tissue extracts 
by Glazko and Wolf (1949), it was observed that the pres-
ence of adenine introduced an interfering color while var-
ious other purine and pyrimidines did not give any colored 
solutions. Woodhouse (19.50), took advantage of this ob-
servation and devised a colorimetric method for the detec-
tion and microdetermination of adenine. Differential -spec-
troscopy has been used by Kalckar (1947) to differentiate 
a number of purine compounds by changes in the ultraviolet 
absorption of these compounds resulting 'from actions of 
specific enzymes. A method developed by Davis (Davis and 
Morris, 1963) for the rapid colorimetric detennination of 
adenine compounds was an important advance since it was 
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specific, rapid, and could be used for determination of a 
number of adenine nucleosides and nucleotides without prior 
hydrolysis of these compounds. Cation-exchange chromatog-
raphy of purines was developed by Cohn (1949) and has been 
employed for the isolation and identification of various 
purines from human urine (Weissman et al., 1957; Wyngaarden 
et al., 1958; Ayvazian et al., 1965). However, this method 
---
required a preliminary purification involvingthe precipi-
tation of. purines as silver salts. Sweetman and Nyhan 
(1969) simplified this procedure and used their modifica-
tion for direct quantitation of different oxypurines in 
urine, serum, and cerebrospinal fluid. In addition, a 
method for the direct enzymatic determination of xanthine 
and hypoxanthine was developed by Jorgensen and Poulsen 
(1955). This method can be used for in vivo as well as 
in vitro studies of inhibition of xanthine oxidase. A com-
bination of two dimensional thin-layer high-voltage elec-
trophoresis and chromatography for the separation .of .uri-
nary purines, pyrimidines, and pyrazolopyrimidines was de-
vised by Simmonds (1969a), and was used to study the uri• 
nary excretion of these substances in patients treated with 
allopurinol or o.xipurinol (Simmonds, 1969b). This tech-
.nique was also used to investigate the purine and pyrimi-
dine excretion in psoriasis (Simmonds and Bowyer, 1974). 
2.3 
partition chromatography on paper was developed by Markham 
·and Smith (1949), which afforded the possibility of the 
separation ofmixture of purine and pyrimidine derivatives. 
in minute amounts. Once a reasonable separation is a-
chieved, the spots are cut out, extracted in a suitable 
solvent, and are estimated by ultraviolet spectroscopy. 
Filter paper chromatographic data in ten solvent systems 
were reported by Fink and Adams in 1966 for several classes 
of compounds, including amino acids, purines, pyrimidines, 
sugars, compounds reacting with p-dimethylaminobenzalde-
hyde, and ultraviolet absorbing or fluorescing compounds. 
The absorption spectra of purines are invaluable for 
identification when they are present in minute amounts. 
The usually, relatively simple spectra of purines.often 
c'omprise two main bands, e.g. purine itself absorbs just 
below 220 and 26.3 nm in neutral solution. Since the imid-
azole ring does not have characteristic ultraviolet light. 
absorption, the spectra of analogous purines and pyrimi-
dines show resemblance, for example the 2,6-disubstituted 
purines resemble the 2,6-disubstituted 4,5-diaminopyrimi-
dines (Cavalieri·et al., 1948). The position and intensity 
of the peaks is often affected by pH since many derivatives 
are amphoteric. The position of substitution also affects 
the spectrum, the order of increasing bathochromic shift 
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usually being .6 8 2 and of increasing hyperchromic effect 
2 6 8 for the longer wavelength band. 
J. M. Gulland and his collaborators were the first to 
use ultraviolet light absorption to elucidate the structure 
of purine derivatives. A comparison of the spectra of nat-
ural and synthetic derivatives of adenine, xarithine, iso-
guanine, and uric acid showed that the natural glycosides . 
· carried the carbohydrate moiety in the 9-position and ·sim-
ilar studies in the theophylline series indicated that the 
synthetic theophylline glycosides were substituted at posi-
tion 7 ( Gulland et al. • 1934). 
The spectra of purines are often markedly affected by· 
pH. The ionization constants and the order in which ioni-
zation occurs in polysubstituted · compounds . have been stud-
ied by spectroscopic methods by Cavalieri (1954), and Berg- . 
mann and Dikstein (1955). Ultraviolet spectra have also 
been used to determine structures of predominant tautomeric 
forms of hydroxy, mercapto, and aminopurines. For . example, 
Mason (1954) concluded that 2-, 6-, · and 8-amino-substituted 
purines exist predominantly in the amino- and not the imino 
forms. In the case of hydroxypurines, the evidence from 
b · ultraviolet spectra alone is sometimes ambiguous; for exam-
~.· 
ple •· 6-methoxypurine, hypoxanthine, and 1-methylhypoxan- . 
thine have similar ultraviolet absorption spectra, and as-
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signments of the predominance of the oxo as opposed to the 
hydroxy form rests on infrared spectral evidence (Mason, 
19 57). 
Emission (Fluorescence and Phosphorescence) spectra 
of purines are at longer wavelengths than the excitation 
(Ultraviolet, Visible, and Infrared) spectra. Purine ex-
hibits a low fluorescence intensity as a neutral molecule, 
but this increases markedly on either acidification or al-
kalinization (Borrensen, 1963). Appreciable fluorescence 
at room temperature can be observed for the cation of ade-
nine. Phosphorescence of purine is readily observed at low 
temperatures, and detailed emission spectra in glasses of 
appropriate composition to retain purine in solution at 
-196°C have been recorded by Drobnik and Augenstein (1966). 
Raman spectras of aqueous solutions of purines were 
studied by Malt in 1966, Lord and Thomas in 1967, and Lautie 
and Novak in 1968. 
Due to the low volatilities and low solubilities in 
nonpolar solvents, infrared spectroscopy has limited appli-
cation in purine chemistry. Even then, useful studies in 
this field have been carried out by studying the spectra 
of solids in the form of mulls or pastes in nujol or per-
fluorokerosene and as potassium bromide discs. 
The infrared spectrum of an organic compound is its 
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most characteristic physical property. The various bands 
in the spectra arise from the normal modes of vibration of 
a moleculer these modes being dependant upon the molecule's 
constituent atomic masses, the bond strengths, and the ge-
ometry of the molecule as a whole. The infrared spectra, 
therefore, has ·a distinctive character, especially in- the 
-1 
region below 1500 em The infrared spectra of adenine, 
guanine, xanthine, and hypoxanthine show some similarities 
near 1600 cm-1, but show distinctive differences in the 
region of 957 to 9.35 cm-1• Willits and co-workers (1955) 
have investigated the variability of purine spectra below 
1000 cm-1 and have also resolved into several components 
and a doublet near 800 -cm-1 • Friedlander and DiPietro 
(1962) have examined purine and a number of its derivatives 
in the region 800 to 650 cm-1 using potassium bromide disc · 
technique. Monosubstituted purines, adenine, and hypoxan-
thine show one absorption below this value, but purine it-
self doesn't absorb below 791 cm-1 . Guanine and xanthine, 
the disubstituted purines, on the other hand, show three 
distinct bands. These different spectral features can be 
used · to identify these compounds either separately or in a 
mixture. 
Montgomery and co-workers applied infrared spectros-
copy for structural identification of a number of deriva-
!. . • 
~ ~ . 
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tives of purine (Montgomery et al., 1956c, 1957, and · l958). 
Hydrazino derivatives give spectra similar to those of am-
ino purines. · Both show broad NH stretching · (NH) bands 
between 2900 and 2400 cm-1 , and the 1750 to 1500 cni-l re-
gion can be used in either case to differentiate .between 
2-monosubstituted, 6-monosubstituted, and 2,6-disubstituted 
purines (Montgomery and Holum, 1957). 
The nuture of the predominating tautomeric forms of 
oxo- and aminopurines has been the center of the long ar-
gued speculations in purine chemistry. It has been sug-
gested that 2- and 6-oxopurines exist in the keto form be-
cause of the absence of OH stretching bands (OH) near 
3400 cm-l in the solid state spectra; but it is very diffi-
cult to differentiate between (OH) and (NH) bands in 
the condensed phase spectra. Deuteration studies of solid 
.;.1 guanine in the 3300· em region support the oxo-amino struc-
ture for these compounds (Angell, 1961). 
In the initial attempts to correlate theoretical cal-
culations of charge densities and relatedphysical proper-
ties of the ring atoms with the order and position of the 
resonance peaks, magnetic resonance spectroscopy was used 
in the studies of purines. The three types of the magnetic .· 
resonance spectroscopy i.e., proton magnetic resonance (pmr 
o:r hmr), electron spin resonance (esr), and carbon-13 res-
..--
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onance spectroscopy have recently been used very extensive-
ly to elucidate the structures of various purines. 
Applications of nuclear magnetic resonance techniques 
to establish chemical structure of different purines began 
a decade ago (Jardetzky and Jardetzky, 1962), and signifi-
cant results were obtained -by a number of investigators 
such as Jardetzky (1960), Kokko et al. (1961), Gatlin (19-
62), Miles (1963), Katritzky (1963), Becker et al. (1965), 
Montgomery et al. · (1966), Chan et al. (1964), and Coburn 
et al. (1965). 
Freese's hypothesis (1959) that mutagenesis may result 
from mistaken base pairings in nucleic acidi due to the 
tautomeric behavior of various purines created a great deal 
of interest in the study of tautomerism and charge distri-
bution in purine derivatives and their nucleosides. Nucle-
ar magnetic resonance spectroscopy has been a very useful 
technique for these studies. The usefulness of this method, 
however, depends on the accuracy of the assignments of the 
peaks arising from the protons attached, to the purine nu!"' 
cleus. 2,6-Disubstituted purine derivatives such as xan-
thine and guanine do not present special problems in as-
signing the peaks, however, derivatives such as adenine and . 
hypoxanthine contain two ring protons situated in very sim- · 
ilar chemical environments and the attempts to assign the 
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peaks unequivocally have been unsuccessful. 
Proton magnetic resonance spectra of.purine shows three 
peaks (Matsuura and Groto, 1963; Schweizer et al., 1964; 
Bullock and Jardetzky, 1964), assigned to the three ring 
protons. 
H H 
~ 
:P-H 
N 
Purine 
Using isotope labeling and effect of substituents to dis-
·tinguish between the two peaks, Jardetzky and Jardetzky 
(1960) successfully made proton magnetic resonance assign-
ments for purine and some of its derivatives. In their 
studies, they observed that theeffect of substituting the 
ribofuranosyl group at N-9 in guanine (2-amino-6-hydroxy-
purine), and in xanthine (2,6~dihydroxypurine) was to shift 
the peak arising from the proton at C-8 down field by 0.3 6 
ppm in both cases. The effect of substituting the ribo-
furanosyl group at N-9 in hypoxanthine (6-hydroxypurine), 
and in adenine (6-aminopurine) was to.shift the high-field 
JO 
peak down-field by O.J p.p.m. These observations enabled 
them to assign the high-field peak in the spectra of hypo-
xanthine and of adenine to the proton at C-8 and the high-
field peak in the spectrum of adenosine to the proton at 
c.;2. In inosine, peaks arising from the protons at C-2 and 
c-8 are superimposed. In the spectrum of purine, since the 
calculations of the charge densities indicated that the 
charge densities at C-6 were greater than at C-8 (Mason, 
19 57), the high-field peak was assigned to C-6., the middle 
peak.to proton at C-8, and the low-field peak to proton at 
C-2. The following interesting facts were observed during 
these investigations. 
a. Unsubstituted purines have the least shielded pro-
tons while substituted purines.have the most shielded 
protons. 
b. The shielding is not proportional to the number 
of negative charges, due to the dissociated groups as seen 
by comparing the shifts in adenine and 2,6-diaminopurine, 
both of which have the imidazole proton dissociated, with 
the shifts in hypoxanthine which bears an additional neg-
ative charge due to the dissociation of the H-N-C=O group. 
c. There is no difference in shielding of the C-8 
proton by an oxy or an amino group. 
d. · Substitution of a dissociated oxy by an amino 
group in the sixth position results in unshielding of the 
C-8 proton by 0.1.3 ± 0.0.3 6 ppm. as indicated from the 
shift in guariine and 2,6-diaminopurine, as well as xan-
thine and isoguanine. 
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Coburn, Thorpe, Montgomery and Hewson (l965a& 1965b) 
correlated the proton magnetic resonance chemical shifts 
of substituted purines with their reactivity parameters. 
Their studiesof proton magnetic resonance spectra of 6-
substituted and 2,6-disubstituted purines in dimethyl sul-
foxide solution showed a linearcorrelation of the chem-
ical shift of the C-8 protonwith the reactivityparameter 
(Brown and Okamoto, 1958). 
The substitution of deuterium for a hydrogen is the 
most accurate method for making proton magnetic resonance 
assignments. Using this technique, Matsuura and Goto (196.3) · 
reported the first truly unequivocal assignment of the pro-
ton magnetic resonance spectrum of purine. They prepared 
purine-2-d by reduction of 2-chloro-4,5-diaminopyr-imidine . 
with deuterium followed by ring closure with formic acid. 
Purine-6-d was similarly prepared from 6-chloro-4,5-di- . 
;. t aminopyrimidine. The spectra of these two compounds were 
run in acidic, basic and neutral solutions of deuterium 
oxide. Studying these spectra Matsuura and Goto assigned 
the low-field peak to the c-6 proton, the middle peak to 
;:. ' •. 
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the C-2 proton, and the high .field peak to the C-8 proton. 
Specific base-pairing between purines and pyrimidines 
was studied by Shoup and co-workers by employing the NMR 
technique . (l966). They reported that the mixtures of sim-
ply substituted purines and pyrimidines in DMSO solution 
interact to form a base-paired complex and the specificity 
of pairing appeared to be similar · to that observed for 
polymer-polymer or monomer-monomer interactions in aqueous 
solutions. The purine and pyrimidine bases are paired 
through hydrogen bonding and it has been shown that hydro-
gen-bonding results in the shift of the proton signal · to 
down field (Pople, Schneider and Bernstein; 1959). Al-
though the organic solvents used (DMSO and DMF) were known 
to be hydr_ogen bond acceptors (Grams tad, 1963), the refer-
ence state was designated as the one in which purine and 
pyrimidine is bounded to solvent and further downfield 
shifts of the NH and NH2 protons upon mixture were observed. 
Fox (1965) made specific spectral assignments of the 
C-2 and . C-8 proton peaks in the nuclear magnetic resonance 
spectra o-f the . free bases and hydrochlorides of adenine, 
6-benzylamlnopurine, 1-benzyladenine, 3-benzyladenine, 7-
benzyladenine, 9-benzyladenine, 9-methyladenine, adenosine, 
6-dimethylaminopurine, hypoxanthine, · 6-chloropurine, and 
6-mercaptopurine and these were .confirmed by unequivocal 
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synthesis of the corresponding 8-g derivatives. 
Hruska and co-workers studied the effect of solvents 
on the NMR spectra of purines (1968). They studied the 
proton chemical shifts of purine, 6-methylpurine, and 9-
ribosylpurine at several concentrations in a series of sol-
vents and binary solvent mixtures with varying proton ac-
ceptor strength and dielectric constants. In an aqueous 
media large variations in the chemical shift of C-8 proton 
were observed, whereas the C-2 and C-6 protons were essen-
tially solvent independent. This shift was attributed to 
hydrogen bond .formed .between C-8 proton and the proton ac-
ceptor group of the solvent molecule. They also observed 
the largest deshielding for C-8 proton and largest shield-
ing for C-2 and C-6 protons; which was again attributed to 
the hydrogen bonding of C-8 proton and also to the base-
stacking interactions. 
Reddy, Mandell and Goldstein (1963), synthesized a 
number of N-acetyl derivatives of imidazoles, purines, and 
benzimidazoles and studied the nuclear magnetic resonance 
· spectra of these N-acetyl products in chloroform solution. 
They made several spectral assignments by comparing these 
spectra with those of the corresponding parent heterocyclic 
compounds. 
Assignments for the proton magnetic resonance spectra 
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of several purines and their nucleosides were made by ex-
changing a facile hydrogen for dauterium in the purine nu-
cleus (Bullock and Jardetzky, 1964). They achieved an un-
ambiguous synthesis of 6- and 8-deuteriopuririe. Jardetzky 
also studies the nucleotide interactions of purine and py-
rimidine derivatives using NMR spectroscopy (Jardetzky, 
1964). His findings indicated that the nitrogenous bases 
of nucleic acids and the_ majority of their derivatives tend 
to form vertical stacks in aqueous solution. The distribu-
tion of bases .was found .to be skewed toward the monomer or 
the smaller polymer. 
It is well known that aromatic character (ability to 
sustain aring current) (Davies, 1965) of a ring affects 
the shielding of ring protons. Thus, Baur and co-workers . 
(1965) observed that the chemical shifts (going upfield) 
for 4-pyrimidones and 4-pyrimidthiones appeared to be in 
the order of C-2 proton, C-6 proton and C-8 proton, but 
were somewhat upfield as compared ·to the pyrimidines. This 
was attributed to the greater degree of shielding of corre-
,-_  sponding protons in pyrimidones and thiones due to their 
~ 
i 
; -
! lesser aromatic character. 
Structures of nucleoside antibiotics like Formycin, 
Formycin B, and Laurusin were studied by Robbins and co-
workers (1966). 
; . 
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Tautomerism of purines and pyrimidines is of fundamen-
.tal biological importance: and has been implicated in the 
mutation (Watson and Creek, 1953; Freese, 1959). The ex-
istence of these bases in tautomeric forms, imine and lac-
tim, instead of the .usual amine and lactam ones, may lead 
to miscouplings of the bases and thus through the purturba-
tion of their sequence and the DNA axis, to a perturbation 
of t;he genetic code. The essential energetic.and electron-
ic aspects of such misc6upl~ngs were investigated by Pull-
man ( 1964) •. The discovery that the crystal of purine (Wat- · 
son, Sweet and Mars.h, 1965) involves long chains of mole-
cules, linked together by single hydrogenbonds aroused new 
interest in phenomenon of tautomerism of purines. Pullman 
also studied the electronic properties of the purines and 
suggested that a proton is·attached to N-7 of the imidazole 
ring of purine rather than to the N-9 ·(Pullman, 1969). 
Lichtenberg, Bergmann and Neiman investigated the phenome-
non of tautomerism · of purines by the NMR technique · ( 1971). 
They found that the chemical shifts of the C-8 protons in 
xanthinas with an unsubstituted imidazole ring and in 7-
methylxanthines were very similar; ·however, the C-8 proton 
signals for 9-methyl derivatives occur at higher field. 
From this observa.tion they concluded that the xanthines 
with an unsubstituted imidazole ring must be essentially 
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present as the N-7 proton tautomers. 
Specific assignments for N-H protons in the purine 
ring were not made until recently when Twanmoh, Wood, Jr., 
and Driscoll (1973) reported their work on purine deriva-
tives. Until then no systematic survey of N-H absorptions 
in purines was available. They observed the N-H absorp-
tions in various purine derivatives as broad signals at 
low field, usually between 10.7 - 14.2 6 ppm. The signals 
from some of the derivatives containing two N-H protons 
appeared as a singlet. These protons were characterized by 
the proper integral intensities and by deuterium oxide ex-
change experiments. 
During these studies it was observed that the moisture 
content of the solvent (DMSO-d6) .had a significant effect 
on the N-H absorptions. In 1,3-dimethylxanthine, the N7-H 
gave a signal at 13.5 6 with Ayl6 Hz in very dry solvent 
only. Two N-H signals at 10.8 6 and 11.4 6 were observed 
for 7-methylxanthine in molecular. sieve dried solvent, while 
only one signal w~s observed in undried DMSO-d6• During 
the investigation of .NMR spectra of a series of 5-azapu-
rines, it was also confirmed that all the N-H signals were 
seen only in carefully dried solvent (Hirata et g., 1972). 
From the studies designed to confirm the extent of water 
content of the solvent that would lead to the non-observa-
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tion of the N-H signals, it was concluded that as a general 
rule, when the moisture content of the DMSO-d6 sample solu-
tion reached 0.15%, one of the N-H signals could not be 
detected. The proton ·. exchange between the sample molecule 
and traces of water in the solvent is the major cause for 
non-observation of N-H signals. The N7-H was found to be 
more susceptible to the exchange and N1-H was the least 
liable (Twanmoh, 197J). 
The positive shielding effect of the neighboring car-
bonyl groups also has a significant effect on the N-H ab-
sorptions (Jackman, 1964). The N1-H signal of 9-methyl.;. 
xanthine is influenced by two adjacent carbonyl groups and 
hence is shifted in the higher field, while the N3-H is 
slightly affected by only one carbonyl group and hence is 
moved downfield. · Similar situation was observed for the 
methyl absorptions· frequencies in methyl xanthines by Lich-
tenberg and his co~workers (Lichtenberg et al., 197la). 
The imidazole ring also provides the deshielding ring cur-
rent of the 5-membered ring to N3-H which is one bond closer 
than N1 -H. 
A C=S group is ·more deshielding than a C=O group (Lich-
tenberg et al., 197lb; Baur et al., 1965). The N1-H signal 
of xanthine was observed at 10.8 6 but that of 2,6:..dithio-
xanthine was observed at 13•3 6. In 2-thioxanthine and 6-
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thioxanthine where N1 is flanked by one C=O and C=S group, 
the N1-H signal appeared at an intermediate position of 
12.00 6 in bo"t;h compounds. 
Thechemical shifts were also found to be dependent 
on the concentration of. the purine compound in DMSO-d6 • 
For purine and 6-mercaptopurine 10 Hz upfield shift was 
observed over a qoncentration range of 12% to 1% (Twanmoh, 
1973). Montgomery et al. (1966) also observed a .sizable 
shift of N-H signals when the concentration of the purine 
compounds was changed. 
· A change in the temperature also has a predominant 
effect on. N-H line broadening and has been investigated by 
Roberts (1956) and Twanmoh (1973). A study of a number of 
factors influencing proton chemical shifts of purine showed 
that, aside from different electron densities at the var-
ious pr6tons, the following perturbing effects are also 
expected to contribute to the proton shifts in purinea (a) 
the ring current effect associated with the mobileir-elec-
tron cloud; (b) the magnetic anisotropy of the hetero atoms 
in the aromatic rings; (c) solvent effects; and (d) solute-
solute interactions (Reddy et al., 1963 and Schweizer et" 
al., 1964). It has nowbeen shown that these are the main 
intrinsic properties of a molecule which are responsible 
for the main resonance peaks of purine. 
~ ,, . 
',;. ' 
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D. BIOLOGICAL APPLICATION OF 
NMR SPECTROSCOPY 
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Direct application of physicochemical methods to human 
pathology was the most significant step taken during the 
early seventies. Workers in the field of purine chemistry 
and nuclear magnetic resonance spectroscopy have developed 
nmr as a new tool in cancer research. Damadian and his 
co-workers have screened human tumors by nmr and came up 
with very important findings. During the initial inves-
tigation, using laboratory animals, it was found that mag-
netic relaxation parameters T1 and T2 (Spin-lattice Relax-
ation) were considerably altered in malignant tissues. For 
Novikoff's hepatoma, a malignant tumor of the liver, the T1 · · 
values were more than two and one half times greater than 
those for the normal liver (Damadian et aL, 1973). Thus, 
nmr spectroscopy has been extensively explored as a possi-
ble diagnostic tool in cancer research. This application 
enables more accurate and specific study of malignant tis-
sues on molecular level; reclassification of tumors accord-
ing to their chemical nature rather than morphologic ap-
pearance; and also early detection and on-line discrimina-
tion of biopsy materials within the operating room. 
The application of nuclear magnetic resonance to can-
cer research originated in the Ion Exchange Resin Theory of 
r .I · 
.. 
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biological structures (Damadian, 197la; Damadian, Goldsmith 
. and Zaner, 1971; Damadian, 197lb). Damadian and co-workers 
showed that biological selectivity varies with medium os-
motic strength and temperature indicating that intracellu-
lar hydration and endosolvent (intracellular water) struc-
ture are important determinants in selectivity. Using 
steady-state nuclear magnetic resonance they concluded that 
changes in the ionic composition of Escherichia coli cells 
are accompanied by changes in endosolvent structure. 
Using these concepts and nmr spectroscopy Damadian 
et al (1973) studied magnetic relaxation parameters T1 and 
.T2 of .malignant tissues from laboratory animals and human 
tumors. They found that considerable . alteration of the 
magnetic relaxation parameters, T1 and T2 accompanied the 
malignant transformation. These findings were confirmed 
by many other laboratories. Hollis et al (1973) found that 
·--
the magnetic relaxation parameters were longer for tumors 
and cultured tumor cells as compared with normal ttssues. 
Frey etal (1972) measured the magnetic relaxation param-
eters and showed that many nonmalignant tissues (spleen, 
kidney, . liver and heart) in mice with a tumor on the hind-
leg had significantly longer relaxation times than the cor-
.· responding tissues in heal thy mice. T1 values for animals 
with a recent (2 days) injection of tumor cells, or with. 
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Salmonella infections, were not significantly different 
from values for the healthy controls in any tissue tested. 
Measurements of T1 values of blood serum 'and liver homog-
enates, determined at various times after Ehrlich-Lettre 
ascites and dead .ascites cell inocculation of mice showed 
that the T1 of both blood serum and liver homogenate of 
animals inocculated with live or dead cancer cells found 
that cancer development is sufficient to induce T1 changes; . 
however, it is not necessarily· the only condition that will 
\ 
"- induce these modifications; thus emphasizing the .need for 
"' ~ : . . 
~- . 
more work to implement an understanding of conditions that 
induce changes in T1 (Floyd et al., 1974 ). Inch et al. 
(1974) found that large, slow-growing tumors interfere with 
induction of longer T1 values. They also found that fetal 
and regenerating liver had longer T1 values than normal· 
liver. 
Phosphorus-13 and Potassium-39 are also being explored 
as the nuclear probe for malignant tissues (Zaner and Da-
madian, . 197 5). 
E. . ALDEHYDE OXIDASE 
The presence of aldehyde oxidase in the liver was pos-
i . tulated by Lemberg et aL , 19)6. Gorden, Green, and Subrah-
manyan confirmed this postulation and isolated partially 
r . . ~· 
~~· . 
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purified aldehyde oxidase in 1940. Mahler and co-workers 
further purified .it and reported the presence of non-heme 
iron and molybdenum as well as flavin adenine dinucleotide 
(Mahler et al. , 19.54) • 
Through the ingenious work .of Rajagopalan ·this en-
zyme has been systematically characterized as the aldehyd.e 
. 
oxidase (aldehydea02 oxidoreductase, EC 1.2.3.1). 
It was shown that each mole of rabbit liver aldehyde 
· oxidase contains 2 moles of FAD, approximately 2 moles of 
. coenzyme Q10 , 8 atoms of non-heme iron, and 2 atoms of mo-
lybdenum (Rajagopalan, 1962). He also 'established that 
the enzymes call~d "the quinine oxidase" (Knox, 1946), . "a . 
form. of xanthine oxidase" ( Igo and Mackler, 1960), "purine 
oxidase" (Chalmers et al., 1969), "methotrexate oxidase" 
(Johns et al., 1965), and aldehyde oxidase are the same 
protein. Purified rabbit liver aldehyde oxidase reduces 
oxygen, ferricyanide, 2,6-dichlorophenolindophenol, meth-
ylene blue~ phenazine methosulfate, ·. silicomolybdate, and 
cytochrome c with either aldehydes or N1 -methylnicotinamide 
+ as substrate. NAD does not serve as an electron acceptor 
either aerobically or anaerobically. 
The markedly different effects of several inhibitors 
on the reduction of various electron acceptors shows the 
existence of multiple sites of action on this enzym~. Thus, 
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reduction of 2,6-dichlorophenolindophenol is sensitive only 
to cyanide and mercuribenzoate, while amytal inhibits re-
duction of all acceptors other than 2,6-dichlorophenoiindo-
, 
phenol. Antimycin A and ascosin inhibit reduction of tri-
nitrobenzenesulfonic acid, nitro blue tetrazolium, oxygen, 
and cytochrome c; but are without effect on other activ-
ities. From these observations Rajagopalan postulated four 
different sites of action corresponding to the four differ-
ent carriers; the flavin, iron, molybdenum, and the co-
enzyme Q10 (Rajagopalan and Handler, 1964a). 
Presence of a quaternary nitrogen greatly facilitates 
the rate of oxidation of heterocyclic .substrates. The prod-
uct of ox~dation of N1-methylnicotinamide by aldehyde oxi-
dase is N1-methyl-2~pyridone-5-carboxamide. The absorption 
spectrum of a standard sample of N-methyl-2-quinolon.e was 
identical to that of the enzymatic oxidation product of N-
methylquinolinium, indicating that the site of attack by 
the enzyme is the carbon atom alpha to the ring nitrogen. 
Hypoxanthine is oxidized by aldehyde oxidase to xan-
thine but 7-methylhypoxanthine is a better substrate than 
hypoxanthine, and is oxidized to 7-methylxanthine. Purine 
itself is readily oxidized to 8-hydroxypurine (Rajagopalan, 
1964b). While 6-methylmercaptopurine is oxidized to 8-
hydroxy-6-methylmercaptopurine by liver aldehyde oxidase 
44 
(Loo _g1 al., 1967) and azathioprine is also oxidized to 8-
hydroxyazathioprine (Chalmers et aL, 1969). Thus purines 
are oxidized predominantly at the C-8 position. The func-
tional arrangement at the enzymatic binding site, and the 
manner in which this interacts with substrate, determines 
the ultimate product of enzymic purine oxidation. 
Rajagopalan has also postulated that both aldehyde ox-
idase and xanthine oxidase can be regarded as· hydroxy lases. 
Therefore, the mechanism of action of these enzymes can be 
viewed as the simultaneous removal of a hydride ion from 
.· the carbon atom, to be oxidized with replacement by a hy-
droxyl ion from the medium. These enzymes facilitate such 
an attack by providing a group which could serve as a Lewis 
acid. Thus, the quaternary nitrogen adjacent to the carbon 
atom which is attacked, becomes a strongly positive nitro-
gen and withdraws electrons from the adjacent carbon atom, 
thereby facilitating attack by a hydroxyl ion with depar-
ture of a hydride ion as shown on the following page. 
, 
Me = a group on aldehyde oxidase 
acting as a Lewis acid. 
Molybdenum atom at the functionaL site of the enzyme 
has been assigned the role of the Lewis acid. 
Aldehyde oxidase and xanthine oxidase are inactivated 
by methanol, and this inactivation is retarded by excess 
substrate and ·competitive inhibitors. These observations 
suggest that methanol exerts its effect at the substrate-
binding site. Nitrat~ reductase, a molybdenum containing 
enzyme is also inhibited by methanol. Thus, the inactivation 
of all these three molybdenum-containing enzymes by metha-
nol suggests that the molibdenum component may be the 
site of meth8nol action. Another observation which 
gives strength to the above hypothesis is that methanol~metal 
complexes have been reported to be formed during non-enzy-
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rna tic oxidation-reduction reactions (Fraser et aL, 19 59) • 
. The non-heme Fe3+ ions, even though Lewis acids, do not 
participate in ·this oxidation-reduction reaction because 
they are the components of the electron transport sequence 
of these enzymes which are far from the active site. · Elec-
tron paramagnetic spectrometric studies have indicated that 
the molybdenum, .Mo6+ is reduced to the Mo5+ in the presence 
of the substrate (Handler et al., 1964). This hypothesis 
was finally confirmed in 1968 when the electronparamagnet-
ic resonance data proved the intramolecular passage of elec-
trons from substrate via molybdenum to flavin and iron com-
plex. These studies showed that at equilibrium; the .molyb-
denum .cornponent was found to be reduced at least. as fast as, 
or faster than; the other carriers (Rajagopalan et al., 
1968a and 1968b). Similar studies on xanthine oxidase have 
also established that the molybdenum centers of xanthine 
oxidase are the sites where the active hydroxylation of sub-
strate is accomplished. Xanthine ·oxidase activity is abol-
ished following the production of molybdenum def'iciency · in 
rats by feeding tungsten (Johnson et al., 1974). 
Aldehyde oxidase have also been detected in potato 
juices and was found to transfer hydrogen to several redox 
dyes including 2,6-dichlorophenolindophenol (Bach, 1913). 
Two isoenz.yrnes of aldehyde .oxidase ·have been isolated by 
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Rothe from potato tubers . (solanum tuberosum). They are 
similar to the enzyme from rabbit liver in their pH optima 
and electron acceptors. The difference between these en-
zymes from two sources is that the enzymes from.potato tu-
ber cannot use ferricyanide and 2,6-d"ichlorophenolindo-
phenol as an electron acceptor; nor can they oxidize quinine 
alkaloids, but oxidize aliphatic aldehydes preferentially 
(Rothe, 1974). 
The presence of. the coenzyme Q10 in aldehyde oxidase 
has been debated. Rajagopalan (1962), Weidenbach and 
Folkers (1971), and Weidenbach (1973) have shown the pres-
ence of the coenzyme Q10 , while Felsted et al. (1973) 
could not detect the .coenzyme Q10 in hog or rabbit liver 
, 
preparations, and Romeo and co-workers showed its absence 
in rabbit liver preparation (Romeo et al., 1974). 
Johns Isolated aldehyde oxidase from human liver. 
This enzyme differed from the rabbi~ liver aldehyde oxidase . 
with respect to the aerobic hydroxylation of phenazine .· 
metbosulfate and N1-methylnicotinamide chloride. The aer-
obic hydroxylation of these two .substances is inhibited 
only by agents with affinity for the substrate-bindingsite 
such as cyanide and N-alkylphenothiazines, and not by the 
agents which inhibit the "internal electron transport chain'i 
of the enzyme such as- menadione and diethylstilbestrol. 
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The inhibition ofoxidation was affected by charged and un-
. I 
charged substrates (Johns, 1967). 
Methotrexate and its dialkyl and dichloro derivatives 
have been shown to be very potent substrates for aldehyde 
oxidase with ·Km values significantly below 0.01 nM (Johns 
et aL , 1973) • 
Oral ingestion of the immunosuppressive agent aza- · 
thioprine is followed by rapid urinary excretion of 6-thio-
uric acid (Chalmers et aL , 1969) , which is also the main 
urinary metabolite of azathioprine in a number of mammalian 
species (Elion, Callahan, Bieber, Hitchings and Rundles, 
1961). It has also been noted that 6-methylmercaptopurine 
was oxidized to 8-hydroxy-6-methylmercaptopurirte by liver 
aldehyde oxidase ( Loo et al. , 1967). These observations 
suggested that azathioprine could be metabolized in vivo 
through a pathway involving aldehyde oxidase sine~ aza-
thioprine is also a 6-S-substituted derivative of 6-mer-
. captopurine and, therefore, a potential substrate for the 
enzyme. The successive steps of 8-hydroxylation and thiol-
ysis would convert azathioprine into 8-hydroxy-6-mercapto- . 
purine which is known to be readily oxidized to 6-thiouric 
acid by xanthine oxidase (Bergmann and Ungar, 196o). 
Chalmers and his co-workers proposed a pathway .for the 
metabolism of azathioprine, L e. , azathioprine __. 8-hy-
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droxyazathioprine ~ 8-hydroxy-6-mercaptopurine ~ 6-
thiouric acid (Chalmers et al. , 1969). This pathway by-
passes 6-mercaptopurine. This alternative pathway of aza- · 
thioprine degradation is of potential physiological sig-
nificance. Inhibitors of aldehyde oxidase and xanthine 
oxidase, either endogenous or therapeutically administered, 
may change the patterns of conversion of azathioprine into 
active and inactive metabolites, This becomes a signifi-
cant factor for development of treatment schedules that 
will give the most favorable balance between therapeutic 
effect and drug toxicity. 
Tsukada and co-workers postulated that aldehyde oxi-
dase oxidizes formycin B to oxoformycin B (Tsukada et al., 
1969). .The conclusive evidence for this postulation was 
offered by Sheen and co-workers. Their studies demonstrated 
.that hepatic aldehyde oxidase oxidizes formycirt B, an in-
osine analogue, to oxoformycin B, a xanthosine analogue 
(Sheen . et al. , 1970). These findings . were very interesting 
since formycins A and B closely resemble the natural nucle-
os.ides, adenosine and inosine, in their ability to interact 
with various enzymes of nucleoside metabolism (Sheen et al., 
1968; Ward et al., , 1969; Henderson et al., 1967), However, 
inosine nor adenosine inhibited enzyme aldehyde oxidase nor 
did they interact with xanthine oxidase. Sheen's studies 
~· · · 
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showed that formycin B, a structural analogue of inosine, 
is an excellent substrate for liver aldehyde oxidase, and 
both formycins A and Bare competitive inhibitors of milk 
xanthine oxidase. These observations cannot be attributed 
wholly to the stereochemical differences between these mol~ 
ecules and a more satisfying explanation of these discrep-
ancies is still being sought. 
One of the physiological roles attributed to aldehyde 
oxidase is the oxidation of N1-inethylnicotinamide. The 
products of oxidation absorb light at 290 nm and this prin-
ciple is used for the assay of aldehyde oxidase. There are 
two products of the oxidation of N1-methylnicotinamide cat-
alyzed by aldehyde oxidase, N1-methyl-4-pyridone-J-car-
boxamide (4-pyrido~e) and N1-methyl-2-pyridone-5-carbox-
amide ( 2-pyridone), Huff ~ al. ( 1967); and Felsted et al. 
(1967). A second physiological role has also been ascribed 
to aldehyde oxidase, namely, the oxidation of pyridoxal to 
4-pyridoxic acid (Shwartz and Kjeldgaard, 1951). 
Pyridoxic acid has long been recognized as the prin-
ciple excretory product of vitamin B6 in man (Huff and Pelz-
weig, 1944; Rabinowitz and Snell, 1949; Reddy et al., 1958). 
These contentions were conclusively proven by Stanulovic 
and Chaykin and it was established that aldehyde oxidase is 
the physiological catalyst of pyridoxal oxidation in vivo 
(Stanulovic and Chaykin, 1971a and 197lb). 
F. ALDEHYDE OXIDASE AND XANTHINE OXIDASEa 
A COMPARISON 
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The possibility of having a common origin and the met-
abolic functions of aldehyde oxidase and xanthine oxidase 
. 
is a continuing conundrum. The similarity in the proper-
ties of the two enzymes rather than their differences are 
most striking. A common evolutionary origin for both of 
the enzymes has been speculated. Another fascinating con-
cept .of this hypothesis is that, aldehyde oxidase is viewed 
as the enzyme in transition (Stanulovic, 197lb). Both en-
zymes show preference for the substituted pyrimidines and 
purines. Significant differences among the specificities 
were the effects of the number and position of the ring 
substituents. While only xanthine oxidase rapidly o·xidizes 
C-disubstituted derivatives of different heterocycles, both 
enzymes oxidized a variety of unsubstituted .and C-monosub- · 
stituted heterocycles. N-substitution in many cases dra-
matically increased the substrate activity with aldehyde 
oxidase ( Kreni tsky et al. , 1972). 
In general, both enzymes are capable of hydroxylating · 
substituted pyrimidines and purines which might be endog-
enously produced or ingested from exogenous sources by the 
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organism. Mammals have a DPNH-dependent aldehyde oxidase 
.which has a nuch higher affinity for aldehydes than does 
aldehyde oxidase (Maxwell et al. , 1961; Deitrich et al. , 
1962), therefore, the oxidation of aldehydes cannot be .the 
principle physiological function of these enzymes. 
Unlike xanthine oxidase, aldehyde oxidase did not use 
NAD+ as an electron acceptor (Krenitsky, 197J). Another 
noticeable difference is that aldehyde oxidase converts 
vanillin to vanillic acid while xanthine oxidase do.es not 
( Wurzinger and Hart ens te in, 1974) • 
Xanthine oxidase and aldehyde oxidase were found in 
higher concentrations in mammalian liver and small intes-
tine. The levels of aldehyde oxidase in guinea pigs and 
rabbits were found to be higher than those in mice, rats, 
cats, dogs, monkeys and humans. Aldehyde oxidase is .also 
found in many non-mammalian vertebrates (Hartenstein, . l97J 
and Lakshmanan et al., 1964), and in the primitive inver-
tebrates like molluscs, arthropods and · crustacea (Wurzinger 
and Hartenstein, 1974). 
In the studies of phylogenic · relationship between al-
dehyde oxidase, xanthine oxidase, xanthine dehydrogenase 
and peroxidase using 79 animal species, Wurzinger .and Hart-
E:mstein concluded that aldehyde oxidase and xanthine oxi- · 
dase was not measurable in phylogenitically primitive spe-
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cies. They showed that the ·order of phylogenetic primitiv-
ity is aldehyde oxidase~ xanthine dehydrogenase ~ 
xanthine oxidase. · 
Aldehyde oxidase thus appears rather widely distrib-
uted in the animal kingdom, which suggests that the primary 
metabolic function of aldehyde oxidase is of a fundamental 
nature rather than a highly specialized one. 
CHAPTER III 
MATERIALS AND METHODS 
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CHAPTER III 
MATERIALS AND METHODS 
A. SYNTHESIS OF 
8,8'-DIOX0-6,6'-AZOPURINE (DOAP) 
A 6.0 mg/ml solution ofadenine was prepared employing 
a special technique described below; the low solubility of 
adenine in 1 N H2so4 made. it necessary to design this tech-
nique. 15.00 g of adenine, obtained from Aldrich Chemical 
Company, was weighed out in a weighing boat, and small por-
tions were added to a glass homogenizer tube containing 
10.0 ml of l N H2so4. It was homogenized with a teflon 
pestle six times up and down. This suspension was then 
poured into a large glass reaction vessel containing l li- · 
ter of l N H2so4 which was constantly being stirred with a 
magnetic stirrer. . In this way, the 15.00 g of adenine was 
dissolved into a total of 2.5 liters of l N H2so4. This so-
lution was then filtered through Whatman No I J filter paper .• 
To this filtrate, 120 ml of a 15 mg/ml solution of KBr in 
distilled H20 was added. The mixture was then stirred with 
a magnetic stirrer for l hr. The solution remained clear 
and colorless after l hr; 800 ml of l N KMno4 was then 
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added, and the reaction mixture was a brownish-purple sus-
pension. After 1 hr of stirring, a total of 50 ml of .30% 
H2o2 was added, ·slowly, in 10 ml portions, with stirring .. · 
The reaction mixture gradually decolorized, resulting in a 
bright orange precipitate. It was then stirred for 1 hr at 
room temperature, and was allowed to stand in the dark for 
16 hr at 4°C. The r:esulting orange precipitate of DOAP was · 
collected by centrifugation at 600 x g for 15 min, · employ-
ing four 150-ml capacity glass centrifuge bottles. The 
DOAP solid present in each of the four centrifuge bottles 
was successively washed 12 tim.es with 1.50 ml portions of 4 
N H2so4 . and collected by c-entrifugation · at 600 x g for 15 
min until no absorbancy at .327 nm could be detected in the 
decanted acid wash. · This was followed by six successive 
washes with 150 ml portions of distilled H2o. During these 
washes it was necessary to centrifuge at 600 x g for 1 hr 
or longer because of the microcrystalline nature of DOAP. 
The DOAP microcrystalline precipitate in each bottle was 
then washed with .four 1.50 ml portions of C!,cetone and col-
lected by centrifugation at 600 x g for 1 hr. The final 
washed DOAP solid was combined from all four centrifuge . 
bottles as an acetone suspension, allowed to evaporate to 
dryness on a large watch glass at room temperature, and 
then placed in a drying oven at atmospheric pressure for 
'. f. 
c: · .• 
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15 hr at 75°C. The dried bright orange microcrystalline 
product was then transferred into a clean dry glass vial, 
placed in a brown plastic container, and stored in a vacuum 
dessicator (Chart 1). 
B. SYNTHESIS OF 
8,8'~DIOX0-6,6'-HYDRAZOPURINE (DOHP) 
To an Erlenmeyer flask containing 10 ml of 1 N HCl, 
1.5 g of DOAP and J.O g of solid SnC12.2H20 were added and 
the flask was heated in a water bath at 70°C for 20 min, 
using an air condensor. The resulting yellow solution was · 
diluted with equal volume of distilled H20 (final normality 
of HCl 0.5 N), was allowed to stand at room temperature for 
3 hr, and in an icebath of 16 hr. The yellow-green pre-
cipitate observed after 16 hr was collected by centrifuga;.. 
tion at 600 x g for 10 min, washed twice with 10 ml 6f 0.5 
N HCl, and distilled H2o. It was then crystallized from 
700 ml of 0.5 N HCl, heated at 70°C in a water bath for 20 
min, and recrystallized by repeating thesame procedure. 
The ye.llow-green crystals obtained after recrystallization 
were washed six times with 150 ml of distilled H2o to re-
move any acid; the acid-free crystals were washed six times 
with 150 ml portions of acetone to remove water, trans-
ferred to a clean watch glass with a few mls of acetone, 
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allowed to ·evaporate to dryness, and finally dried in a 
drying oven at . 75°G for 16 hr to -obtain tan-yellow crystals 
(Chart 1), 
G. SYNTHESIS OF 
8,8'-DIOX0-6,6'-AZOXYPURINE (NaDOAXP) 
Method a (fom DOHP)a 0.60 g of DOHP were dissolved in 
125 ml of 0.5 N NaOH by homogenization usinga teflon pes-
tle, and air was bubbled through it for 2 hr. The brick 
red product was allowed to precipitate slowly over 16 hr by 
letting it sit . in an icebath at 4°C, and was then collected 
by centrifugation at 600 x g for 10 min. It was washed 
three times ·each with 200 ml portions .of 90% EtOH, absolute 
EtOH, and acetone, in that order; it was transfe-rred to a 
clean watch glass with a few mls of acetone, allowed_ to air 
d4y to complete dryness, dried in a drying oven at 50°G for 
1 hr, and then in a dessicator until cons~ant weight was 
reached. 
Method b (from DOAP)a 0.1 g of DOAP was ·dissolved by 
taking small portions each time and homogenizing -in 10 ml 
portions of 0.005 N NaOH, requiring a total of 125 ml of 
0.005 N NaoH to get a red solution. It was then filtered 
through Whatman qualitative filter paper to remove the few 
particles from it, and the clear red solution was placed in 
' 
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an icebath at 4°C for 60 hr which resulted in a cherry red 
precipitate. The precipitate was collected by centr~fuga­
tion at 600 x g for 10 min. It was washed with 200 ml por-
tions of 90% EtOH, absolute EtOH, and acetone. The precip-
itate was then transferred to a clean watch glass with a 
few ml of acetone, allowed to evaporate to dryness and fi-
nally dried in a drying oven at 50°G for 1 hr, and then in 
a dessicator until constant weight was .obtained. 
D. ELEMENTAL ANALYSES 
All the elemental analyses were carried out by Schwarz-
kopf Microanalytical Laboratories, Woodside, New .York. The 
·analyses were carried out under two different conditions for 
each compound in order to detennine the number of moles of . 
water of hydration for each compound. The samples were an-
a!yzed as they were received, without any prior drying. 
The values obtained from this analysis gave the percentages 
of all the elements present in the sample. The samples 
were then dried at ·1oo0c under a stream of nitrogen for 1 
hr to remove all of the water associated with .the molecule 
and were again analyzed for the elements they contained. 
Subsequent drying of the samples for 1 hr at ·150 and 200°C 
did not result in any further change in the analyses. Em-
. 
pirical formulae from these two analyses were obtained, and 
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~ · [;: the number of moles of water of hydration were obtained by 
f . . · 
.· subtracting the empirical fonnula of the dried (anhydrous) . 
compound from that of the non-dried (hydrous) compound. 
The water of hydration was also determined directly 
by measuring the sample weight loss and the vaporized wa-
ter absorbed in magnesium perchlorate and the increase in 
weight of thedrying agent. 
E. UV, IR, AND NMR SPECTRAL STUDIES 
A Beckman DB-G recording spectrophotometer was used 
to obtain the uv spectra of all the compounds. To deter-
mine the ultraviolet abso;rption characteristics and to cal.;. 
culate the molar extinction coefficients, a pre-weighed 
sample of a compound was dissolved in appropriate solvent 
by homogenization in a glass tube with a teflon pestle. A 
J .·00 ml sample of the solution was then placed in a silica 
cuvette with 1.0 em pathlength, and read against an appro-
.priate blank. The concentrations of the solutions were so 
adjusted that the optical densities would be between O.J 
and 0.9 because of the higher sensitivity of the spectro-
photo~eter in this region. 
A similar procedurewas used to investigate the sta-
bilities and absorption characteristic of the compounds 
utilized for various experimental purposes. To study the 
r . 
. ·; ' 
.. I 
. 
. 
~· 
I
t ·· 
.. 
·' 
f
·.·. 
' :·" 
.. 
( 
r· 
\ · 
't .. 
61 
biochemical and pharmacological properties of 8,8'-dioxo-
6,6'-azop~rine (DOAP) and a structurally similar compound, 
6,6'-azopurine disodium salt, abbreviated as NaAP, the 
effect of pH on the stability of these compounds in 0.05 M 
potassium phosphate buffer -at room temperature was inves-
tigated. 6,6'-Azopurine disodium salt (NaAP) was obtained 
as a generous gift from Dr. Alfred Giner-Sorolla of the 
Sloan-Kettering Institute for Cancer Re.search, New York, 
New York. Potassium phosphate buffer solutions (0.05 M) 
of .pH 6.2, 6.6, 7.0, 7.4, 7.8 and 8.2 were prepared. 2.85 
ml of the buffer at the desired pH was placed iri a silica 
.. 
cuvette and 150 Jll of 500 pg/ml solution of DOAP in 0.005 · 
N NaOH was added to obtain a final concentration . of 8.0 x 
. 
10-5M; this solution was scanned vs J.O ml buffer of the 
same pH. Similar scans were obtained at all the pHs~ From 
' 
these scans it was inferred that a change in O.D. at 455 nm 
can be used to monitor the stability of DOAP in 0. ·o 5 M po-
tassium phosphate buffer at these pHs. ·· 
Thus, in another series of experiments, 2.8.5 ml of 
0.05 M potassium phosphate at the desired pH was placed in 
I a silica cuvette and 150 Jll of 500 llg/ml solution of DOAP · 
in 0.00.5 N NaOH was monitored for 60 min using a chart 
speed of 0.1 inch/min. Thus, in these two sets of experi-
ments, it was confirmed that DOAP solutions in Oi05 M po-
~· 
3 
~ · 
~ -
tassium phosphate buffer were stable up to 3.0 minutes at 
.· pH 7.4 and 7.8. The solution at pH 8.2 was stable up to 
10 min. 
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Sini.ilar .sets of experiments were performed using NaAP 
and it was confirmed that NaAP solutions in 0.05 M potas-
sium phosphate were stable up to 3.0 minutes at pH 7.0. 
The solutions at pH 7.0, 7.4, 7.8, and 8.2 were stable up 
to .10 min. 
The infrared spect~a were obtained on a Beckman Accu-
lab 1 grating infrared spectrophotometer. 
ardized to be within 15 crn-l between 4000 
It was stand-
and 2ooo cm-1 , 
-1 -1 and 8 em between 2000 and 600 em • The recorded -spectra 
of the commercially available . standard compounds such· as 
adenine, isoguanine sulfate, 2,8-dioxoadenine, xanthi'ne, 
hypoxanthine, and uric acid were in good agreement w~th 
their reported spectra. The spectral assignments were made 
by using several standard compilations such as the Aldrich . 
Infrared collection, Katritzky (1963 and 1971), and the 
catalog of Infrared Spectrograms by Sadtler Research 
Laboratories. 
The nmr spectra were determined in DMSO-d6 solvent at 
60 MHz with a Varian A-60A spectrophotometer. Tetrameth-
ylsilane (TrJIS) was used as an internal standard; .and the 
chemical shift values are expressed in 6ppm relative to 
the . TMS reference. All of the compounds were dissolved to 
a concentration of approximately 20 mg/ml by homogenizing 
in DMSO-d6 using a teflon pestle and a glass tube. The 
spectra were run at the probe temperature • . The NH protons 
were identified by n2o-exchange. · 
During this investigation it was observed that the · 
moisture content of the DMSO-d6 solvent was a very critical 
factor influencing particularly labile protons like the N-H 
protons. In order to detect the N-H protons, the solvent 
had to be free from moisture. A fresh bottle of DMSO-d6 , 
obtained from Bio-Rad .Laboratories, Richmond, California, 
was used each time in order to eliminate the picking up of 
moisture; its moisture content was determined by scanning 
the DMSO-d6 · alone. Only the solvent containing a minimum 
amount of moisture was used to dissolve the compound~ 
investigated. 
Thedeuterium oxide used in the n2o-exchange studies 
was 99.87%mole n2o and was also obtained from Bio.:.Rad Lab-
oratories. 25 ~1 of the n2o was added to the nmr tube con-, 
taining the solution of a compound, shaken well and scanned • 
. F. PAPER CHROMATOGRAPHY 
After investigating a number of solvent systems, four 
of the following were found to be excellent for the paper 
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chromatography of oxoazopurines. They arec 
1. abs. EtOHs Pyridines Distilled water 
67s 20 13 
2. n-Propanola Cone. NH40Ha Distilled water 
60a 30 10 
3· n-Butanola Glacial acetic acid a Dist.illed water 
80a 20 20 
4. abs. EtOHa 0.5 M Ammonium acetate 
5• 2 
500-600 ml of each solvent system were placed in a 
· tightly closed tall glass jar and the system was allowecl 
to equilibriate at room temperature for 2 hr. The compounds 
were dissolved in appropriate solvents and were spotted so 
that the final concentration of each spot would be 4 IJ.g. 
Whatman chromatographic paper grade 1 was cut into strips 
of 8" x 173/8" and the compounds were spotted on a base 
line drawn 2" from the bottom of the strip. The solvent · 
was then allowed to run for 16-20 hr. The chromatograms 
were dried at room temperature and then in an oven at .60°C 
for 10 min. The spots were marked visually and also under 
262 nm and 360 nm ultraviolet lamps. 
G. COLUMN CHROMATOGRAPHIC SEPARATION OF PRODUCTS 
FORMED DURING THE SYNTHESIS OF DOAP 
The synthesis of DOAP was carried out as described in 
Section A. The resulting reaction mixture was centrifuged 
at 600 x g for 15 min and a clear yellow supernatant was 
obtained. The supernatant was adjusted to ·0.5N H2so4 by 
adding equal volume of distilled H2o to a final volume of 
6)6 ml. 
AG 50W-X8 (H+ form), 200-400 mesh cation exchange res-
in, purchased from Bio-Rad Laboratories, Richmond, Califor- .· 
nia, was used for the column chromatography. This resin 
was regenerated by taking the following stepsa 
L In a brown bottle, 1 lb of the resin was stirred 
2. 
with 5 liters of distilled H2o, allowed to sit for 
20 min and then decanted. This was repeated a 
second time. 
The resin was then stirred with 1 liter of 5 N 
HCl, mixed for 2 hr and decantedr this was re-
peated once. 
J, Next the resin was washed with 5 liters of dis.;. 
tilled H2o, allowed to sit for 20 min decanted 
and repeated 4 times to neutrality. 
4. It was then stirred with 5 liters of 1 N NaOH, al-
lowed to sit for 20 min and decanted. 
5· The resin was then washed with 5 liters of dis• 
tilled H2o, allowed to sit for 20 min decanted 
and repeated 4 times to neutrality. 
66 
6. It was next stirred with 5 liters of 1 N HCl, al-
lowed to sit for 20 min, and decanted. 
7• Next, the resin was washed with 5 liters of dis-
tilled H2o, allowed to sit for 20 min, decanted 
. and repeated to neutrality. 
8. Subsequently, it was stirred with 5 liters of 1 
N NaOH, allowed to sit for 20 min and decanted. 
9. The resin was then washed with 5 liters of dis-
tilled H2o, allowed to sit for 20 min, decanted 
and repeated to neutrality. 
10. It was next stirred with 5 liters of 1 N HCl, al-
lowed to sit for 20 min, and then decanted. 
11. Finally the resin was washed with 5 liters of ~is­
tilled H2o, allowed to sit for 20 min, decanted 
and repeated to neutrality. 
The resin is stored in a brown bottle filled with dis-
tilled H2o. The resin was washed twice with distilled H2o 
prior to use on the day the resin was used. 
The column was fitted with a glass wool plug at one 
end and was filled with distilled H2o 'to 1/J of its length •. 
A slurry of the resin in distilled H20 was then poured into 
the column and .5 psi of air pressure was applied. By re-
peating this procedure the column was filled with resin. 
The resin in the 'coluinn was kept submerged under distilled 
H20 so that air would not get into the resin. The column 
then washed by passing 400 ml distilled .H2o through it 
using 
.5 psi air pressure. 636 tnl of the sample was then 
applied to the column and .640 ml of neutral eluent was col-
lected in 2.5 ml portions. 
The column was washed again by passing distilled H2o 
through it until the O.D. · at 260, 280, 30.5, 330 and 420 nm 
was zero. The column was then connected to a gradient of 
HCl with a reservoir containing 4,500 ml of .5 N HCl and a 
mixing chamber containing 1000 ml of distilled H2o. The 
flow rate was adjusted by changing the air pressure to 2 
psi which eluted 6.0 ml/tube/min; or .5 drops/l0.5 · sec. 
Thus 810 tubes were collected and the O.D. at 260, 280, 
30.5, 330 and 420 nm were recorded using a Beckman DB-G 
spectrophotometer. 
A graphical plot of O.D. vs eluted fraction showed the · 
presence of 10 different products in the reaction mixture. 
The peak tubes were pooled together and were flash evapo-
rated at .50°C for 30 min. The solid product obtained after 
flash evaporation was transferred into a ·test tube with .5 
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rnl of distilled H20; and was washed with 10-ml portions of 
distilled H20 for 6 times, followed by 10-ml portions of 
acetone for 4 times. It was then air dried and the dried 
solid was stored in a dessicator. 
The products were identified by comparing their uv and 
ir absorptions with those of the authentic compounds. Hy-
poxanthine and adenine were found to be the major products 
in the final reaction mixture. The other seven compounds 
are yet to be identified. 
H. COLUMN CHROMATOGRAPHY OF OXOPURINES 
For column chromatography, uric acid xanthine, hypo-
xanthine, and adenine were obtained from Sigma Chemical 
Co., St. Louis, Missouri. 2-Hydroxyadenine and 2,8-dihy-
droxyadenine were purchased from Aldrich Chemical co., Mil-
waukee, Wisconsin. 8-Hydroxyadenine sulfate was a generous 
gift from Dr. Bernard Regan of Baxter Laboratories, Morton 
Grove, Illinois. 
The cation exchange resin used was AG 50W-X8 (H+ form), 
200-400 mesh, purchased from Bio-Rad Laboratories, Rich-
mond, California. One pound of resin was washed by suspen-
sion, settling, and decanting with two volumes of the fol-
lowing solutions, using 5 liters of each for every washing• 
···.; 
~:: 
·\ ' .. 
~: . . 
distilled water, 5 N HCl; distilled water, 1 N NaOH; dis-
tilled water, 1 N HCl; distilled water, 1 N NaOH; distilled 
water, 1 N HCl; distilled water. The resin was washed be·-
tween each acid and alkali wash until the pH of wash water 
is the same as that of distilled water. Resin generated 
this way ·can be stored in a brown bottle. On the day of 
its use, it was washed twice with distilled water (the pro-
cedure is described in detail in Section G). 
The resin was packed as a distilled water suspension 
in a 40 X 0~9 em pyrex glass column with 5 psi air pressure 
with a glass wool plug at the bottom and 50 ml of 0.5 N HCl 
was passed through it. The . sample was applied using 2 psi 
air pressure. A~ter application of the sample, 1 ml of dis-
tilled water was passed through the column and was then con-
nected to gradient system having a reservoir containing 2000 
ml of 5 N HCl . and a mixing chamber with 500 ml of distilled 
water. The running pressure was adjusted to give a con-
. stant flow rate of 1 tube containing 3 ml of eluent per 5 
·min (0.6 psi); this was also equal to 2 drops dripping from 
the column per 9.5;..10 sec. A total of 350 tubes were col-
lected on an automatic fraction collector. Optical densi-
., 
ties of these tubes were read at 208, 215, 250, 260, 280, 
and 305 nrn, using a Beckman DB_.G recording spectrophotometer. 
I. REDUCTION OF 
8,8'-DIOX0-6,6'-AZOPURINE (DOAP) WITH 
SODIUM HYDROSULFITE 
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2.5.0 mg of 8,8'-dioxo-6,6'-azopurine were dissolved in 
:1.50 m1 of 1 N NaOH by homogenizing it with a teflon pestle, 
which resulted in a dark red solution. It was heated at 
6)°C for 1.5 min and 1. o gm of sodium hydrosulfi te (Na2s2o4 ) 
wap added while stirring the solution with a magnetic stir-
rer. The original dark red solution turned yellow upon ad-
dition of sodium hydrosulfite. This clear yellow solution 
was then refluxed in a water bath at 80°C for 1 hr, and 
cooled to room temperature. A 4 ml aliquot of the clear -
yellow solution was neutralized to pH 7.0 with 1 N HCl, ad-
justed to equivalent of 0 • .5 N HCl, and was then applied to 
a 21.0 X 0.9 cmcolumn of AG .50W-X8 200-400 mesh resin in 
H+ f . 2. . • • orm, usJ.ng . ps1 aJ.r pressure. The column was then 
eluted with a gradient of HCl equipped with a reservoir 
containing 2000 ml of .5 N HCl and a mixing chamber contain-
ing 500 ml of distilled water. The running pressure was 
adjusted to 0.6 psi which gave a constant flow rate of 0.6 
ml/min. Fractions of J ml were collected every 5 min for a 
total effluent volume of 1050 ml. The optical density of 
each tube was determined at 208, 215, 2.50, 260, 280, and 
~ . 
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)05 nm, using a Beckman DB-G spectrophotometer. The uv 
characteristics of tubes · l23-1JO exactly matched those of 
an authentic sample of 8-hydroxyadenine sulfate. The .ef-
fluent from these tubes was collected and ·dried in a 25ml 
tube placing it in a water bath at 40°C and passing gaseous 
. nitrogen through it to obtain a yellow solid. Uv spectral 
characteristics of the yellow solid exactly matched those 
of the authentic 8-hydroxyadenine sulfate in 1 N HCl, .l N 
NaOH and dimethylsulfoxide • . 
J. STUDIES OF THE IN VIVO INHIBITION OF XANTHINE 
OXIDASE AND THE METABOLISM OF DOAP 
A previous report .from this laboratory has shown that 
DOAP is an extremely potent inhibitor of bovine milk xan• 
thine oxidase in vitro (Davis, et al., 1974). This finding 
·was confirmed in vivo by studying the urinary excretion of 
xanthine, hypoxanthine. uric acid, and creatinine in male 
. Sprague-Dawley rats between the ages of 63 and 110 days, 
weighing 23.5 to .380 gm, injected subcutaneouslywith a sin-
gle dose of 25 mg/kg body weight of DOAP dissolved in 0.01 
N NaOH, behind the nape of the neck. The rats were placed 
in Holdge Metabolic Cages. The collected urine was used 
for determination of xarithine, · hypoxanthine, uric acid and 
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creatinine. Attempts were also made to isolate the prod-
ucts of the metabolic degradation of DOAP. 
a. Collection of Rat Urine 
A rat was placed in a Holdge Metabolic Cage, fed 
mushed Purina Lab Chow (a thick paste of ground Purina Lab 
Chow obtained by mixing it with a small amount of water), 
and given tap water to drink. The outlet for urine and 
feces was plugged with a glass wool to separate the urine 
from feces and food particles. The urine would then flow 
through the spout into a funnel and then into a test tube 
placed on an automatic fraction collector. The lower con-
ical part of the Ho1dge Metabolic Cage was cleaned thor-
oughly every 2 hr to eliminate prolonged contact of the 
urine with the feces. 
The automatic fraction collector was set to change the 
tube every 2 hr; thus, the urine for the desired period was 
collected in 2-hr fractions. One drop of 5 N HCl was then 
added to each tube to change the pH of the urine to 2.0. 
This was necessary to precipitate the dissolved DOAP in the 
urine. The amount of 5 N HCl thus added to all tubes . was 
recorded and then subtracted from the final volume of ·all 
the tubes to obtain the true volume of the.urine collected. 
After adding the drop of , 5 N HCl, each tube . was centrifuged 
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at 600 x g for 10 min. The urine collected after the sub-
cutaneous injection of DOAP gave an orange precipitate and 
a clear yellow supernatant. 
The orange precipitate was then analyzed for the a-
mount of DOAP and the clear yellow supernatant . was analyzed 
for xanthine, hypoxanthine, uric acid, and creatinine and 
also any possible metabolites of DOAP. 
b. Analysis of DOAP Excreted in Rat Urine After a 
Single Subcutaneous Injection. 
The orange precipitate obtained as described above was 
washed 3 times with distilled H2o. The uv scans of these 
water washes did not show presence of any uv light absorb-
ing materiaL Then the .washed orange precipitate was dis-
solved in 3.00 ml of 0.1 N KOH. There was no insoluble ma-
terial left in the tubes after dissolving the orange pre-
cipitate in 0.1 N KOH. The O.D. of this solution was then 
read at 513 nm and the amount of DOAP calculated from a · 
calibration curve. The calibration curve was prepared by 
measuring the o.n. at 513 nm of 2.5, 5.0, 10.0, 15.0, 20.0, 
and 22.0 IJ.g/ml solutions DOAP in 0.1 N KOH. 
c. Determination of Xanthine and Hypoxanthine in Rat 
Urine. 
Xanthine and hypoxanthine were determined by using a 
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modification of the method of Jorgensen and Poulsen (1955). 
In this method, pre-existing uric acid in rat urine is de-
stroyed by uricase; xanthine and hypoxanthine are then con-
verted to uric acid by the action of xanthine oxidase. 
This newly formed uric acid is then destroyed by uricase 
and the change ,in o.D. at 292 nm, which is proportional to 
the amount of uric acid degraded is measured. Uricase is a 
highly specific enzyme for· uric acid and even methyl deriv-
atives are not attacked by this enzyme. Therefore, this 
·method is very sensitive and accurate when compared with 
other methods. The procedure and the reagents added to two 
silica cuvettes marked "blank" and "test" ares 
1. 500 ~1 of urine 
2. 1500 ~1 of M/15 (0.066 M) glycine buffer, pH 9.30 
J, Measure pH: 9.25 
4. 25 ~1 of uricase 
5· Incubate at room temperature for 1 hr 
6. 200 ~1 of 1.5 N NaOH (pH after adding NaOH = 11.60) 
7• Wait 15 min at room temperature 
8. 200 ~1 of 1.6 N HC1 
· 9. JOO ~1 of 0.6 M glycylg1ycine buffer, pH 8.20 
10. Measure pH = 8.25 
11. 25 ~1 of xanthine oxidase ( 25 ~1 of dist H2o. to 
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blank) 
12. Incubate at room temperature for 1 hr 
lJ. 200 ~1 of 0.6 N NaOH 
14. 500 ~1 of 0.7 M glycine buffer, pH 9.4 
15. Read O.D. at 292 m~ vs blank 
16. 25 ~1 of uricase (25 ~1 dist H2o to blank) 
17. Incubate at room temperature for 1 hr 
18, Read O.D. at 292 m~ vs blank 
Jlg/ml of uric acid due to xanthine and hypoxanthine in 
·rat urine is calculated by Praetorius' and :Poulsen's 
formula asa 
- ~A292nm m+b !J.g/ml of. Uric Acid X -
- 0.0745 m 
Where, · 
~A292run is the difference of O.D. s before and af-
ter adding uricase in step 16. 
0.0745 is the decrease iri extinction when 1 ~g of 
uric acid is destroyed by uricase. 
m + b = total vol. of the contents of the cuvette. 
m = vol. of urine present in the cuvette. 
The urine used i:t:J. step 1 was the clear yellow superna-
tant of the collected urine sample as described in Section 
K (a) ·. Glycine, glycylglycine, bovine milk xanthine oxi-
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dase containing 6;9 units/ml, and uricase 0,4 units/ml were 
. obtained from Sigma Chemical Co., St. Louis, Missouri. 
1/15.M (o.o66 M) glycine buffer was prepared by dissolving 
2.5033 gm of solid glycine in 200 ml of triple distilled 
water. To this solution 12.0 ml .of 1 N NaOH were added to 
obtain a pH of 9.)0 and the whole solution was diluted to a 
final volume of 500 ml by triple distilled water. 0.6 M 
Glycylglycine buffer, pH 8.2 was prepared by dissolving 
7.9260 gm of glycylglycine into 10.0 ml of ' 1 N NaOH and was 
diluted to 75 ml with triple distilled water. The pH of 
this soiution was then adjusted to 8.2 by adding 19.0 ml of 
!,, 1 N NaOH and was again diluted to a final volume of 100 ml 
with tr~ple distilled water. The solution was filtered 
through double Whatman filter paper. The final pH was 8.20. 
d. Determination of Uric Acid in Rat Urine. 
A combination of the procedures described by Blauch 
and Koch ( 19)9); Henry et al. ( 1957), and Sigma Technical 
Bulletin No. 680 (Sigma, 1972) was used to determine the a .. 
mount of uric acid in rat urine. Uric acid has maximum ab-
sorption at 292 nm, and, when degraded by the enzyme uri-
case, the change in O.D. at 292 nm is proportional to the 
amount of uric acid degraded. A calibration curve is pre-
pared by measuring the change in o.n. at 292 nm produced by 
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degrading 5, 10, 20, 30, 40, and 50 ~g of uric acid by uri-
case. The prodecure used is outlined in the following . 
stepss 
1. Take 1.0 ml of the clear yellow supernatant of the 
collected urine as described in Section K (a); and 
.· add 9. 0 ml of distilled H2o to it 
2. Take 0.5 ml of this diluted urine 
3· 
4. 
Add 1.0 ml of 0.7 M glycine 
Add 5·7 ml of distilled H20 
solution for preparing the 
also during the assays was 
buffer, pH 9.40 
(final volume of 
calibration curve 
7.20 ml) 
this 
and 
5· Take 3.0 ml of this solution and read O.D. at 292 
nm vs 3.0 ml of distilled H2o 
6. Add 10 ~1 of Uricase (Sigma, 0.4 units/ml) 
7. Read o.n. at 292 nm after 15,· 30, 45, 60, 120, and 
240 min. The O.D. did not change after 30 min, 
indicating that the reac.tion was completed within 
30 min 
Exactly the same procedure was followed for the preparation 
of the calibration curve. 
Inherent absorption of Uricase 
To find the inherent absorption of uricase, 10 ~1 of 
the enzyme were added to 3.0 ml of 0.7 M glycine buffer, pH 
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9.4, and the O.D. at 292 nm was measured. It was found to 
.be o.oo, indicating that the enzyme uricase did not have 
any inherent absorption under the experimental conditions. 
The amount of uric acid in the urine was calculated 
using the following formula. The change in O.D. at 292 ·nm, 
as measured in · step 7, was used to obtain the concentration 
of uric acid in ~g/ml . of the diluted ur.lne from the cali-
bration curve. It was multiplied by the dilutionfactor 10 
which gave ~g of uric acid in urine. 
~g/ml of Uric Acid in diluted urine obtained .from cal-
ibration curve X dilution factor (10) = ~g of uric 
acid/ml of urine 
~g of uric acid/ml X 100 = mg% of uric acid. 
e. Determination of Creatinine in the Rat Urine. 
A spectrophotometric adaptation of the methods and 
modifications of Folin and Wu (1919), Hoffman (1941), Pe-
ters . (1942) and Phillips (1946) was used .to determine the 
amount of.creatinine in rat urine. Creatinine in a pro-
tein-fr~e .filtrate was treated with picric acid in alkaline 
solution to produce a deep red complex of creatinine pic-
rate. The procedure is outlined as followss 
1. Take 1.0 ml of clear yellow supernatant of the 
collected urine as described in Section K (a) and 
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add 9.0 ml of distilled H2o 
2. Take 1.0 ml of this diluted urine and place it in 
a 50-ml Erlenmyer flask containing 8.0 ml of 1/12 
N (0,083 N) H2so4 , mixing -by rotation 
3. Add L 0 ml of 10% sodium tungstate, drop by drop, 
while gently but constantly rotating the flask. 
A turbid solution is .obtained 
4. Centrifuge this solution at 600 x g for . lO min 
5· Take 5.0 ml of the supernatant in a test tube and 
5.0 ml of distilled H2o 'in another test tube 
marked "blank" 
6. Add 2.5 ml of freshly prepared alkaline picrate 
reagent and mix 
7. Incubate in a waterbath at 25°C for 1 hr 
8. Measure O.D. vs the blank at 520 nm 
Preparation of alkaline picrate reagent 
One percent Picric acid solution was prepared as fol-
lows a 12. 00 gm of picric acid ( J. T. Baker Chemical Co,. , 
Phillipsburg, New York) were dissolved in 200 ml of dis-
tilled water and diluted to 1000 ml. 20.0 ml of this solu-
tion was titrated against 0.1 N NaOH using phenolphthalein 
as an indicator. It required 8.65 ml of 0.1 N NaOH. (20.00 
ml of the picric acid solution in distilled water should 
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require 8.61 to 8.81 ml of 0.1 N NaOH. If it did not re-
quire this amount of titrant, the concentration of picric 
acid was adjusted accordingly and retitrated.) This solu-
tion was stored in a brown bottle. 
5.0 ml of 1.0% picric acid was added to an Erlenmyer 
flask containing 2.5 ml of 2.5 N NaOH. The contents were 
mixed by gentle but constant rotation of the flask and the 
solution was diluted to 25 ml with distilled H2o. This so-
lution was prepared f~esh every time andwas used within 5 
min after its preparation. 
A calibration curve was prepared by using 10, 20, .30, 
40, 60, 80, and 100 flg of creatinine from a stock solution 
and following the procedure outlined above. The stock so-
lution of creatinine (1.0 mg/ml) was prepared by dissolving 
160.24 mg of creatinine zinc chloride, (c4H7N3o) 2.zncl2, in 
100 ml of 0.1 N HCl. 
f. Metabolites of DOAP. 
A single subcutaneous injection of 25 mg/kg of DOAP, 
dissolved in 0.01 N NaOH was given to an adult male rat. 
The urine was collected over a period of 24 hr, and the ex-
cretion DOAP was precipitated by adding a few drops of 5 N 
HCl. The urine was then centrifuged at 600 x g/10 min and 
the clear yellow supernatant obtained by c.entrifuging the 
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collected urine was analyzed using column chromatography. 
A sample of 2. 0 ml .of the clear yellow supernatant was ap-
plied to a cation exchange colUmn as described in Section 
G. The flow rate was J ml/15 min. The eluent showed the 
presence of a compound having absorption character,tstics 
similar to those of DOHP. 
Presence of DOHP, which is a hydrazo derivative of 
DOAP, in the urine of a rat, injected with DOAP, which is 
an azo compound, indicates that the liver azoreductase sys-
tem plays a major role in metabolizing DOAP. 
K. ISOLATION AND PURIFICATION OF ALDEHYDE 
OXIDASE FROM RABBIT LIVER 
Aldehyde oxidase was isolated. from the livers of young 
adult male New Zealand rabbits. Two rabbits weighing .3.2 
and }.4 Kg were sacrificed by decapitation. The livers 
were removed, washed twice with distilled H2o, dried by 
blotting over paper towels and weighed • . 240 gm oflivers 
were then chopped into smaller pieces and were divided into 
4 equal portions, each weighing 60 grn. Each portion was 
then homogenized in .300 ml of distilled H2o (la5, WaY) in a 
Waring blender at room temperature for .3 min. The final 
volume oi' the total homogenate was 1450 ml. 
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This homogenate was then rapidly heated with continu• 
ous stirring to 70°C in a boiling water bath and was al-
lowed to remain at 70°C for 2 mi.n. The homogenate was then 
rapidly cooled to 55°C by adding ice to the water bath. It 
was transferred to a beaker kept in an ice bath and was 
cooled to 12°C; stirring occasionally. The homogenate was 
· then centrifuged at 8000 rpm (6.500 x g) for 20 min in are-
frigerated centrifuge at 4°c. The sediment was discarded 
and the supernatant was filtered through glass wool and a 
total of 117.5 ml of the supernatant was stored in a cold 
room at 4°C overnight. All the steps from this stage on 
were performed in a cold room at 4°C. 
The nextmorning, the supernatant was brought to a .50% 
saturation of (NH4)so4 by adding 313 gm . of solid ammonium 
sulfate per liter of the supernatant. A total of 367.78 gm 
of solid ammonium sulfate were added, slowly, with continu-
ous stirring, to 117.5 ml of the supernatant to obtain the 
50% saturation of ammonium sulfate. The supernatant was 
then stirred very slowly with a mechanical stirrer for 1 
hr. The light-brown precipitate obtained after 1 hr was 
collected by centrifugation at 8000 rpm for 20 min in a re-
frigerated centrifuge at 4°c. 
The precipitate was then ·dissolved in 15.0 ml of 0.05 
M potassium phosphate, pH 7.8, containing 0.005% EDTA. The 
8J 
pH of this solution dropped below 7.8, hence, was adjusted 
adding a few drops of 1 N NaOH very slowly while the so-
lution was stirred continuously. Thus, the final solution 
of pH 7.8 was then diluted to 20.0 ml by adding the buffer. 
This solution was then dialyzed overnight against 3750 ml 
of distilled H2o containing 0.005% EDTA at 4°C. The cellu-
lose dialysis bags were obtained from Sigma Chemical Co., 
st. Louis, Missouri, and were boiled in L 0 mM EDTA solu-
tion for 15 min prior to their use. The volume of the di-
alyzate was found to increase from 20 ml before dialysis to 
J2.J ml after dialysis. This solution was used as the 
source of alde.hyde oxidase in all the experiments. 
L. DETERMINATION OF PROTEIN 
IN THE RABBIT LIVER HOMOGENATE 
The protein content of the rabbit liver homogenate, 
used as a source of aldehyde oxidase, was determined by 
using the spectroscopic method of Waddell (1956). · The pep-
tide bonds of a protein absorb at the shorter wavelengths 
than the aromatic amino acids which usually absorb at 280 
nm; the presence of nucleic acids interferes the measure-
ment of proteins by a method based on the absorption at 
280 nm. 
Waddell's method is based on the measurement of the 
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difference of absorption between 215 run and 225 run by pro-
teins. The use of the difference rather than the absorp-
tion at a single wavelength minimizes the error introduced 
.. by non-protein constituents of the sample. At 215 nm the 
protein solutions conform closely to Beer's Law as long as 
the absorption is less than 2.0. Another advantage of this 
method is that the absorption of protein in this spectral 
region is practically independent of pH over the range of 
4 to 8; hence it is unnecessary to use a buffer as diluent. 
The accuracy of this method was checked by measuring a pro~ 
tein concentration Of a solution of human serum albumin in 
our laboratory. 
The dialyzed rabbit liver homogenate was diluted la250, 
la500, 1&1000 and la 2000 by a 9.0 gm/liter solution of 
NaCl in distilled H2o (0.154 M). Optical densities of 
these solutions was measured at 215 and 225 nm. The O.D. 
at 215 run was subtracted from that at 225 nm. This differ-
ence, multiplied by 144, gave the protein concentration in 
diluted solutions expressed in micrograms per milliliter. 
The concentration of protein in the stock solution is ob ... 
· talned by multiplying with the dilution fac:tor i.e. 250, 
500, 1000, or 2000. 
A o. D. x 144 = ~g/ml of protein in the diluted solution 
6. 0 ~D. x 144 x dilution ·factor = llg/ml of protein in 
original solution 
. The factor 14l~ is the ratio of Jlg/ml of protein and the 
difference in O.D. at 215 and 225 nm. 
Jlg/ml of protein in the diluted solution 
144 = -------------------------------------b.O.D. 
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It was calculated from a series of solutions of known pro- . 
tein concentration • 
. M. ASSAYS OF ALDEHYDE OXIDASE IN 
RABBIT LIVER HOMOGENATES 
Aldehyde . oxidase activity of the rabbit liver homog ... 
enate was assayed . using N1~methylnicotinamide chloride, 
also called 1-methylnicotinamide chloride, as the sub-
strate; this compound should not be confused with the N'-
methylnicotinamide, the difference being that N1-methyl-
nicotinamide or 1-methylnicotinamide has the methyl group 
on the N1 quaternary ring nitrogen, while the N'-methyl-
methylnicotinamide has the methyl group on a tertiary ni-
trogen in the side chain. Menadione was used as an inhib-
itor of the N1-methylnicotinamide oxidase activity (al-
dehyde oxidase activity). N1-methylnicotinamidechloride 
and menadione sodium bisulfite salt were purchased from 
Sigma Chemical Co., St. Louis, Missouri. 
A modification of the spectrophotometric methods of 
'·.· ,.. 
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Rajagopalan ( 1964) arid Sheen et al. ( 1970) was used to as-
,say the aldehyde oxidase activity of the rabbit liver ho-
mogenate. The method is based on the principle that N1-
methylnicotinamide chloride (NMN) has a maximum absorption 
at JOO nm and, when it is oxidized to 2-pyrone, the O.D. de-
creases. The change in O.D. at JOO nm thus gives the rate 
of this oxidation reaction since the product of the oxida-
t,ion does not absorb at this wave length. The procedure 
used is tabulized as followsa 
Each experimental cuvette contained 2.25 ml of 0.05 M 
potassium phosphate containing 0.005% EDTA, pH 7.8, 0.25 ml 
of 0.06 M solution of N1-methylnicotinamide chloride, and 
0.25 ml of 2.5 mg/ml solution of NaAP in 0.05 M potassium 
phosphate buffer, pH 7.8. After a 5 min equilibration pe-
riod a:t 25°C, 0.25 ml of 5.04 mg protein/ml rabbit liver 
aldehyde oxidase was added to the cuvette. The cuvette 
contents were rapidly mixed, .and A300 was recorded with 
time against a reference cell from which the substrate had 
been omitted. The ~A300/min was obtained from the linear 
portion of the curve of decreasing extinction in the pres-
ence and absence of NaAP (Chart 2). 
The optimum substrate concentrate and the amount of 
enzyme used in the assay prodecure was also determined 
using this method. The xanthine oxidase activity of this · 
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suspension was ·found to absent as a similar assay procedure 
_(AA290 , Davis et al., 1974) employing xanthine as a sub-
strate showed the absence of any xanthine oxidase ·activity 
in the final dialyzed rabbit liver homogenate. Oxidation 
of N1-MN is also a very specific reaction and only aldehyde 
oxidase can use it as a substrate while xanthine oxidase is 
unable to oxidize it. 
N. INHIBITION OF ALDEHYDE OXIDASE BY NaAP 
The assay procedure used to study the inhibition of 
aldehyde oxidase in rabbit liver homogenate has been de-
scribed in Section M. Similar experiments were performed 
using menadione, to compare the inhibition of NaAP vs 
menadione. DOAP, an extremely potent inhibitor of bovine 
milk xanthine oxidaf;>e .was also screened :for possible rabbit 
liver aldehyde oxidase inhibitory activity using the same 
procedure outlined earlier. The investigation of the sta-
. bili ty of DOAP in 0. 05 M potassium phosphate, as described 
in Section E, revealed that DOAP solution was relatively 
unstable at pH 7.8 but was stable at pH 8.2 up to 10 min. 
Therefore, the assays employing DOAP, NaAP and menadione 
were carried out at pH 7.8 and also at pH 8.2. 
0. ENZYMATIC SYNTHESIS OF DOAP FROM NaAP 
During the studies of inhibition of aldehyde oxidase 
by NaAP, it was observed that the product of the interac-
tion. between NaAP and rabbit liver aldehyde oxidase was 
DOAP. This finding was confirmed as follows. 
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2.5 mg of NaAP was dissolved in 10 ml of distilled H2o 
to obtain a cle~ yellow solution. To this solution, 7-·5 
· ml of 0.05 M potassium phosphate buffer containing 0.00.5% 
EDTA at pH 7.8 and 2 • .5 ml of 5.04 mg protein/mlof the al-
dehyde oxidase suspension were added. A control reaction 
was carried out using the same reactants with the exception 
that, instead of the aldehyde oxidase suspension, 2.50 ml 
of the buffer was added in the last step. Blth reaction 
mixtures were incubated at room temperature for 15 min. At 
the end . of 1.5 min, both solutions were brought to .a .50% 
ammonium sulfate saturation by adding 31.3 gm of solid ammo-
nium sulfate per liter of the reaction mixture. The solu-
tions were then centrifuged at 8000 rpm for 20 min at4°c. 
A brown precipitate was obtained from the reaction mixture 
with the enzyme suspension while a yellow precipitate was 
obtained from the control reaction mixture. Both precipi- . 
tates were dissolved in 2.5 ml of distilled H2o separately 
and, to each solution, 2.0 rnl of 5 N HCl were added. This 
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4oc· solution was centrifuged at 8000 rpm for 20 min at and 
the precipites obtained were treated with the same proce-
dure once again. 
At the end, a bright orange precipitate was obtained 
from the reaction mixture containing the enzyme suspension 
while a yellow precipitate was obtained from the control 
reaction. The orange precipitate was identified to be the 
DOAP since -it had exactly the same Rf values in three dif-
ferent solvent systems (Table 35) and also uv characteris-
tics as that of authentic .DOAP. The yellow precipitate -was 
identified as NaAP. ·NaAP was found to be unchanged under 
the same conditions even after 6 hr in the absence of en-
zyme. DOAP was also obtained from NaAP using the same _ pro-
cedure except using 5 N HCl and incubation in a boiling 
water bath for 10 min instead of using 50% saturation of 
ammonium sulfate to precipitate out the brown-orange pre-
cipitate of DOAPaprotein complex. 
CHAPTER IV 
RESULTS 
90 
CHAPTER IV 
RESULTS 
A. STRUCTURE OF 
· s~B'-DIOX0-6,6'-AZOPURINE (DOAP) 
The elemental analysis at room temperature and follow-
ing drying at l00°C for 1 hr under nitr6gen was fbund to be 
within the acceptable experimental error of ±0.4% as .shown 
in Table 1. These .analyses gave the impirical formulae of 
DOAP as c10H8N10o3 at room temperature and c10H6N10o2 after 
drying (Table 2). The difference in the two empirical for-
mulae was found to be a mole of water which indicated the 
presence of·a mole of water of hydration per mole of DOAP. 
· The presence of 1 -mole of hydration per mole of -the DOAP 
solid was confirmed _ by drying the sample under a stream of 
nitrogen for 1 hr at 100°C and trapping the evolved H2o in 
. magnesium perchlorate. In this manner. the trapped H2o was 
found to account for 5.41% of theundried molecular weight, 
corresponding to a theoretical value of 5.7% (Table J). 
The number of carbon and nitrogen atoms in the anhy-
drous empirical furmula of c10H6N10o2 was double that of 
the starting material, adenine. This indicated that the 
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compound was a purine dimer. The nuclear magnetic reso-
nance (nmr) spectrum of DOAP at a concentration of 20 mg/ml 
in DMSO-d6 was obtained from a Varian A-60A nmr spectropho-
tometer, using TMS as an internal standard (Figure 15). 
Three single peaks were found at 6 8.84, 12.05, and 12.64 
ppm relative to the TMS reference (Table 12). Integration 
of the three proton peaks revealed an integral ratio of 
lalal, confirming the presence of six hydrogen atoms in the 
DOAP molecule. Peak assignments were made on the basis of 
n2o exchange and the ranges of known 6 ppm values (Fox, 
1965; Shoup et al., 1966; Robins et al., 1966; Chan et al., 
1972; Twanmoh et al., 1973), These assignments indicated 
the presence of two c 2-H protons (8.84 ppm), two amide N9-H 
protons (12.05 ppm), and two imidazole N7-H protons (12.64 
ppm). Since the two protons originally present on the ni-
trogen attached to·c-6 of adenine were found to be absent 
in the nmr spectrum of DOAP, it appeared that the dimeriza-
tion of adenine occurred through the formation of an azo 
linkage resulting in an oxoazopurine which is shown in Fig-
ure 1, having the chemical structure of 8,8'-dioxo~6,6'-
azopurine monohydrate, abbreviated as DOAP. 
Additional evidence for the oxo groups at the c8 and 
c8 • positions was obtained from the infrared spectrum of 
DOAP which showed the presence of a strong and broad C=O 
(': 
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absorption band at 1760 cm-1• Oxopurines are known to form 
keto and enol tautomers, depending .on their chemical envi-
ronment (tichtenberg, 1973; Mason, 1957). The keto-enol 
tautomerism of DOAP is shown in Figure 2. 
The synthesis of DOAP from the oxidation 6,6'-azopu-
rine disodium salt by rabbit liver aldehyde oxidase and .re-
ductiv~ cleavage of DOAP by sodium hydrosulfite to 8-oxo-
adenine confirmed the structure of DOAP. The results of 
these two observations .are described in , detail in Sections 
H and J. 
B. STRUCTURE OF 
8,8'-DIOX0-6,6'-HYDRAZOPURINE (DOHP) 
The elemental analysis at room temperature and follow-
ing drying at 105°C for 1 hr under nitrogen was found to be 
within the experimental error of ±0.4%, as shown in Table 
3. These analyses gave the empirical formulae of DOHP as 
c10H10N10o3 at room temperature and c10H8N10o2 after drying 
(Table 4). The difference between the two empirical for-
mulae was found to be a mole of water, which indicated the 
presence of a mole of water of hydration per molecule of 
DOHP. The, presence of one mole of water of hydration per 
. mole of DOHP was confirmed using the procedure described 
for DOAP. 
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The structure of DOHP was obtained by studying its nmr 
.spectrum and also its alcoholic oxidation. The nmr spec-
trum of DOHP (Figure 18) at a concentration of 20 mg/ml in 
DMSO-d6 was obtained using a Varian A-60A (6). Four single 
peaks were found at 6 8.)4, 8.92, 10.42, and 11.88 ppm rel-
ative to the TMS reference. Integration of the four pro-
ton peaks revealed an integral ratio of lalalal, confirm-
ing the presence of eight hydrogen atoms in the molecule of 
DOHP as shown in Table 12. Peak assignments were made on 
the ·basis of n2o exchange and ranges of known o ppm values 
(Fox,. 1965; Shoup et al., 1966; Robins et al., 1966; Chan 
et al., 1972; Twanmoh et al., 1973). These assignments in-
dicated the presence of two c2-H protons (8.)4 ppm), two 
amide N9-H protons (10.42 ppm), and two imidazole N9-H pro-
tons ( 11.88 ppm). The assignment of the hydrazo N-H pro-
tons at 8. 92 ppm was confirmed by obtaining the nmr sp·ec-
trum of 6,6'-bisadenine under the similar experimental con-
ditions. The hydrazo protons of 6,6'-'bisadenine were found 
to be in the same range as that of DOHP. 
The fact that DOHP is a partially reduced, i.e. a hy-
drazo, derivative of DOAP was confirmed by studying its slow 
oxidation to DOAP. DOHP has a maximum absorption at 282 nm 
in absolute ethanol, while DOAP has a maximum absorption at 
442 nm. The oxidation of DOHP to DOAP was followed bymon-
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itoring the decrease in the o.n. at 282 run of a 10 llg/ml 
solution of DOHP in absolute ethanol at room temperature. 
No significant change in the optical density at 282 nm was 
found up to JO min. ·After JO min, the O.D. at 282 nm 
started to decreas.e while that at 442 run started to in- . 
crease (Figure 5). As shown in Table 8, over a period of 
24 hr, the O.D. at 282 nm disappeared completely while that 
at 442 run reached a peak which was identical to t .he absorp-
tion maxima of DOAP. 
• Thus, these experiments confirmed the fact that DOHP 
is a hydrazo derivative of 8,8'-dioxo-6,6'-azopurine having 
the chemical structure of 8,8'-dioxo-6,6'-hydrazopurine· 
monohydrate as shown in Figure :3, which is abbreviated as 
. ·. DOHP. 
C. STRUCTURE OF 
8,8'-DIOX0-6,6'-AZOXYPURINE 
TRISODIUM SALT (NaDOAXP) 
The elemental analyses·and the determination of six 
· moles of water of hydration per mole of NaDOAXP was carried 
out as described for DOAP and DOHP. The results are shown 
in · Tables 5 and 6. The empirical formula at room tempera-
ture was found to be c10H15N10o9Na3 while after drying, it 
was found to be c10H3N10o3Na3• 
The structure of NaDOAXP was· arrived at by studying 
its rtmr spectrum and also its reduction to DO,AP under acid-. 
ic conditions. The nmr spectrum of NaDOAXP at a concentra-
tion of 20 mg/ml was obtained using a Varian A-60A (6) and 
·was found to contain two single peaks at 6 8. 56 and 11.78 
. ppm, relative to the TMS reference. Integration of the two 
proton peaks revealed an integral ratio of 2al, respective-
ly, confirming the presence of three hydrogen .atoms in . the 
NaDOAXP molecule. Peak assignments were made on the basis 
of n2o exchange and the sources quoted previously. These 
assignments indicated the presence of two c2-H protons . 
( 8. 56 ppm) and one imidazole N7-H proton ( 11.78 ppm). 
The anhydrous empirical formula of NaDOAXP of 
c10H3N10o3Na3 contained three hydrogen atoms fewer and one 
additional ·. oxygen . atom than the anhydrous empirical formula 
of DOAP, c10H6N10o2, in addition to the three sodium atoms. 
This indicated that the three hydrogen atoms in DOAP had 
been replaced by three sodium atoms when it was converted 
to NaDOAXP during its synthesis in NaOH as cescribed in 
Chapter III. Section c. The fact that NaDOAXP was obtained 
by air oxidation of ·DOAP in NaOH also ~xplained the pres-
ence ofan additional atom of oxygen in azoxy form. These 
observations indicated that NaDOAXP is a sodium salt of the 
azoxy derivative of DOAP. This was confirmed by studying 
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the reduction of NaDOAXP to DOAP (i.e. azoxy--+ azo) under 
aquious as well as under acidic conditions. It was found 
that an aqueous solution of NaDOAXP slowly, over a period 
of 72 hr, gave a precipitate of DOAP. This reduction was 
instantaneous when the pH of the aqueous solution was 
changed to 2. 0 by adding 5 N HCL This is a characteristic 
behavior of an · azoxy compound, hence, it was concluded that ·· 
. NaDOAXPwas a sodium salt of the azoxy derivative of DOAP, 
having.a chemical structure of 8,8'-dioxo-6,6'-azoxypurine 
hexahydrate trisodium salt as shown in Figure 4. abbrevi-
ated NaDOAXP. 
D. -CHEMICAL PROPERTIES OF DOAP, DOHP AND NaDOAXP 
8,8'-dioxo-6,6'-azopurine monohydrate (DOAP) was ob-
tained as a brillant orange microcrystalline solid. The 
yield on a preparative scale was found to be 5.2%. Because 
of its hydrophobic nature, DOAP was found to be practically 
insoluble in distilled water, dilute HCl, dilute H2so4 , and 
non-polar organic solvents _ such as ·CHC13 , cc14 , benzene, 
toluene, cyclohexane, xylene, etc. It is .soluble in HaOH 
at different concentrations depending on the normality of 
NaOH. It is also soluble in polar organic solvents such as 
absolute ethanol, n-butanol, and dimethylsulfoxide. It is 
soluble in Tris-HCl buffer above pH 6. 6. Its so.lubili ty 
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characteristics in 0.05 M potassium phosphate buffer at 
various pHs, at a concentration · of 8.0 X 10-5 M, at room 
temperature, is shown inFigure 35· In this buffer, the 
DOAP solution is not soluble at pH 6.2, 6.6, and 7.0 and it 
precipitates out within one minute. At pH 7.4 and 7.8, the 
DOAP solution is fairly stable for up to J.O min. At pH 
8.2, the solution is adequately stable for up .to 10 min 
(Figure 37). 
8,8'-dioxo-6,6'-hydrazopurine monohydrate (DOHP) was 
isolated as a tan-yellow solid. It was obtained from par-
tial reduction of DOAP at ·a 75% yield. DOHP is soluble at 
smaller concentration in dilute HCl and dilute H2so4 • It 
is not soluble in non-polar organic solvents but is soluble 
in absolute ethanol, n•butanol, and dimethylsulfoxide. As 
was mentioned earlier, it was oxidized to DOAPin absolute 
ethanol after JO min of standing at room temperature. 
8,8'-dioxo-6,6'-azoxypurine hexahydrate trisodium salt 
(NaDOAXP) was obtained as a cherry-red solid. It was ob-
. tained from the air oxidation of DOAP in NaOH as described 
in Chapter III, Section c. Because of its polar nature, 
NaDOAXP is very soluble in water. . In water solution, 
NaDOAXP is slowly reduced to DOAP ·while in acidic solution 
it is instantly reduced, as described earlier. 
In a series of experiments designed to determine the 
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melting points of DOAP, DOHP, and NaDOAXP, using Fisher-
Johns melting point apparatus, it was observed that none of 
. . 0 . 
these compounds melted belowJOO c. DOHP ·started to change 
its tan-yellow color to tan-brown at 285°C and this .color 
change was completed at 290°C, however, it did not melt be-
· low J00°C. The cherry-red color of NaDOAXP deepened slowly 
but it did not melt below J00°C. 
Figures 29-36 and Table9; shows the uv characteris-
tics of these compounds in various solvents. Table 11 
shows their Rfvalues in three different solvent systems. 
E. CHEMICAL PROPERTIES OF HP, NaAP, AND NaAXP 
6,6'-bisadenine monohydrate (c10H8N10 .H2o), 6,6'-azo-
· purine hemihydrate disodium salt (c10H4N10Na2.-?zH20), and · 
6,6'-azoxypurine dihydrate disodium salt (c10H4N10oNa2.2H20) 
were obtained as a generous gift from Dr. A. Giner-Sorolla 
of the Sloan-Kettering Institute for Cancer Research, New 
York, New York. 
6,6'-bisadenine monohydrate, abbreviated as HP (indi-
cating that it is a hydrazopurine for comparison with 8,8'-
dioxo-6;6'-hydrazopurine, DOHP), was obtained as a yellow 
microcrystalline solid. Its solubility characteristics 
were found to be similar to those of DOHP. 
6,6'-azopurine hemihydrate disodium salt, abbreviated 
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as NaAP, was obtained as a brick-red crystalline solid. 
NaAP is soluble in water and aqueous solvents but these so-
lutions were ·reported to decompose when treated with dilute 
acid (Giner-Sorolla, 1970). For our experimental purposes, 
the solubility and the stability of NaAP in 0.0.5 M potassi- . 
urn phosphate buffer, at room temperature at a concentration 
of 8.0 X 10-5M at various pHs was studied • . At pH 6.2 and 
6.6, NaAP solutions in this buffer were found to be un-
stable. They were fairly stable at pH 7.0 for up to 3 min 
and were practically stable at pH 7.4, 7.8, and 8.2 for up 
to 10 min. 
6,6'-azoxypurine dihydrate disodium salt, abbreviated 
as NaAXP; was obtained as a red solid. Its solubility 
characteristics were found to be similar to those of 
NaDOAXP. 
Figures 29-}6 and Table 9 shows the uv characteristic·s 
of these compounds in various solvent.s. Table 11 shows 
their Rf values in three different solvent systems~ 
F. NMR AND IR SPECTROSCOPIC STUDIES OF OXOAZOPURINES 
Thenmr spectra of oxoazopurines, azopurines, and pu-
rine derivatives are tabulated in Table 12. The two amino 
NH2 protons of adenine were found at 6 7.36 ppm, however, 
when two molecules of adenine were dimerized through a hy-
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.drazo linkage on C6 and C6' as in 6,6'-bisadenine (HP), the 
N-H protons of the hydrazo linkage were found to be shifted 
downfield to 6 10.04 ppm. The shielding effect of carbonyl 
· groups at the 8 and 8' positions in 8,8'-dioxo-6,6'-hy-
drazopurine (DOHP) was ·found to have a considerable effect 
on the hydrazo N-H .proton of DOHP and · were found upfield at 
6 8.92 ppm. The shielding effect of the adjacent carbonyl 
group was also · observed when the 6 ppm values of the amide 
N-H protons in xanthine, hypoxanthine, 8,8'-dioxo-6,6'-azo-
purine (DOAP), and DOHP were compared. The amide N-H pro-
tons of hypoxanthine were found to be 6 12.88 ppm, while 
those of xanthine were moved upfield at 6 11.92, and 11.20 
·ppm, those of DOAP to 6 12.22 ppm, and those of DOHP to be 
6 10.42 ppm. The imidazole N7-H ·proton in adenine was 
found at 6 1.3.28 ppm. The azo, hydrazo, and azoxy linkages 
of DOAP, DOHP, and NaDOAXP, in addition to the carbonyl 
groups at the 8 and 8' positions, increased the shielding 
of ~7-H imidazole protons which were thus shifted upfield 
to 6 12.84, 11.88, and 11.78, respectively. In the case of 
6, 6' -bisadenine, in spite of the presence of a hydrazo 
linkage, there .was no effective shielding because of the 
absence of the carbonyl groups at the 8 and 8' positions, 
· therefore, the N7-H imidazole protons moved downfie1d to 6 
12.42 ppm. This was found to be in agreement with the. 
·. · strong shielding effects of carbonyl groups and· thiol 
groups reported by Baur et al. (1965) and Lichtenberg et 
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. ~· ( 1971). ·The c8-H of purine is less shielded than the 
c2-H which, in turn, is less shielded than the c6-8 (Fox, 
1965). Insertion of C=O groups at the 8 and 8' positions 
reduces the aromatic character of the imidazole ring as it 
does that of pyrimidine ring. This decreases the ring cur-
rent which, · in turn, has a shielding effect on the N7-H 
protons. 
Standard compilations were used to analyze the ir 
spectra of oxoazopurine monomers (Sadtler Research Labora-
tories, American Petroleum Institute; Kitritzky, 196J and 
1971). The frequencies for oxoazopurines and the purine 
monomers are tabulated in Tables lJ and 14, respectively. 
The region from J700 to 2200 cm-l was found to be · 
char~cterized by very broad hydrogen bonded peaks which 
nearly obscured the C-H absorptions between JlOO and JOOO 
cm-1 • All oxoazopurines, with the exception of NaDOAXP, 
exhibited a free N-H stretch in the J200-J500 em -l region. 
Broad absorptions with decreasing intensities were found . 
in the region between JOOO and 2200 cm-1 , characteristic of 
N7-H stretch. All compounds except NaDOAXP showed this 
feature, indicating that N7-H has formed a hydrogen bond 
with the azoxy oxygen. 
lOJ 
Carbonyl absorptions were found as strong but broad 
peaks at 1760 cm~ 1 in DOAP, and at 1750 cm-1 in DOHP. No . 
carbonyl absorption for NaDOAXP was found because both car-
bonyls exist predominantly in the enolate configuration 
with the electron density on the oxygen (Spinner, 1960). · 
· The N=N stretch of the azoxy groups of NaDOAXP and NaAXP 
was found at 1545 and 1550 cm-1 , respectively. The major 
difference between the spectrum of adenine and 6,6-bisad-
enine (HP) was the loss of the adenine NH2 scissors at 1720 
cm-1 ; in the dimer, this was accompanied by the appearance 
of a more prominent 1580 cm-1 shoulder on the 1600 cm-1 
ring mode. 
The oxopurines showed characteristic broad peaks be-
tween 1500 and 1200 cm-1 • The carbonyl group absorptions 
in the purine monomers were found between 1600 and 1750 
cm-1 • Carbonyl group at the c2 position was found in the 
region between 1680 and 1710 cni-1 , at c6 position they were 
found between 1600 and 1960 cm-1 , and at c8 position they 
were found between 1700 and 1750 cm-1 . 
G. COLUMN CHROMATOGRAPHIC SEPARATION OF OXOAZOPURINES 
Figure 9 shows the technique for chromatographic sep-
aration and identification of oxopurines. Table 15 lists 
the peak tube number and their uv characteristics. 
104 
Among the numerous chromatographic methods available 
for the separation of purines (Wall, 19 53; Weissman et al. , 
1957; Wyngaarden et al., 1958; Ayvazian et al., 1965), a 
modification of the method described by Sweetman and Nyhan 
. (1969), was found to be very efficient for the separation 
of oxopurines and is described in detail in Chapter III, 
Section G. For the chromatographic analysis, three purines 
with the 6, 2,6, and 2,6,8 positions oxidized {i.e. hypo-
xanthine, xanthine, and uric acid) and three derivatives o.f 
adenine with the 2, 8, and 2, 8 positions oxidized ( L e. 2-
oxoadenine, 8-oxoadenine, and 2,8-dioxoadenine) were chosen. 
As shown in Figure 9, the three oxidized purines were 
eluted in a definite order, the most oxidized (u~ic acid) 
being eluted first, followed by the less oxidized (xanthine 
and .hypoxanthine). These were followed by adenines, again 
in the same order, the most oxidized 2,8-dioxoadenine (2,8-
DOA) was followed by 8-oxoadenine (8-0A) .and then by 2-oxo-
adenine (2-0A). A pure purine base like adenine, which was 
not oxidized, was eluted last. The elution time was .fur-
ther enhanced by dimerization of two purine units, as is 
shown by the position of 8,8'-dioxo-6,6'-hydrazo purine 
(DOHP) on the chromatogram. 
H. REDUCTIVE CLEAVAGE OF 8,8'-DIOX0-6,6'-AZOPURINE 
(DOAP) BY SODIUM HYDROSULFITE 
10.5 
As shown in Figure 10, the product of the reductive 
cleavage of 8,8'-dioxo-6,6'-azopurine (DOAP) was identified 
as a single large peak of absorbance at an effluent volume 
of 381 ml with two >. values of 280 and 267 nm, having an max 
A280 aA 267 ratio of 1.04 which matched the chromatographic 
position and spectral characteristics of the authentic sam-
ple of 8-hydroxyadenine sulfate. 
The tubes representing the single large peak of ab-
sorbance (fraction No. 123-130) were pooled in a 2.5-ml tube 
and gaseous nitrogen was passed through it for 20 hr; the 
tube was kept in a water bath at 4°C. A yellow solid was 
obta.ined·at the end of the 20 hr period. Uv spectra of the 
yellow solid were obtained in 1 N NaOH and dimethylsulfox-
ide (Figure 14) which exactly matched those of the authen-
tic 8-hydroxyadenine sample (Figure lJ). 
I. ·STUDIES OF in vivo INHIBITION OF XANTHINE OXIDASE 
AND THE METABOLISM OF DOAP IN AN ADULT MALE RAT 
a. Urinary Excretion of DOAP 
A single subcutaneous injection of 8,8'-dioxo-6,6'-
azopurine (DOAP) was given to a rat behind the nape of the 
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neck. The dose used was 25 mg of DOAP dissolved in 0.01 N 
NaOH/kg (Table 16). The urine was collected in 2 hr sam-
ples over a period of 24 hr, using an automatic fraction 
collector. The DOAP excreted in each 2 hr urine sample was 
precipitated by adding one drop of 5 N HCl and was washed 
·and dissolved in 0.1 N KOH. The optical density of this 
solut·ion was measured at 513 nm and the concentration of 
DOAP in llg/ml (Table 18) was obtained, for each of the 2 hr 
samples, from the calibration curve (Fibure 56). This pro-
cedure is described in detail in Chapter III, Section J 
(b). A graphical plot of llg/ml of DOAP per 2 hr urine sam-
ple vs hours after injection (Figure 57), showed that the 
rate of urinary excretion of DOAP after a single subcuta-
neous injection of 25 mg/kg in an adult male rat may be 
biphasic. Two hours after injection, 4.5 llg of DOAP/ml 
were found in the excreted urine; the peak of the first 
phase was reached at 6 hr after injection when 20.8 llg of 
DOAP/ml were excreted. The rate of excretion of DOAP was 
then reduced and at 14 hr after injection it was found to 
be 18.9 llg of DOAP/ml. The peak of the second phase was 
reached at 18 hr after the injection when 30.9 llg of DOAF/ 
ml were excreted. At 24 hr after the injection, the rate 
of excretion diminished to 2.7 llg of DOAP/ml. A total of 
O,J8J7 mg of DOAP were excreted over the 24 hr period after 
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the injection which amounted to 6.73% of the injected dose 
of DOAP. DOAP was not found in the urine samples collected 
at 26, 28, · or 30 hr after the injection of DOAP. This in-
dicated that 93.27% of the injected DOAP remained in the 
body of the rat 24 hr after the single subcutaneo.us injec-
tion. DOAP might have been excreted in smaller amounts 24 
hr after the injection but the technique used to analyze 
DOAP in rat urine was unable to detect this amount. 
The urine output after injecting 25 mg/kg DOAP in-
creased slowly (Table 19) until it reached a peak at 16 hr 
after inje.ction. The output of urine was also found to be 
increased 16 hr after injecting 0.01 N NaOH. The amount of 
0.01 N NaOH injected was the same as used to dissolve the 
DOAP. The increase in the urine output, 16 hr after the 
injection of 25 mg/kg DOAP was twice that found ,after in-
jecting the equal volume of 0.01 N NaOH (Figure 58 and 
Table 19). Thus, the relatively moderate increase in urine 
output after the injection of DOAP indicates that DOAP may 
have diuretic properties. The urine volume remained at a 
higher level until 5 days after injecting DOAP but returned 
to normal, as .shown in Figure 59· 
b. Effect of a Single Subcutaneous Injection of 25 
mg/kg DOAP on Urinary Excretion of Xanthine and Hypoxan- . · 
thine 
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xanthine and hypoxanthine were determined enzymat-
ically, using a method modified from that of Jorgensen and 
poulsen (1955). As described in Chapter III, Section J 
.. (c), the pre-existing uric acid in rat urine is destroyed · 
by uricase, following which, xanthine and hypoxanthine are 
converted to uric acid by the action of xanthine oxidase. 
This newly formed uric acid is then destroyed by uricase 
again and the change in O.D. at 292 nm is determined; this 
is proportional to the amount of measured uric acid de-
graded (Table 22). Figure 60 shows the effect of 25 .mg/kg 
DOAP ·on urinary excretion of xanthine and hypoxanthine in 
an adult male rat. 
The .level of uric acid due to xanthine and hypoxan-
thine (0.22 mg%) was found to be unaffected by the dose of 
an equal volume of 0.01 N NaOH (0.21 mg%). Uric acid due 
to xanthine and hypoxanthine increased to 0. 67 and o·. 99 mg% 
at 24 hr and 48 hr after injecting 25 mg/kg DOAP, respec-
tively. · The level. of uric acid due to xanthine and hypo-
xanthine remained slightly elevated on the Jrd, 4th, and 
5th day after the injection of DOAP. The level returned 
normal on the 6th day after the injection of DOAP. 
c. Effect of a Single Subcutaneous Injection of . 25 
·mg/kg ·noAP on Urinary Excretion of Uric Acid 
The determination of uric acid in rat urine is de-
to 
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scribed in Chapter III,_ Section J (d), and the calibration 
curve is shown in Figure 62. The uric acid level in the 
urine of a normal adult male rat (0.77 mg%) was found to be . 
unaffected by the injection of equal volume of 0.01 N NaOH 
(0.75 mg%). The uric acid levels dropped to 0.25 mg% 24hr 
after the injection of 25 mg/kg DOAP (Table 21) and re- · 
turned to 0.70 mg% at the end of 48 hr. The level of uric 
acid dropped again to 0.45 mg% at the end of the 4th day 
after the injection of DOAP and then returned to normaL 
Thus, the excretion of uric acid after the injection of 25 
mg/kg DOAP may also be following biphasic pattern. 
d. Effect of a Single Subcutaneous Injection of 25 
tng/kg DOAP on Urinary Excretion of Creatinine 
Creatinine levels in the .urine of an adult male rat 
injected .with25 mg/kg DOAP, were monitored in order to in-
vestigate the effect of DOAP on renal fundtion. . The level 
of creatinine (Table 24) in the urine of a normal adult rat 
(5.77 mg%) was .not altered after the injection of an equal 
· volume of 0.01 N NaOH (5.80 mg%). The creatinine level 
dropped to _l.J5 mg% 24 hr after the injection of 25 mg/kg 
DOAP (Figure 6J). The level of creatinine slowly returned 
to nonnal at the end of the 5th day after the injection of 
DOAP. · This indicated that one of the toxic effects of DOAP 
was its . nephrotoxicity. 
! 
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e. Metabolites of DOAP 
As described in Chapter III, Section J (f), the metab-
olites of DOAP in rat urine, after a single subcutaneous 
injection of 25 mg/kg DOAP, were separated by using column 
chromatography. The fraction eluted in tube 196 showed.the 
exact same characteristics of that of authentic DOHP in 1 
N HCl (Figure 66}. It was concluded that one of the pos-
sible metabolites of DOAP in the rat was its hydrazo deriv-
ative, DOHP. 
J. INHIBITION OF RABBIT LIVER ALDEHYDE OXIDASE BY 
6,6'-AZOPURINE DISODIUM SALT (NaAP) 
The isolation and purification of aldehyde oxidase 
from rabbit liver is described in Chapter III, Section K. 
The protein content of the rabbit liver aldehyde oxidase 
was determined by using Waddell's method and results are 
shown in Table 25. The aldeh,yde oxidase suspension was 
found to contain an average of 5.04 mg protein/mi. 
Oxidation of 5.0 X 10-J M N1-methylnicotinamide chlo-
ride by rabbit liver aldehyde oxidase is shown in Figure 
4J, The rate of oxidation increased linearly as the amount 
of enzyme used was increased from 50 f.ll to 250 f.ll• Figure 
44 shows the optimal substrate concentration ( 5· 0 X 1.0-J M) 
and optimal enzyme concentration (250 f.ll of s.o4 mg pro-
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tein/ml). Inhibition of rabbit liver aldehyde oxidase was 
measured using the .6A300 method (Figure 42). It was de-
cided to compare the inhibition of aldehyde oxidase by 6, 
6'-azopurine disodium salt (NaAP) to that by 8,8'-dioxo-
6,6'-azopurine (DOAP). As described earlier, DOAP at a 
final concentration of 8.0 X 10-5 M in 0.05 M potassium 
phosphate buffer, pH 7.8, was unstable at room temperature 
but at pH 8.2, it was found to be adequately stable for up 
to J min • . A series of experiments were designed to . inves-
tigate the inhibition of rabbit liver aldehyde oxidase by 
NaAP at pH 7.8 arid at pH 8.2 and that by DOAP at pH 8.2. 
Figure 45 shows the concentration of inhibitor (NaAP) that 
was found to cause a 50% inhibition of the rabbit liver 
aldehyde oxidase C (I) 50 ) ... The (I) 50 at pH 7.8 was found 6 . . 
to be 2.6 X 10- M NaAP • . The (!) 50 at pH 8.2 was found to 
be J,4 X 10-6 M NaAP (Figure 46) • . 
The inhibition ·of rabbit liver aldehyde oxidase was 
also compared with a non-competitive inhibitor, i.e. menad-
ione. Menadione influences the internal electron transport 
chain and does not bind at the substrate site. The (!) 50 
at .pH 7.8 for menadione was found to be 1.1 X 10-7M (Fig-
ure 47). 
The inhibition .of rabbit liver aldehyde oxidase by 
NaAP was found to be competitive, as shoWn by the Line-
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weaver-Burk plot (Figure 49) which showed the characteris-
tic straight lines with differing slope intersecting at a 
.common intercept .on! axis and>.. unaffected by the in-
. v m~ 
creasing concentration of NaAP. This finding was further 
confirmed by plotting a Dixon plot (Figure 50). The in-
hibitor constant (KI) for the inhibition of rabbit liver 
-6 aldehyde oxidase by NaAP was found to be J,J X 10 M. The 
inhibition of rabbit liver aldehyde oxidase by menadione 
was found to be non-competitive (Figure 51) • 
. K. ENZYMATIC SYNTHESIS OF 
8,8'-DIOX0-6,6'-AZOPURINE (DOAP) 
The investigation of the interactions between 6,6'-
azopurine disodium salt (NaAP) andrabbit liver aldehyde 
oxidase showed that 8,8'-dioxo-6,6'-azopurine was the prod-
uct of oxidation of .NaAP by the aldehyde oxidase. 
When rabbit liver aldehyde oxidase was added to the 
solution containing NaAP (Chapter III, Section 0), a brown-
orange precipitate of the complex of aldehyde oxidase and 
DOAP (AOaDOAP) ·was formed in the solution. The AOaDOAP 
complex was then broken up by dissolving it in distilled 
H2o and acidifying the solution with 5 N HCl to pH 2.0. 
·The resulting solution was centrifuged and DOAP was iso-
lated as a bright-orange precipitate (Charts J and 4). 
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The enzymatically synthesized DOAP and chemically syn-
thesized DOAP showed the exact · same uv characteristics 
(Figure 5.5) and Rf values in three solvent systems (Table 
·3.5)• The uv characteristics of the AOaDOAP couple is shown 
in Figure .53· 
CHAPTER V 
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CHAPTER V 
DISCUSSION 
Synthesis of new, biologically active purines has long 
been an obj.ect of research because of their obvious bio-
chemical properties. 
This investigation has established the chemical struc-
tures, physical properties and some preliminary biological 
properties of purine dimers. 
The parent member of a new class of purine compounds, 
which have been named the oxoazopurines, was first isolated 
as an orange adenine chromophore in 1956 by Professor Jo-
seph R. Davis. The unsubstituted azopurine itself was sub-
sequently synthesized in 1970 by A. Giner-Sorolla, Sloan-
Kettering Institute of Cancer Research, New York. 
Employing uv, ir, and nmr spectroscopic techniques and 
preparing functional group derivatives, the structure of 
the orange adenine chromophore as shown in Figure 1 was 
confirmed to be 8,8'-dioxo-6,6'-azopurine monohydrate 
(DOAP). Partial reduction of this azopurine gave a hydrazo 
derivative having the chemical structure (Figure J) as 
8,8'-dioxo-6,6'-hydrazopurine monohydrate (DOHP). Complete 
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reduction of DOAP with sodium hydrosulfite/NaOH gave 8.- · 
hydroxyadenine, thus confirming that DOAP was a dimer con-
taining two molecules of 8-hydroxyadenine joined by a.n azo 
bond betweenc6 and c6 ,. The structure of DOAP was fur-
ther confirmed by preparing a sodium salt of the azoxy de-
rivative of DOAP, 8,8'~dioxo~6,6'-azoxypurine hexahydrate 
trisodium salt (NaDOAXP) shown in Figure 4. 
Additional evidence for the structure of DOAP was pro-
vided by its enzymatic synthesis (Figure 52) from 6,6'-azo-
purine disodium salt (NaAP). Rabbit liver aldehyde oxidase 
is known to oxidize purines selectively at the c8 position. 
· Thus, the carbon atoms at the 8 and 8' positions of NaAP 
are oxidized by rabbit liver aldehyde oxidase to give DOAP, 
confirming the fact that the oxo groups in the molecule of 
DOAP are on the c8 and c8 ,. 
The structure of DOHP was confirmed on the basis of 
its synthesis by the partial reduction of DOAP, and ·its 
slow oxidation to DOAP in absolute ethanol (Figure 5). 
Similarly, the structure of NaDOAXP was confirmed on the 
basis of its synthesis by oxidation of DOAP, and its slow 
reduction to DOAP in acidic as well as in aqueous solution 
(Figure 15). 
The ir spectroscopic investigation of the purine mon-
omers and dimers showed that the C-H absorption in the re-
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gion from .3700 to 2200 cm-l was almost obscured by very 
broad hydrogen bonded peaks (Tables 1.3 and 14). The free 
N-H stretch in the region between .3200 and J500 -1 em · was 
found to be present in all the oxoazopurinesexcept NaDOAXP. 
Broad absorptions with decreasing intensities were found in 
the region between JOOO and 2200 cm-1 , characteristic of 
. N7-H stretch. All compounds except NaDOAXP showed these 
features, indicating that N7-H has formed a hydrogen bond 
with the azoxy oxygen. Carbonyl absorptions were also 
found to be absent in the ir spectrum of NaDOAXP because 
both of the carbonyis at c8 and .c8 , exist predominantly in 
the enolate configuration with the electron density on the 
oxygen (Spinner, 1960). 
Carbonyl absorptions for the purine derivatives, azo-
purines, and oxoazopurines were found between 1600 and 1760 
c~-l, depending on the position of the carbonyl group. The 
carbonyl groups at c 2 in .the molecules of 2-oxoadenine, 
2,8-dioxoadenine, xan;thine (2,6-dioxopurine), and uric acid 
(2,6,8-trioxopurine)were found· between-1680 and 1710 cm-l 
(Table 14), while those at c6 were found between 1600 cm-l 
and 1660 cm-1 • . The carbonyl groups . at c8 in the molecules 
of 2,8-dioxoadenine, uric acid, 8,8'-dioxo-6,6'-azopurine 
(DOAP), and 8,8'-dioxo-6,6'-hydrazopurine (DOHP) were found 
at 1750, 1700, and 1750 cm-1 , respectively. Thus, the ir 
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frequencies of the carbonyl groups were found to increase 
in an orderasa c6=o (1600-1660 cm-
1 ), c2=o (1680-1710 
cm-1 ), and c8=o (1700-1760 cm-
1). 
It has been shown that in aromatic azo compounds with 
the trans configuration, the N=N band occurs between 1410 
and 1440 cm·l and, for those with the cis configuration, it 
occurs between 1511 and 1576 cm-l (Bellamy, 1968). Both 
8,8'-dioxo-6,6'-azopurine (DOAP) and 6,6'-azopurine diso-
dium salt, have an N=N band at 1590 and 1535 em-~, respec-
tively, indicating that both of these compounds exist in · 
the cis configuration. 
The nuclear magnetic resonance spectra of the purine 
monomers and dimers studied during this investigation con-
sisted of one or two sharp absorption signals for the aro-
matic c2-H protons between 6 8.J4 and 9.08 ppm, while those 
for c8-H protons were between 6 8.26 and 8.64 ppm (Table 
12). This is consistent with the literature data (Schwei-
zer, et al., 1964; coburn, Jr., et . al., 1965; Hruska, et 
al., 1968, and Twanmoh et . al., 1973). .The imidazole N7-H 
signals for DOAP, DOHP, and NaDOAXP appeared as broad sig- · 
nals at low field between 6 11.78 and 12.84 and for HP it 
was found at 6 13.42 ppm. The imidazole N7-H signal for 
adenine (6-aminopurine), hypoxanthine (6-oxopurine), and 
xanthine (2,6,-dioxopurine) were found between 6 13.28 and 
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1.3.76 ppm. Twanmoh (197.3) reported the imidazole N-H sig-
nals for a series of purine derivatives between 6 1.).2 to 
1.3.5 ppm which was found to be consiste~t with our data. 
The signals from some of the purine dimers containing two 
imidazole N7-H protons appeared as a singlet. These pro-
tons were characterized by the proper int~gral intensities 
and by deuterium oxide exchange experiments. 
The two amino NH2 protons of adenine were found at o 
7 . .36 ppm, however, when two molecules of adenine were dim-
erized through a hydrazo linkage on c6 and c6 ,, as in 6,6'-
bisadenine (HP), the N-H protons of the hydrazo linkage 
shif.ted downfield to o 10.04 ppm. (The shift of a proton 
signal to a lower value of o ppm is called upfield shift; 
while that towards a higher value of o ppm is called the 
downfield shift.) ·. The carbonyl group is known for its pos~ 
itive shielding effect (Jackman, 1964; Lichtenberg et al., 
1971, and Twanmoh et al. , 197.3) and moves the adjacent N7-H 
signal upfield. Thus, the shielding er'fect of carbonyl 
groups at the 8 and 8' positions in the molecule of DOHP 
was found . to have considerable effect on the hydrazo N-H 
protons of DOHP and were found upfield at o 8.92 ppm. The 
amide N1-H proton of hypoxanthine (6~oxopurine) was found 
at 6 12.88 ppm, however, when an additional carbonyl group 
is .added, as in xanthine (2,6-dioxopurine), the amide N.1-H 
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~ moves upfield to 6 11.20 ppm. In the molecule o.f 8,8 •-
t dioxo-6,6'-azopurine (DOAP), the amide N9-H protons were 
t. ·found at 6 12.22 ppm but in 8,8'-dioxo-6,6'-hydrazopurine 
~· (DOHP), they were found to be shifted upfield to 6 10.42 
ppm, as a result of deshielding by the hydrazo N-H protons. 
During these studies, it was observed that the mois-
ture content of the solvent (DMSO-d6).had a significant 
effect on the N-H signals. A fresh bottle of DMSO-d6 was 
used for each experiment and the moisture content of the 
solvent was determined by scanning.it first. Only the sol-
vent with a minimum amount of moisture was utilized to dis-
solve the compounds. 
It has been shown that the orange adenine chromophore 
(i.e. DOAP), can only be obtained from adenine and adenine 
nucleoside and cucleotides and that the formation of the 
orange adenine chromophore was dependent on the concentra- . 
tion of KBr, H2so4 , and KIVIn04 in the reaction medium (Davis 
and Morris, 1963). Attempts to synthesize DOAP from 2-
oxoadenine, 8-oxoadenine, 2,8-dioxoadenine, and adenine-
N1-oxide have failed. These observations indicate that the 
presence of an amino group at the c6 position and the ab-
sence of electron withdrawing groups (i.e. oxogroup) at the. 
N1 , c2, and c8 positions of the purine ring are essential 
for the formation of DOAP. 
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The mechanism of the reaction, through which DOAP was 
synthesized, seems unique. Oxidation of adenine by KMn04 
with KBr, in acidic medium; appears to be most likely at 
the c8 position in view of the fact. that purines are known 
to selectively form highly reactive c8 halogen atoms that 
can give rise to the 8-oxo derivative via acid hydrolysis 
(Brown, 1971). Manganese dioxide (Mn02) has been shown to 
cause the dimerization of two molecules of aromatic pri-
mary amine through an azo bond (March, 1968). Thus, the -
oxidation of the amino groups at the c6 position of two 
molecules of adenine, most likely by Mn0 2 formed in the 
reaction medium, and the subsequent dimerization, may form 
. the 8,8~-dioxo-6,6'-azopurin& (DOAP) molecule. 
Urinary excretion of 8,8'..;dioxo-6,6'-azopurine (DOAP) 
after a single .subcutaneous injection of 25 mg/kg, was ap-
parently biphasic. The apparent biphasic nature of the 
excretion of DOAP in rat urine indicates that DOAP binds 
with protein in vivo. It has been demonstrated, in our 
laboratory, that DOAP binds .with bovine serum albumin, hu-
man plasma proteins, Baker's yeast RNA, and calf thymus DNA 
in varying degrees, ih vitro ( Fareed et al., 197 5). The 
unbound DOAP is excreted during the first phase which ends 
at 14 hr after the subcutaneous injection. 
At the end of the first phase, the concentration of 
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DOAP in the body of the rat is very low and the DOAP-pro• 
tein complexes diss~ciate releasing free DOAP. This newly 
released DOAP makes more DOAP available for excretion, 
hence is responsible for the second phase which reaches a 
maximum at 18 hr after the injection. 
It was observed that 8,8'-dioxo-6,6'-hydrazopurine 
(DOHP) appears in the rat urine within 24 hr after a single 
subcutaneous injection of 25 mg/kg 8,8'-dioxo-6,6'-azo-
purine (DOAP). Thus, it can be concluded from the studies 
of the metabolism of DOAP in rat that, after a single sub-
cutaneous injection of 25 mg/kg, 1) DOAP may bind with se-
rum and other proteins, and 2) DOAP is .partially reduced to 
a hydrazo .derivative, DOHP, therefore, indicating that the 
rat liver azoreductase system is playing a significant role 
in metabolizing DOAP~ 
DOHP may not be the final metabolite of DOAP and could 
be further degraded to 8-hydroxyadenine by reductive cleav-
age in vivo. This possibility can be ·explored by examining 
urinary excretion of 2, 8-dihydroxyadenine, since it has· 
been shown that 8-hydroxyadenine is oxidized to 2,8-dihy-
droxyadenine by xanthine oxidase (Wyngaarden and Dunn, 
19 57). 
The effect of 8,8'-dioxo-6,6'-azopurine (DOAP) on the 
urinary excretion of xanthine and hypoxanthine, as shown in 
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Figure 60, confirms the observation that DOAP is. an inhibi-
tor of xanthine oxidase in vivo. The levels of xanthine 
•and hypoxanthine in the rat urine remained elev~ted until 
48 hr after the subcutaneous injection of 25 mg/kg DOAP. 
The mechanism of the inhibition of xanthine ·oxidase by 
DOAP in vivo can be postulated to bea 1) DOAP may be bind-
ing to xanthine oxidase in vivo, and thus, inactivating it, 
2) 8-hydroxy adenine, formed from the reductive cleavage of 
DOAP, may be competing with xanthine and hypoxanthine .for 
the substrate sites on the enzyme. As indicated above, 
these . postulations can be further confirmed by examining 
urinary excretion of 2,8-dihydroxyadenine. 
The excretion of uric acid does not follow the same as 
that pattern followed by .the excretion · of xanthine and hy-
poxanthine after the injection of DOAP. The uric acid ex-
·cretion in the rat urine decreased until 24 hr after the 
injection but returned to normal at the end·of 48 hr. The 
excretion of uric acid dropped again, to a lesser extent, 
until the end of 96 hr and then returned to normal. This 
fall and rise in the uric ·acid excretion indicates that, in 
addition to the inhibition of xanthine oxidase, DOAP may 
have the same effect on the enzyme uricase. Effect of DOAP 
on the .metabolism of xanthine and hypoxanthine in rat can 
be summarized as follows, where X indicates inhibitiona 
Hypoxanthine 
DOAP--X~ Jxanthine oxidase 
Xanthine 
DOAP-•X_. l;anthine oxidase 
Uric acid 
I 
DOAP--x-. uricase 
• Allan to in 
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The extent of the inhibition of xanthine oxidase may 
be greater than that of -the inhibition of uricase until 24 
hr after the injection of DOAP, thus, the levels of xan-
thine and hypoxanthine were found to be increased at this 
time. However, after 24 hr, the extent of inhibition of 
uricase may be greater than that of xanthine oxidase. This 
may compensate for the loss of uric acid, bringing its lev-
els back to normal. -
Urinary excretion of creatinine decreased, while the 
urine output increased after the injection of DOAP, indi-
cating that DOAP affects the glomerular filtration rate. 
Therefore, these· preliminary studies indicate that,· a 
detailed study of the metabolism of DOAP in rat will eluci-
date the mechanism of inhibition of xanthine oxidase and 
uricase in vivo, identify the.azoreductase system respon-
sible for the metabolism of azopurines which in turn will 
lead to the development of DOAP or its derivatives as ther-
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apeutic agents used for the treatment of a number of .dis-
eases involving impaired purine metabolism. 
Aldehyde' oxidase appears only in the soluble fraction 
of a liver homogenate, hence is of cytoplasmic origin (Lem-
berg, . l9J6, Mahler et al., 1954, and Rajagopalan et al., 
1962). It was shown that each mole of rabbit liver alde-
hyde oxidase contains 2 moles of FAD, approximately 2 moles 
of coenzym~ Q10 , 8 gm-atoms of non-heme iron, and 2 gm-
atoms of molybdenum (Rajagopalan et al., 1962). The phys-
iological compound most rapidly oxidized by rabbit liver 
aldehyde oxidase is N1-methylnicotinamide (Knox, 1946). 
The products of the N1-methylnicotinamide oxidation by liv-
er aldehyde oxidase in a number of mammals have been . found 
to be (Felsted and Chaykin, 1967) N1-methyl-4-pyridone-3-
carboxamide (4-pyridone) and N1-methyl-2-pyridone-5-car- . 
boxamide (2-pyridone), The oxidation of both N1-methyl-
nicotinamide and pyridoxal is the physiological function 
of a single liver enzyme, aldehyde oxidase (Stanulovic and 
Chaykin, 197lb). 
The substrate specificity and the ·manner in which in-
dividual purines are oxidized by the three molybdenum con• 
taining flavoproteins, i.e. aldehyde oxidase, xanthine ox-
idase, and xanthine dehydrogenase, depend on the electronic 
structures of the purines as well as on .the environment of 
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the substrate-binding site of the enzyme. Thus, whereas 
purine is initially oxidized to hypoxanthine by xanthine 
oxidase, it is converted to 8-hydroxypurine by aldehyde ox-
idase and xanthine dehydrogenase. Xanthine is the most ef..; 
ficient substrate for bovine milk xanthine oxidase and xan-
thine dehydrogenase but is not a substrate for aldehyde ox-
idase. Hypoxanthine is oxidized to xanthine by aldehyde · 
oxidase . and to 6,8..;dihydroxypurine by xanthine dehydrogen-
ase,whereas 7-methylhypoxanthine is oxidized to 7-methyl-
. xanthine by both enzymes. These examples indicate that the 
manner of attack and the ultimate product of the enzymic 
purine oxidation are largely determined by the functional 
arrangement at the enzymatic binding site and the ·manner in 
which this interacts with substrate. 
During the investigation of the structure and function 
of iron-flavoproteins, Handler, Rajagopalan, and Aleman 
(1964), . demonstrated that the pathway of internal electron 
transport in aldehyd·e oxidase as a . 
Mo+6 
SUBSTRATE --1 + -+ FAD __,. CoQ10 
-s-s-
Electron paramagnetic resonance studies showed that, 
the iron atoms behave as an "electron sink", and it was al-
so concluded that, in the internal electron transport se-
quence of the rabbit liver aldehyde oxidase, iron is the 
127 
· carrier closest to the site of oxygen reduction while mo-
. . lybdenum is the most remote (Greenlee et al., 1962). The 
sequence of the electron transport was further confirmed by 
Palmer et al. (1963). 
The fact that the molybdenum atoms of the xanthine and 
·aldehyde oxidase are the. first components of these enzymes 
. to be reduced explains the manner of their oxidizing at-
tacks on their substrates. 
It has been suggested that both aldehyde oxidase and 
xanthine oxidase may properly be regarded as hydroxylases 
rather than dehydrogenases ( Peraul t et al. , 1961; Handler · 
et al. , 1964, and Rajagopalan et aL , 1964h). The "hydrox• 
ylase" reactions cart be visualized . as the simultaneous re-
moval of a hydride ion from the carbon atom which is oxi-
dized by the replacement of a hydroxyl ion from the reac-
tion medium. Presence of a group on the enzyme which could 
serve as a Lewis acid would facilitate such an attack. 
This role is played by molybdenum (Greenlee and Handler, · · 
1963). Competitive inhibitors of rabbit liver aldehyde ox-
idase such as phenazine methosulfate, 1-(4-pyridyl)pyri-
dinium, and formycin B also serve as substrates. Phenazine 
methosulfate is oxidized to 3-hydroxyphenazine methosulfate 
(Johns, 1967), 1-(4-pyridyl)pyridinium is oxidized to 1-(4-
pyridyl) -4' -pyridone ( Rajagopalan and Handler, 1964b) , and 
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. forinycin B is oxidized to oxoforrnycin B ( Tsukada et al., 
1969). 
6,6'-Azopurine disodium salt was found to be a conipet-
. . 
itive inhibitor of the N1-methylnicotinamide oxidase activ-
ity of the rabbit liver aldehyde oxidase and was also found 
to act as a substrate. This finding indicates that N1-
methylnicotinamide and 6, 6' -azopurine .disodium salt compete 
for a same site on the enzyme. The competitive inhibitors 
of rabbit liver aldehyde oxidase react with sulfhydryl 
groupsnear the substrate-binding site of the enzyme (Ra-
jagopalan and Handler, 1964b), Thus, the flow of the elec-
trons during the oxidation of 6,6'-azopurine disodium salt 
(NaAP) by rabbit liver aldehyde oxidase can be visualized 
as a 
Mo+6 
NaAP --• + -+ FAD -+- CoQ10 ....,. Fe __ ,. 02 
-s-s-
Aldehyde oxidase has also been isolated from human 
liver. Human liver aldehyde oxidase activity for the hy-
droxylation .of nonaldehydic heterocyclic compounds is lower 
than that in the rabbit or guinea pig liver aldehyde oxi-
dase. Like the rabbit enzyme, the human enzyme catalyzes 
the .)-hydroxylation of phenazine methosulfate and the 6-hy-
droxylation of N1-methylnicotinamide but the mechanism of 
hydroxylation of both .of these compounds is different for 
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the human enzyme. The hydroxylation of phenazine methosul-
and N1-methylnicotinamide by human liver aldehyde oxi-
is inhibited only by agents with affinity for the sub-
strate-binding site such ascyanide and N-alkylphenothia-
zines, and not be agents which inhibit the internal elec-
tron transport chain of the enzyme such as menadione and 
diethylstilbestrol (Johns, 1967). This mode of oxidation 
is unique to substrates with a positively charged nitrogen. 
The hydroxylation of other nonaldehydic heterocyclic sub-
strates follow the conventional mechanism as discussed 
earlier. 
Aldehyde oxidase has also been isolated from potato 
tubers (Solanum tuberosum) by Rothe (1974) and from Avena 
. coleoptile (Rajagopal, 1971), The difference between the · 
aldehyde oxidase from plants and liver tissues of animals 
is that . the enzyme from livers can use ferricyanide and 
2,6-dichlorophenol indophenol as an electron acceptor, 
while the enzyme from plants cannot. 
The investigation of the genetic basis of the varia-
tion in activity. of· the mammalian liver aldehyde oxidase 
showed that, iri mice, the magnitude of the enzyme activity 
is controlled by autosomal alleles (one of a pair, or any 
one ·of a series, of genes having the same locus on homoge-
neous chromosomes) acting. in an additive manner, The ac-
1.30 
tivity of enzyme was found to be under genetic control, 
while the level of the enzyme activity was found to be reg-
ulated by the endocrine system ( Gluecksohn-Waelsch et aL, 
1967, and Huff and Chaykin, 1967). 
6,6'-azopurine disodium salt (NaAP) is the first ex-
ample.of a purine dimer that can react with rabbit liver 
aldehyde oxidase. This is a very significant finding be• 
cause it has been suggested that controlled inhibition of 
aldehyde oxidase will reduce the cytotoxic effects of the 
immunosuppressive agent azathioprine and modify its chemo-
therapeutic effects in order to develop more effective 
treatment schedules (Chalmers et al., 1969). It can be 
postulated that in vivo investigation o.f the inhibition of 
mammalian aldehyde oxidase by 6,6'-azopurine disodium salt 
will provide a beneficial approach to find such an agent. 
Because of the significance of aldehyde oxidase in the 
metabolism of. a variety of biologically active N-heterocy-
clic compounds, 6,6'-azopurine disodium salt can be used in 
the investigation of the mechanism of the action of these 
compounds. 
It has been shown in our laboratory that 8,8'-dioxo-
6,6'-azopurine (DOAP) inhibits bovine milk xanthine oxidas~ 
and forms a blue chromogen. This interaction of DOAP with 
xanthine oxidase. does not .produce any change on DOAP mole- · 
lJl 
cule and the chromogenic coupling may involve a non-protein 
component of xanthine oxidase. DOAP has also been found to 
bind with bovine serum albumin (BSA). 
6,6'-Azopurine disodium salt, when oxidized by rabbit 
liver aldehyde oxidase, forms a brovin-orange complex. This 
. complex contains DOAP, possibly bound to the protein, and 
DOAP was isolated from this complex by dissolving it in 
distilled water. The structure of .the protein complex of 
DOAP would also be very interesting as compared to the 
structure of the blue chromogen of DOAP and xanthine oxi-
dase, and the DOAP-BSA complex. The elucidation of the 
· structures of these complexes would 1) establish the con-
formation of the binding sites ·involved, .2) explain the na-
ture of the interactions between oxoazopurines and molybde-
num containing metalloflavo proteins, J) throw some light 
on the mechanism of the reaction of oxoazopurines with 
these macromolecules, ' 4) help to explain the possible bio- · 
logical functions of aldehyde oxidase in ·vivo, and finally, 
5) will resolve the continuing conundrum of the complemen-
tarity of biological functions of aldehyde oxidase and xan-
thine oxidase in vivo, since it has been shown on many oc-
casions that they share some of their biological act.i,vities 
(Stanulovic, 197la). 
Knowledge of the conformation of the substrate-binding . 
132 
, . 
f 
' site would also assist in the design of specific active 
site directed inhibitors with potential value in slowing 
the metabolic inactivation of pharmacologically active sub-
strates for the enzyme. 
8,8'-Dioxo-6,6'-azopurine (DOAP) is not adequately 
soluble in physiological buffers which seriously limits the 
investigation of its in vivo biological properties. 6,6'-
Azopurine disodium is very soluble in these buffers, and 
hence can be administered at any ·desired dose. The alde-
hyde oxidase in liver would then convert !t into 8,8'-di-
oxo-6,6'-azopurine, therefore, the investigation of its bi-
ological properties in vivo can be satisfactorily caz:'ried 
out. 
The metabolic role of aldehyde oxidase is . still under 
investigation. Three possible physiological functions for 
this . enzyme have been postulated. The first is that alde-
hyde oxidase tnay be serving a protective function as a .non-
specific drug-metabolizing enzyme. · It has . been shown, for 
example, that the ?-hydroxylation and subsequent biologic . 
inactivation of the anti-neoplastic agent methotrexate by 
aldehyde oxidase in rabbit proceeds so rapidly that, for 
all practical purposes, a toxic level of this compound for 
this species cannot be. obtained (Redetzki et al., 1966; 
Johns and Loo, 1967). 
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A second possibility is that the nonphysiologic heter-
ocyclic compounds which serve as substrates that can be hy-
. droxylated .by this enzyme bear a structural resemplance to 
an as yet unidentified physiologic nonaldehydic heterocy-
clic substrate for this enzyme (Johns, 1967). 6, 6' -Azopu-
rine disodium salt (NaAP), unique in its chemical struc-
. ·ture, ·· could serve this purpose if its presence in the body 
· is demonstrated. Administration of an inhibitor of alde-
hyde oxidase at an adequate dosage shouid result in an in- .· 
creased urinary excretion, the hypothetical substrate, or 
NaAP. A third role postulated for aldehyde oxidase is the 
oxidation of aromatic aldehydes arising from dietary 
sources, or occurring .in the course of intermediarymetab-
olism (Johns, 1967). 
As mentioned earlier, · in depth study of the interac-
tions between oxoazopurines and azopurines and human . liver 
aldehyde oxidase will certainly help establish the meta-
bolic function of human liver aldehyde oxidase. 
The biochemical lesion in most cases of gout has not 
been elucidated, however, the major biochemical feature of 
gout is an elevated level of urate in the serum. - Inhibi- · 
tion of xanthine oxidase by agents like allopurinol is be-
ing used as one of the therapeutic measures .to decrease the 
serum urate levels. 8,8'-Dioxo-6,6'-azopurine (DOAP) is a 
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very potent xanthine oxidase inhibitor in vitro as well as 
in vivo. Thus, DOAP has a great potential of being de-
.. - ---
veloped as a therapeutic xanthine oxidase inhibitor in the 
treatment of gout. 
-CHAPTER VI 
SUMMARY 
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Sur/JMARY 
8,8'-DIOX0-6,6'-AZOPURINE MONOHYDRATE (DOAP) 
A. Synthesist 
i) Adenine dissolved in sulfuric acid was re-
acted with potassium bromide, potassium 
perrnanganate, and hydrogen peroxide. A 
bright-orange microcrystalline precipitate 
was isolated. 
ii) · From the enzymatic oxidation of 6,6'-azo-
purine disodium salt (NaAP) by rabbit liver 
aldehyde oxidase. 
B. Chemical . propertiesa 
· i) Empirical formulae 1 
at room temp. 1 c10H6N10o2 • H2o 
at 105°C/l hr/N2 1 c10H6N10o2 • 
ii) Partially reduced to a hydrazo compound 
8,8 1 -dioxo-6,6'-hydrazopurine monohydrate 
(DOHP). 
iii) Complete reductive cleavage resulted in 8-
hydroxyadenine. 
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iv) Air oxidation in alkali gave an azoxy com-
pound, 8,8'-dioxo-6,6'-azoxypurine hexahy-
drate trisodium salt (NaDOAXP). 
c. Physical propertiesa 
i) Bright-orange microcrystals. 
ii) · Decomposition point > 300°c. 
iii) uV characteristics• 
abs. EtOHa 230 (17.1 X 103), 302 (5.6 X 
103) , 442 ( 1L 5 X 103), and 490 ( 7. 4 X 103). 
0.1 N KOHa 220 (25.2 X 103), 245 (20.7 X 
103 ) , and 513 ( 16. 3 X 103 ) • 
0.05 M potassium phosphat~a 215 (15.8 X 
103), 242 (14.3 X 103), 345 (4.8 X 103), 
and 455 (9.0 X 103). 
i v) Ira 
C=O 1 J1760 em - 1 
-N=H- 1 1590 cm-1 
v) . Rf valuesa 
abs. EtOH1 Pyridine a 
67 . I 20 
n-Propanola Cone. NH3 a 
60 30 
Dist. H20 
13 
Dist. H20 
10 
abs. EtOH1 0.5 M Ammonium acetate 
2 
= 0.168 
= 0.267 
= o. 297 
vi ) nmr, o ppm a 
c2-H = 8.96, amide N9-H = 12.22, 
imidazole N7-H = 12.84. 
D. Biochemical and Pharmacological propertiesa 
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i) A potent inhibitor of xanthine oxidase in 
vivo. 
ii) Reduced to a hydrazo derivative, possibly 
by liver azoreductase system in vivo, and 
was excreted as such in rat urine. 
iii) Inhibited rabbit liver aldehyde oxidase, to 
a lesser extent, in vitro. 
iv) Was synthesized from the oxidation of 6,6'-
azopurine disodium salt (NaAP) by rabbit 
.!>· 
liver aldehyde oxidase. 
2 .. 8,8'-DIOX0-6,6'-HYDRAZOPURINE MONOHYDRATE (DOHP)· 
A. Synthesisa 
i) From a partial reduction of 8,8'-dioxo-
6,6'-azopurine monohydrate (DOAP by 
Sncl2/HCL 
B. Chemical propertiesa 
i) Empirical formulaea 
at room temp.a c10H8N10o2.H2o 
at l00°C/l hr/N2a c10H8N10o2• 
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ii) Slowly oxidized in alcoholic solution to 
8,8'-dioxo-6,6'-azopurine (DOAP). 
iii) Air oxidation in alkali gave an azoxy corn-
pound, 8,8'-dioxo-6,6'-azoxypurine hexahy-
drate trisodium salt (NaDOAXP). 
c. Physical properties• 
i) Tan-yellow precipitate. 
ii) Decornposi tion point > 300°G. 
iii) Uv characteristics• . 
abs. · EtOHa 280 (22.2 X 103). 
0.1 N HGla 210 (34.5 X 103), 287 (17.8 X 
103 ) .. 
i v) Ira 
G=O 1 1750 crn-l 
v) Rf .valuesa 
abs. EtOH1 Pyridine: Dist. H20 
67 20 I 13 = 0.194 
n-Propanolr Gone. NH3 a. · Dist .• H20 
60 I 30 10 ·- 0.278 
abs. EtOHr 0.5 M Ammonium acetate 
5• 2 = 351 
· vi) nmr, 6 ppm a 
C -H 2 
N -H 7 
= 8.34, amide N9-H = 10.42, imidazole 
11.88, and hydrazo N-H = 8. 92. 
D~ Biologieal propertiess 
i) Excreted in rat urine as a metabolite of 
8~8'-dioxo-6,6'-azopurin~ (DOAP) • 
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.3· . 8,8'-DIOX0-6,6'-AZOXYPURINE HEXAHYDRATE TRISODIUM SALT 
.(NaDOAXP) 
A. Synthesiss 
i) From air oxidation of DOAP in alkali. 
B. Chemical propertiess 
i) ·Empirical formulaes 
at room .temp. a c10H3N10o3Na3.6H2o 
at 165°C/l hr/Nt c10H3N10o3Na3. 
ii) Reduced to 8,8'-dioxo-6,6'-azopurine {DOAP) 
instantly in acidic solution, and slowly in 
aquious solution. 
c. Physical properties• 
i) Cherry-red precipitate. 
ii) Decomposition point >J00°G. 
iii) Uv characteristicss 
abs. EtOHs . 245 (8.4 X 10.3), J67 (2.7 X 
10.3), 416 (4.0 X 10.3), and 490 (5.5 X 10.3), 
0.1 N KOHs 220 (J0.4 X 10.3), 245 (22.4 X 
10J) , and. 51.3 ( 18. 8 X 10.3) . 
iv) Irs 
. 
r 
~: . 
~: . ;: ..•. 
f{ 
i. 
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-N=N- a 1.540 em -1 
v) Rf valuesc . 
abs. EtOHt Pyridinea Dist. H2o 
I 20 13 = 0.164 
n-Propanol: Cone. NH3 a Dist. H2o 
60 .I 
vi) nmr, o ppm 1 
C -H 2 . 
30 10 
4. 6,6'-AZOPURINE HEMIHYDRATE DISODIUM SALT (NaAP) 
A. Synthesis: (Giner-Sorolla, 1970) 
= o. 286. 
i) Air oxidation of 6,6'-bisadenine in alkali• 
B. Chemical propertiesa (Giner-Soro1la, 1970) 
i) Empirical Formulaa c10H4N10Na2.t H2o. 
ii) Aqueous solution decomposed when treated 
with dilute acid. 
C. Physical prope~ties: 
i) Red needles. 
ii) Melting point> 3.50°c. 
iii) Uv characteristics• 
abs. EtOH 1 216 ( 21. 7 X 103) , 416 ( 9. 9 X 
3 10 ). 
0,1 N KOHa 220 (14.6 X 103), 232 (15.6 X 
103), and 407 (9.5 X 103). 
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0.05 M potassium phosphatea 212 (17.8 X 
103), 392 (8.7 X 103 ). 
iv) Ira 
-1 
-N=N- 1. 1530 em · 
v) Rf valuesa 
abs. EtOHs Pyridiner Dist •. H2o 
67 20 13 
abs. EtOHa 0.5 M Ammonium acetate 
5r 2 
vi) nmr, 6 ppmr 
C2-H = 8~82, c8-H = 8.38. 
D. Biological propertiesa 
= 0.248 
= o. 773 
i) Potent inhibition of rabbit liver aldehyde 
oxidase in vitro, causing 50% inhibition at 
a final concentration (I) 50 of 2.6 X 10-
6 
M, and with an inhibitor constant (K1 ) of 
-6 3.33 X 10 M at pH 7.8. 
ii) Acted as substrate for rabbit liver alde-
hyde oxidase and was oxidized to 8,8'-di-
oxo-6,6'-azopurine (DOAP). 
5· 6,6'-BISADENINE MONOHYDRATE (HP) 
A. Synthesis: (Giner-Sorolla, 1970) 
i) 6-Chloro·purine in 50% aqueous ethanol and 
14) 
6-hydrazinopurine in water were refluxed at 
70°C for 6 hr. 
B. Chemical propertiesa (Giner-Sorolla, 1970) 
i) Empirical Formulas c10H8N10 .H20. 
ii) Alkaline solution turned red due to air 
oxidation (transformatipn into the azo 
derivative). 
iii) Uv characteristics& 
iv) 
abs. EtOHa 211 (6.1 X lOJ), 272 (4,) X 
lOJ), and )45 (),2 X lOJ). 
0.1 N HCla 210 (24.) X lOJ), 274 (22.6 X 
103), and JJ8 ( 7. 2 X lOJ). 
Rf values a 
abs. EtOHa Pyridine a Dist. H20 
67 20 lJ = 0.2)6 
n-Propanola Cone. NHJa Dist. H20 
60 JO 10 = 0.495 
v) nmr, 6 ppm& 
c2-H = 8.52, c8-H = 8.52, imidazole N7-H = 
1).42, and hydrazo N-H = 10.04. 
6. 6,6'-AZOXYPURINE DIHYDRATE DISODIUM SALT (NaAXP) 
A. Synthesis: (Giner-Sorolla, 1970) 
i) 6-Hydroxylamine was suspended in concen-
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trated ammonium hydroxide for .5 days and 
. precipitate was treated with sodium hy-
droxide. 
B. Chemical propertiesa (Giner~Sorolla. i970) 
i) Empirical formula1 c10H4N10Na2o2 ~ H20. 
ii) Aqtieous solution decomposed when treated 
with .dilute acid. 
C. Physical properties1 
i) . Red needles. 
ii) Melting poin~ >J50°C. 
iii) Uv characteristics1 
abs. EtOH1 216 (21 . .5 X 103), 416 (9.6 X 
103) ~ 
0 .• 1 N KOH1 220 (15.7 X 103), 232 (16.0 X 
J . . 3 
10 ), and. 407 (9.9 X 10 ). 
iv) Ira 
-N=N- 1 1.530 cm-l 
v) Rf valuesa 
abs. EtOHa Pyridinea Dist. H 0 2 
67 . I 20 I . 13 
abs. EtOH1 0.5 M Ammonium acetate 
5: 2 
vi) nmr, 6 ppm1 
c2-H = 9.08, c8-H = 8~64. 
- 0.248 
= 0.773 
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Figure 1 
. Chemical structure of a parent member of a new class 
of compounds, i.e. oxoazopurines • . 8,8'-dioxo-6,6'-azo-
purine monohydrate (DOAP) was synthesized by reacting ade-
nine dissolved in H2so4 with KBr, KMno4 and H2o2• 
8,8'-DIOXO-- 6,&'-AZOPURINE MONOHYDRATE 
(DOAP} 
Figure 1 
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0• H 0 2 
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Figure 2 
Keto-enol tautomerism of 8,8'-dioxo-6,6'-azopurine (DOAP) 
KETO-ENOL. TAUTOMERISM OF 
B,I:...DIOXO -&,6'- AZOPUAINE (DOAP) 
Figure 2 
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Figure 3 
Chemical structure of a hydrazo derivative of 8,8'-
. ' 
dioxo-6,6'-azopurine monohydrate (DOA::P). It was synthe-
sized by partial reduction of DOAP using SnC12/HCl at 70°C, 
and has the structure of 8,8'-dioxd-6,6'-hydrazopurine 
monohydrate (DOHP). 
' ~r· 0•~0 
9 . 
N ~-
8,8'~DIOX0-6,6'-HYDRAZOPURINE MONOHYDRATE 
(DOHP) 
Figure 3 
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Figure 4 
Chemical structure of sodium salt of an azoxy deriv-
ative of 8,8'-dioxo-6,6'-azopurine monohydrate (DOAP). It 
was synthesized by air oxidatibn of DOAP dissolved in 0.005 
N NaOH and also of that of DOHP dissolved in 0.5 N NaOH and 
has the structure of 8,8'-dioxo-6,6'-azoxypurine hexahy-
drate trisodium salt (NaDOAXP). 
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8,8'-DIOX0-6,6~AZOXYPURINE HEXAHYDRATE TRISODIUM SALT 
(NaDOAXP) 
Figure 4 
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Figure 5 
The oxidation of 8,8'.:.dioxo-6,6'-hydrazopurine (DOHP) 
to 8,8'-dioxo-6,6'-azopurine (DOAP) was followed by moni-
toring the decrease in the optical density at 282 nm of a 
10 llg/ml solution of DOHP in absolute ethanol at room tem-
perature. No significant change in the optical density at 
282 nm (). of DOHP) was found up to 30 min. · After 30 
. max · 
min, the optical density at 282 nm started to decrease 
while that at 442 nm ( Aa· of DOAP) started to increase. m x 
·After standing at room temperature for 48 hr the optical 
density at 282 nm completely .disappeared and that at 442 nm 
reached a peak, indicating that DOHP was converted to DOAP. 
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OXIDATION OF 8,8'-DIOX0-6,6'-HYDRAZOPURINE (DOHP) 
TO 8,8'-DIOX0-6,6'~AZOPURINE (DOAP) 
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Figure 6 
Chemical structure of 6,6'-azoputine hemihydrate 
disodium salt (NaAP) . . Source& Giner-Sorolla, 1970. 
l~ 
r 
N===================N 
6,6~AZOPURINE HEMIHYDRATE DISODIUM SALT 
(NaAP). 
Figure 6 
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Figure 7 
Chemical structure of 6,6'-bisadenine monohydrate 
(HP). Sourcer · Giner-Soro11a, 1970~ 
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6,6'- BISADENINE MONOHYDRATE 
( 6,6'- HYDRAZOPURINE MONOHYDRATE) 
( HP) 
Figure 7 
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Figure 8 
Chemical structure of 6,6'-azoxypurine dihydrat~ 
disodium salt (NaAXP) • . Sourcea Giner-Sorolla, 1970. 
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Figure 9 
Separation of authentic samples of purine der~vatives 
on a 40 X 0.9 em glass column packed with AG .50W-X8 (H+ 
form), 200-400 mesh resin. The column was eluted with a 
gradient . system having a reservoir containing 2000 ml of .5 
N HCl and a mixing chamber with .500 ml of distilled water. 
The running pressure was adjusted to give a constant flow 
rate of 1 tube containing 3 ml of the eluent per .5 min 
' (0.6 psi). A total of 3.50 tubes were collected on an auto-
matic fraction collector. Optical densities of these tubes 
were read at 208, 21.5, 2.50, 260, 280, and 30.5 nm, us.ing a 
Beckman DB-G recording spectrophotometer. 
Abbreviations u~eds 2,8-DOAd= 2,8-Dioxoadenine, 
8-0Ad= 8~0xoadenine, 2-0Ad= 2-0xoadenine, Ad= Adenine, and 
DOHP= 8,8'-Dioxo-6,6'-hydrazopurine monohydrate. 
AUTHENTIC SAMPLES . OF PURINE DERIVATIVES 
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Figure 10 
Reductive cleavage of 25 ' mg ,of 8,8'-dioxo-6,6'-azo~ 
purine (DOAP) dissolVed in 150 ml of 1 N NaOH was carried 
out by reacting it with 1.0 gm of sodium hydrosulfite 
(Na2s2o4). The reaction mixture was rafluxed at 80°C for 1 
hr. A 4ml aliquote of the resulting yellow solution was 
neutralized to pH 7.0 byadding 1 N HCl, adjusted to equiv-
alent of 0.5 N HCl and was applied to a 21.0 X 0.9 em glass , I 
+ column packed with AG 50W-X8, 200~l.J-OQ mesh, H form resin. 
The .column was eluted with a gradient of HCl equipped with 
a reservoir containing 2000 ml of 5 N HCl and a m~xing 
chamber containing 500 ml of distilled water. The r ,unning 
pressure was adjusted to a constant flow rate of 1 tube 
containing 3 ml of the eluent per 5 miri (0,6 psi). A total 
350 tubes were collected on an automatic fraction collector. 
The optical dens.ities of each tube was determined at 208, 
215, 250, 260, 280, and 350 nm, using a Beckman DB-G 
spectrophotometer. 
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Figure 11 
Uv spectra of authentic sample of oxoadenine com-
pounds. in 1 N HCL 
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Figure 12 
Uv spectra of AG 50Vl-X8 chromatographic fraction 
no. 127 obtained fr~m Na2s2o4/Na0H reductive cleavage of 
8,8t-dioxo-6,6'-azopu~ine (DOAP). 
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Figure 13 
Uv spectra of' authentic sample of 8-oxoadenine in 
1 N NaOH and dimethylsulfoxide (DMSO). 
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Figure 14 
Uv spectra of 8-oxoadenine obtained from Na2s2o4/NaOli 
reductive cleavage of 8,8'-dioxo-6,6'-:-azopurine and iso-
lated · from a AG .50W-X8 chromatographic column in 1 N NaOH 
and dimethylsulfoxide (DMSO}. 
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Figure 15 
Interconversion of oxoazopurines and the structure of 
the product of the reductive cleavage of 8,8'-dioxo-6,6'-
azopurine (DOAP). 
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Figure 16 
Nuclear magnetic resonance spectrum of 8,8'-dioxo-
6,6'-azopurine monohydrate (DOAP). 
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NUQ.EAR MAGNETIC RESONANCE SPECTRUM OF 
8,8~DIOX0-6, 6~AZOPURINE MONOHYDRATE ( DOAP) 
Nucleus• 1H InstrUJDent. Varian A-60A 
Reference• TMS Solvent• DMSO-d6 
Temp, ( °C )I probe Sweep rate (Hz/ sec). 4 
Assignments• 
Peak PPM (a) relative int. ('' integer area 
to TMS in mm. ratio 
a 8,90 22 1 
b 12.26 20 1 
c 12.72 21 1 
Figure 16 
Frequency• 60 
Cone, (~/ml)• 20 
Formula• c10H6N10o2.H20 
type of protons 
present 
2 c2-H protons 
2 amide N9-H 
protons 
2 imiduo1e 
N7-H protons 
TMS 
177 .· 
l 
r 
r 
Figure 17 
Nuclear magnetic resonance spectrum of8, 8 '-dioxo-
6,6'-azopurine monohydrate (DOAP)a o2o exchange. 
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NUCLEAR MAGNETIC RESONANCE SPECTRUM OF 
8,8'-DIOX0--6,6'-AZOPURINE MONOHYDRATE (DOAP) 
( + 25 .,, 020) 
Instrument• Varian A-60A 
Referencea TMS Solventa DMSO-d6 
T.-p •. (°C)a probe Sweep rate (Hz/sec)a 4 
Frequencya 60 
Cone. (mg/ml)a 20 
. Pormulaa c10H6N10o2.~o 
Assignments 1 
Peak PPM (6) relative int. area integer type of protons 
to TMS in ll1111. 
a 8.90 
16 15 14 13 12 11 
ratio present 
H20 
a 
9 8 7 6 5 4 . 3 2 
PPM ( 1J J 
Figure 17 
TMS 
1 
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Figure 18 
Nuclear magnetic resonance spectrum of 8,8'-dioxo-
6,6'..:hydrazopurine monohydrate (DOHP). 
NUCLEAR MAGNETIC RESONANCE SPECTRUM OF 
8,8'-DIOX0-6,6:._HYDRAZOPURINE MONOHYDRATE ( DOHP) 
Nucleusa 1H Instrument• Varian A-60A Frequency• 60 
Reference• TMS Solvent• DMSO-d6 
Temp. (°C)a probe Sweep rate (Hz/sec)t 4 
Cone, (mg/ml)a 20 
Formulat c10H8N10o2.H20 
Assignments a 
Peak PPM ( 0) relative int. area integer type of protons TMS 
to TMS in mm. ratio :Qresent 
a 8,J4 41 1 2 c2-H protons 
b 8.92 42 1 2 hydrazo H'N-N~H 
protons CHd2SOCd3 
c 10.42 40 1 2 amide N9-H 
protons 
d 11.88 39 1 2 imidazole N7-H 
protons 
16 15 14 13 1 2 11 1 Cl 9 8 7 6 5 4 3 0 
PPM (b) 
~!!"--·-·-··--~---,· ----------- ---~---- -- ·---------~-- ·--
Figure 18 
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Figure 19 
Nuclear magnetic resonance spectrum of 8,8'-dioxo-
6,6'-hydrazopurine monohydrate (DOHP)t o2o exchange • . 
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NUCLEAR MAGNETIC RESONANCE SPECTRUM OF 
8,8'-DIOX0-6,6~HYDRAZOPURINE MONOHYDRATE (DOHP) 
(+ 25 ~· 020) 
Nucleusa 1H 
Referencea TMS 
Instrument• Varian A-60A 
Solventa DMSO- d6 
Temp. (·°C)a probe Sweep rate (Hz/sec)a4 
Frequencya 60 
Cone. (mg/ml)a 20 
Formulaa c10H8N10o2.H20 
Assignments a 
Peak PPM (6) relative int. area integer type of protons TMS 
-- to TMS in mm. ratio Ere sent 
a 8.)4 
- -
2c2-H protons CHd2SOCd3 
a H20 
. 
l.owa.tAIAo~. ............ , • &A.. a.rc.. ... - ~- ~ \ ..,J,._,). .......,. ,._ .,., i "'""j' ... 1 ... .. i I ~ I T~· 1 .•. .,.. 
16 15 14 13 12 11 10 9 8 7 6 5 4 3 2 1 0 
PPM ( 6 ) 
Figure 19 
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Figure · 20 
Nuclear magnetic resonance spectrum of 8,8'.;.dioxo-
6,6'-azoxypurine hexahydrate trisodium salt (NaDOAXP). 
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NUCLEAR MAGNETIC RESONANCE SPECTRUM OF 
8, a'-DIOX0-6, 6'-AZOXYPURINE HEXAHYDRATE TRISODIUM SALT ( NaDOAXP) 
Nucleus• 1H Instrument• Varian A-60A 
Reference• TMS Solvent• DMSO-d6 
Temp. ( 0 c) 1 probe Sweep rate (Hz/ sec) • 4 
Frequency• 60 
Cone. (mg/ml)• 20 
Formula! ClOHJNl003NaJ.6H20 
Assignments• 
Peak PPM (6.) relative int. area integer type of protons 
to TMS in mm. ratio present CH2dSOCd3 
a 8.56 35·5 2 2 c2-H protons 
b 11.78 17.5 1 1 imidazole TMS 
J K7-H proton 
__/ H20 
a 
16 15 14 13 12 11 10 9 7 6 5 4 3 2 1 
PPM ( & ) 
Figure 20 
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Figure 21 
Nuclear magnetic resonance spectrum of 8,8'-dioxo-
6,6'-azoxypurine hexahydrate trisodium salt (NaDOAXP)• n2o 
exchange. 
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NUCLEAR MAGNETIC RESONANCE SPECTRUM OF 
8,8'-DIOXQ-6, &:....AZOXYPUR IN E HEXAHYDRATE TRISODIUM SALT ( NaDOAXP) 
(+ 25 ... 020) 
Nucleuss 1H 
References 'l'MS 
Instruments V9r!an A-60A 
Solvents DMSO-d6 
Temp. (°C)s probe Swe.ep rate (Hz/sec)s 4 
Frequency• 60 
Cone. (mg/ml)s 20 
Formulas c10H3N10o3Na3 .6H20 
Assignments• 
Peale PPM (6) relatl.ve int. area integer type ot protons 
-- to T14S in mm. ratio present 
a 8.56 
- -
2 c2-H protons CH2dSOCd3 
TMS 
H20 
a 
J&J, 
-·-
.J. • .II. Jl. _']. \..L .-.A. \1 
·-
,. ... .. ,.,.. 
'I 
·-
~ ] _j_ - ..... l 
16 15 14 13 12 11 10 9 8 7 6 5 4 3 2 1 0 
PPM (0) 
---- ~-- ··-- - -
Figure 21 
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Figure 22 
Nuclear magnetic resonance spectrum of 6,6'-azopurine 
hemihydrate disodium salt (NaAP). 
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NUCLEAR MAGNETIC RESONANCE SPECTRUM OF 
6,6'-AZOPURINE HEMIHYDRATE . DISODIUM SALT (NaAP) 
NucleuS! 1H Instrument, Varian A60-A Frequency (MHz)• 60 
189 
Reference• TMS 
Temp. (°C), probe 
Solvent• DMSO-d6 
Sweep rate (Hz/sec), 4 
Cone. (mg/ml)l 20 
Formula! c10H4N10Na2.tH20 
Assignments, 
Peak PPM (6) relative int. area integer type of 
a 
b 
to TMS in mm. ratio protons 
8.42 18 1 
8.84 18 1 
b a 
PPM (b) 
Figure 22 
present 
2 c8-H 
protons 
2 c2-H 
protons 
TMS 
-l 
r 
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Figure 23 
Nuclear magnetic resonance spectrum of 6,6'-azopurine 
hemihydrate disodium salt {NaAP) a n2o exchange. 
NUCLEAR MAGNETIC RESONANCE SPECTRUM OF 
6,6'-AZOPURINE HEMIHYDRATE DISODIUM SALT ( NaAP) 
· Instrument• Varian A-60A 
Reference• TMS Solvent• DMSO-d6 
Temp. (°C)I probe Sweep rate (Hz/sec)l 4· 
Assignments• 
Peak PPM (6) relative int. area integer 
-- to TMS in mm. ratio 
---
a 8,)2 19 1 
b 8.76 19 1 
..... 
b a 
-
t.A •. II, ,.., II . • L .l ... " 
. .,.,r ""'"P" ...,... . ,, "1-r..-T' I' ., ..,. . 
Frequency (MHz)• 60 
Cone. (mg/ml)• 20 
Formula! c10H4N10Na2.tH2o· 
type of c ~2dSOCd3 
protons 
present 
2 c8-H 
protons 
2 c~-H 
protons 
H20 TMS 
y ......... J J 
t" ,..-
;... 
16 15 14 13 12 11 10 9 8 7 6 5 4 3 2 1 0 
PPM ( ~) 
Figure 23 
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Figure 24 
Nuclear magnetic resonance spectrum of 6,6•-bisade- . 
nine monohydrate (HP). 
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NUCLEAR MAGNETIC RESONANCE SPECTRUM OF 
6,6'-BtSADENINE MONOHYDRATE (HP) 
Nucleusa 1H Instrument• Varian A60-A 
Referencea TMS Solventa DMSO-d6 
Temp. (°C)a probe Sweep rate (H!!/sec)a 4 
Frequency (MHz)a 60 
Cone. (mg/ml)a 20 . 
Formula• c10H8N10.H20 
Ass1gnmentsa 
Peak PPM (6) relative int. area integer type of protons . 
to TMS in mm. ratio present 
TMS 
a 8.52 6J 2 2 c2-H and 2 c8-H protons 
b 10.04 Jl 1 2 hydrazo H'N-N'H 
CHd2SOCd3 protons 
c 1,).42 26 · r 1 2 imidazole N7-H 
protons 
c a H20 
16 15 14 13 12 11 10 9 8 7 6 5 4 3 2 1 0 
Figure 24 
Figure 25 
Nuclear magnetic resonance spectrum of 6,6'-azoxy-
purine dihydrate disodium salt (NaAXP). 
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NUCLEAR MAGNETIC RESONANCE SPECTRUM OF 
6, 6!.-AZOXYPURINE DIHYDRATE DISODIUM SALT 
(NaAXP) 
Reference• TMS 
Temp. (°C)• probe 
Instrument• Varian 1.60-1. 
Solvent, DMSO-d 6 
Sweep rate (Hz/ sec) ·, 4 
Frequency (MHz)t 60 
Cone. (mg/ml) 1 20 
Pormulat c10H4N100Na2.2H20 
Assignments• 
Peak PPM (6) relative 
--
int. area integer type of protons 
to TMS in mm, ratio present 
---
a 8.64 J2 1 2 c8-H protons 
TMS 
b 9.04 29 1 2 c2-H protons 
CHdaSOCd3 
b rr a H20 
-
I~ 
.-
~ y ; -.. ,'"" T I _[ ._l ., j -, ... I I 1 
16 1 5 14 13 12 11 10 9 8 7 6 5 4 3 2 1 0 
Figure 25 
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Figure 26 
Nuclear magnetic resonance spectrum of adenine (6-
aminopurine). 
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NUCLEAR MAGNETIC RESONANCE SPECTRUM OF 
ADENINE 
Reference• TMS 
Temp. (°C )t probe 
relative 
to TMS 
?.J6 
8.44 
1).28 
Instrument• Varian A60-A 
Solvent• DMSO-d6' 
Sweep rate (Hz/sec)t 4 
Frequency (MHz)' 60 
Cone. (mg/ml)' 20 
Formula' C 5H 5N 5 . 
int, area integer type of protons 
in mm. ratio present 
TMS 
60 2 2 amino NH2 CHd2SOCd3 protons 
. 59 2 1 c2-H and 
1 c8-H proton 
29 1 1 imidazole 
N7-H proton 
16 15 14 13 12 11 10 9 8 7 6 5 4 3 2 1 0 
PPM ( t) 
Figure 26 
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Figure 27 
.Nuclear magnetic resonance spectrum of hypoxanthine 
(6-oxopurine). 
NUCLEAR MAGNETIC RESONANCE SPECTRUM OF 
HYPOXANTHINE 
Nucleus, 1H Instrument• Varian A60-A 
Reference• TMS Solvent1 .DMSO-d6 
Temp. ( 0c) • probe Sweep rate (Hz/ sec), 4 
...::.. 
Frequency (MHz)• 60 
Cone • (.mg/m1) • 20 
Formula• c5H4N4o 
Assignments• 
Peak PPM (6) relative int. area integer type of protons TMS 
-- to TMS in mm. ratio present 
---
a 8.28 40 i 1 c8-H proton CHd2SOCd3 
b 8.4) 41 1 1 c2-H proton 
.c 12.88 35 1 1 amide N1..;H 
proton 
d 1).?6 J9 r1 1 imidazole J. N7-H proton H20 b • 
. ....-
..•. -
.J '1' .l.J ~ I ~I lAo. 
1 .. " .,.., ..... ] ..1 
16 15 14 13 12 11 10 9 8 7 6 5 4 3 2 1 0 
PPM ( c6) 
Figure 27 
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Figure 28 
Nuclear magnetic resonance spectrum of xanthine (2,6-
dioxopurine). 
NUCLEAR MAGNETIC RESONANCE SPECTRUM OF 
XANTHINE 
Nucleus• 1H Instrument• Varian A60-A 
Reference• TMS Solvent• DMSO-d6 
Temp. (°C)I probe Sweep rate (Hz/sec)• 4 
Frequency (MHz)• 60 
Cone. (mg/ml)• 20 
Formula• c5H4N4o2 
Assignments• 
~ PPM (6) relative int. area integer type of protons TMS 
to TMS in nun. ~ present CHd2SOCd3 
a 8.26 )8.5 1 1 c8-H proton 
b 11.20 41.0 1 1 amide N1-H 
proton 
c 11.92 )7.5 1 1 amide N3-H 
proton 
d 1).76 )9.0 1 1 imiclazole 
1 
( (b r N7-H proton c a 
-
H20 
~ 
-
~· 
....tt-rw-r""" .... L '" .! J. J ... .iAJ ~ 
_L 
··r I _:t ... I I ., 
16 15 14 13 12 11 10 9 8 7 6 5 4 3 2 1 
Figure 28 
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Figure 29 
Uv spectra of 8, 8 '-dioxo-6 ,6' -hydrazopurine ( DOHP) ,' · 
8,8'-dioxo-6,6'-azopurine (DOAP), and 8,8'-dioxo-6,6'-
azoxypurine trisodium salt (NaDOAXP) in .absolute ethanol 
qbtained at appropriate concentrations on a Beckman DB-G 
recording spectrophotometer. 
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UY SPECTRA OF .8,1' - DIOXO- &,s'- HYDRAZOPURI NE (DOHP) 1 
l,i- DIOXO- 6, 1' -AZOPURINE (DOAP), AND 8,1'- DIOXO-
6,1-AZOXYPURINE TRISODIUM SALT (N•DOAXP) IN obo. EIOH 
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Figure 30 
Uv spectra of 6,6'-bisadenine (HP), 6,6'-azopurine 
disodium salt (NaAP) and 6,6'-azoxypurine -disodium salt 
(NaAXP) in absolute ethanol obtained at appropriate concen-
trations on a Beckman DB-G recording spectrophotometer. 
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Figure 31 · 
Uv spectra of 8,8'-dioxo-6,6'-hydrazopurine (DOHP), 
8,8'-dioxo-6,6'-azopurine (DOAP), and 8,8'-dioxo-6,6'- . 
azoxypurine trisodium salt (NaDOAXP) in 0.1 N KOH obtained 
at appropriate concentrations on a Beckman DB-G recording 
spectrophotometer. 
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Figure .32 
Uv spectra of 6,6'-bisadenine (HP), 6,6'-azopurine 
. , 
disodium salt (NaAP) and 6,6'-azoxypurine disod,ium salt 
· (NaAXP) in 0.1 N KOH obtained at appropriate concentrations 
ori a Beckman DB.:.G recording spec;:trophotometer. 
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UV SPECTRA. OF &,1'-BISADENINE (HP), 6,6'-AZOPURINE 
DISODIUM SALT ( NaAP), AND &,S-AZOXYPURINE . DISODIUM 
SALT (NaAXP) IN 0.1 N KOH 
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Figure 33 
Uv spectra of 8,8'-dioxo-6,6'-hydrazopurine (DOHP) 
and 6,6'-bisadenine (HP) in 0.1 N HCl obtained at appropri-
ate concentrations on a Beckman DB-G recording spectro~ 
photometer. 
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Figure 34 
Uv spectra of 8,8'-dioxo-6,6'-azopurine (DOAP) and 
6,6'-azopurine disodium salt (NaAP) in 0.05 M potassium 
phosphate, pH 7.8 obtained at appropriate concentrations on 
a Beckman DB-G recording spectrophotometer. 
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OF 111'-DIOX0-111'-AZOPURINE Y!OAP) AND 
DISODIUM SALT · (N•AP) IN 0.05 M POTASSIUM 
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Figure 3 5 
Uv spectra of 8.0 X 10-5 M 8,8'-dioxo-6,i'-azopurine 
(DOAP) in 0.05 M potassium phosphate at pHs 6.2, 6.6, 7.0, 
7.4, 7.8 and 8.2 were obtained on a Beckman DB-G recording 
spectrophotometer. 
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Figure 36 
Uv spectra of 8,8'-.dioxo-6,6'-azopurine (DOAP) in 
0.05 M potassium .phosphate containing 0,005% EDTA, pH 7.8 
obtained at appropriate concentration on a Beckman DB-G 
recording spectrophotometer. 
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UY SPECTRUM OF 1,1'-DIOXO-a,e-AZOPURINE IN O·OSM POTASSIUM 
PHOSPHATE CO.NTAINING Q.Oos% EDTA, pH 7.1 
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· Figure · 37 · 
Effect of pH on stability of 8,8'-dioxo-6,6'-azo-
purine (DOAP) in 0.05 M potassium phosphate buffer at 25°C. 
Optical density at 455 nm of 8.0 X 10-5M DOAP in 0.05 M 
potassium phosphate was monitored against the buffer for 10 
min using a chart speed of 1 inch/min. 
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Figure 38 
Effect of pH on stability of 8,8'-dioxo-6,6'-azo-
purine (DOAP) in 0.05 M potassium phosphate buffer at 25°C. 
Optical density at 455 nm of 8.0 X 10-5M DOAP in 0.05 M 
potassium phosphate was monitored against the buffer for 60 
min using a chart speed 0.1 inch/min. 
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Figure 39 
Uv spectra of 8.0 X 10-5 M 6,6'-azopurine disodiurn 
salt (Na.AP) in 0.05 M potassium phosphate at pHs 6.2, 6.6, 
. . 
7.0, 7.4, 7.8, and 8.2 were obtained on a Beckman DB-G ·re-
co~ding spectrophotomete~. 
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Figure 40 
Effect of pH on ·stability of 6,6'-azopurine disodium 
salt (NaAP) in 0.05 M potassium phosphate buffer at 25°C. 
Optical . density at 390 nm of 8.0 X 10-5M NaAP in 0.05 M 
potassium phosphate was monitored against the buffer for 10 
min using a chart speed of 1 inch/min. 
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Figure 41 
. Ef'fect of pH on stability of 6, 6' -azopurine disodium 
salt (NaAP) in ·o.05 M potassium phosphate buffer at 25°C. 
Optical d~nsi ty at 390 nm of 8. 0 .X 10 ... 5 M NaAP in 0. 0 5 M . • 
potassium phosphate was monitored against the buffer for 60 
min using.a chart speed of 0.1 inch/min. 
EFFECT OF pH ON STABILITY OF ... AP IN 
. 0 
0.05M POTASSIUM PHOSPHATE BUFFER, 25 C 
pH7.4 
:;.:;==-
pH7.1 
PH6.8 
t 
0 . 10 al 79) pg/al Ne.AP in dbt. H2o added 
to 2.90 al of 0.0!)111 Pota .. iua Phosphate 
Buffer fOr · a final cone, of 8 x 10-1M Ne.AP 
-------·- --- --
··- ·--·-----
min. efler eddltlon of NeAP 
Figure 41 
227 
l 
-···. 
228 
Figure 42 
A300 method used to investigate the in vitro inhibi~ 
tion of rabbit liver aldehyde oxidase by 6,6'-azopurine di-
sodium salt (NaAP). Each experimental cuvette contained 
2.2.5 mlof 0.0.5 M.potassium phosphate buffer containing 
0.00.5% EDTA, pH 7.8, 0.2.5 ml of 0.06 M solution of N1-meth-
ylnicotinamide chloride, and 0. 2.5 ml of 2 • .5 mg/ml solution . 
of NaAP in 0.0.5 M potassium phosphate buffer pH 7.8. After 
a .5 min equilibration period at 2.5°C, 0.2.5ml of ,5.04 mg 
protein/ml rabbit liver aldehyde oxidase was added to the 
cuvette. · The cuvette contents were rapidly mixed, and A300 
nm was recorded with time against a reference cell from 
which the substrate had been omitted. 
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INHIBITION OF RABBIT LIVER ALDEHYDE OXIDASE BY 6,6:.,..AZOPURINE DISODIUM SALT (NaAP) 
( 6 A300 METHOD) 
0.05 M POTASSIUM PHOSPHATE BUFFER, pH 7.8, 25°C 
250 pi OF ALDEHYDE OXIDASE (5.04 mg PROTEIN/ml) 
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Figure 42 
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Figure 4} 
Oxidation of 5.0 X 10-3 M N1-methylnicotinamide chlo-
ride by . rabbit liver aldehyde oxidase. Each experimental 
cuvette contained 3 ml of reaction mixture containing an 
appropriate volume of 0~05 M potassium phosphate buffer 
containing 0.005% EDTA, pH ?.8, and 0.25 ml of 0.06 M solu-
tion of N1-rnethylnicotinamide chloride. After a 5 min 
equilibration period at 25°C, 25, 50, 100, 150, 200, and. 
250 pl of 5. OL~ mg prote in/ml rabbit liver aldehyde oxidase 
was added to the cuvette and its contents were mixed rap-
idly. Optical density of this solution at 300 nm was re-
corded against a reference cell from which the substrate 
. ha~ been omitted. 
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OXIDATION OF S.O X 10-3M N
1
-METHYLNICOTINAMIDE CHLORIDE BY 
RABBIT LIVER ALDEHYDE OXIDASE 
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Figure 44 
Determination of optimal substrate and enzyme concen-
tration for the oxidation of N1-methylnicotinamide chloride · 
by the rabbit liver aldehyde oxidase. A procedure same as 
that described for Figure 4J was used. 
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(5·04 mg PROTEIN/ml) 
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Figure 45 
Inhibition of rabbit liver aldehyde oxidase by .6,6'-
azopuririe disodium salt (NaAP) at 2.5°Ca Concentration of 
NaAP causing a .50% inhibition of rabbit liver aldehyde 
oxidase in vitro, i.e. (!) 50 at 7.8. Each experimental · 
cuvette contained an appropriate volume of 0.0.5 M potassium 
phosphate buffer containing 0.00.5% EDTA, pH 7.8, 0.2.5 ml of 
o.o6 · M solution of N1-methylnicotinamide chloride, and an 
appropriate volume of ·2 • .5 mg/ml solution .of NaAP in 0.0.5 M· 
potassium phosphate buffer, pH 7.8. After a .5 min equili-
bration peri()d 0.25 ml of ).04 mg protein/ml rabbit liver 
aldehyde oxidase was added to the cuvette. The cuvette 
contents were rapidly mixed, and AJOO nm was recorded a-· 
gainst a reference cell from which the substrate had been 
omitted. 
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Figure 46 
Inhibition ofrabbit liver aldehyde oxidase by 6,6'-
azopurine disodium salt (NaAP) at 25°Ca Concentration of 
NaAP causing a 50% inhibition of rabbit liver aldehyde oxi-
dase in vitro, i.e. (I) 50 at pH 8.2. The~A300 nm method 
described for Figure 45 was used. 
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Figure 47 
Inhibition of rabbit liver aldehyde oxidase by men-
adione at 25°Ca Concentration of menadione causing a 50% 
inhibition of the enzyme in vitro, {!) 50 at pH 7.8. The 
A300 mil method describeci for Figure 45 was employed sub-
stituting menadione for NaAP. 
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Figure 48 
In vitro inhibition of rabbit liver aldehyde oxidase 
by 8,8'-dioxo-6,6'-azopurine (DOAP) at pH 8.2. The~A300 
nm method described for Figure 45 was employ€d using DOAP 
instead of NaAP. 
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Figure 49 
Lineweaver-Burk plot of the in vitro inhibition of 
rabbit liver aldehyde oxidase by 6,6'-azopurine disodium 
salt ( NaAP) at pH 7. 8. TheA A300 nm method described for 
Figure 42 was used. 
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Figure SO 
Dixon plot of the in vitro inhibition of rabbit liver 
aldehyde oxidase by 6,6'-azopurine disodium salt (NaAP) at 
pH 7.8. TheD.A300 nm method described for Figure 42 was 
used. 
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Figure 51 
Lineweaver-Burk plot of the in vitro inhibition of 
rabbit liver aldehyde oxidase by menadione -at pH 7.8. The 
oA300 _nm method described for Figure 45 was used. 
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Figure . sz · 
Enzymatic synthesis of 8,8'.:.dioxo-6,6'-azopurine 
(DOAP) from the oxidation of 6,6'-azopurine disodium salt 
(NaAP) by rabbit liver aldehyde oxidase. In a 25-ml glass 
tube, . 2. 5 mg NaAP dissolved in 10 ml of dist. H20, 7·. 5 ml 
of 0.05 M potassium phosphate buffer containing 0.005% 
EDTA, pH 7.8, · 2.5 ml of 5.04 mg protein/ml rabbit liver 
aldehyde oxidase were incubated at 25°C for 15 min. A 
brown precipitate. was obtained from the reaction mixture, . 
by adding 6.16 gm of solid ammonium sulfate (NH4 ) 2so4 for 
a 50% saturation and centrifugation at 8000 rpm for 20min 
at 4°c. · The brown precipitate was washed twice .bydis-
solving in 25 ml of dist. H2o acidified with 2 ml of 5 N 
HCl, and centrifugation at 8000 rpm for 20 min at 4°C. At 
the end, a bright-orange microcrystalline precipitate hav-
ing uv characteristics and Hf values exactly the same as 
those of authentic sample of DOAP was obtained. 
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Figure 53 
Uv spectra of the reaction mixture containing 250 f..Ll 
of 5.04 mg protein/ml rabbit liver aldehyde oxidase, 250 J..Ll 
of 0.25 mg/ml 6,6'-azopurine disodium salt (NaAP), and 2.5 
ml of 0.05 M potassium phosphate buffer containing 0.005% 
EDTA, pH 7.8 at·o min (before adding enzyme), 15 min and 
360 min after adding the enzyme. 
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Figure ·s4 
Uv spectra ·of . the reaction mixture containing 250 ~1 
of 0.25 mg/ml 6,6'~azopurine disodium salt (NaAP) in dist. · 
H2o and 2.50 ml of 0.05 M potassium phosphate containing 
0.005% EDTA, pH 7.8 at 0 min, 15 min, and 260 min, showing 
that NaAP under these conditions did notchange up to .360 
min •. 
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Figure 55 
Uv spectra of enzymatically synthesized 8,8'-dioxo-
6,6'-azopurine (DOAP), chemically synthesized DOAP, and 
6,6'-azopurine disodium salt (NaAP) dissolved in absolute · 
ethanoL 
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Figure 56 
· Calibration curve for B,B'~dioxo-6,6'-azopuririe 
(DOAP) in 0.1 N KOH~ 
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Figure 57 
Urinary excretion of 8,8'-dioxo-6,6'-azopurine (DOAP) 
after a single subcutaneous injection of 25 mg/kg in an 
adult male rat. The .urine of the rat was collected on an 
automatic fraction collector for every 2 hr. It was acidi.:. 
fied by adding a drop of 5 N- HCl to change the pH of the 
urine to 2.0 and centrifuged at 6oo X gfor 10 min to ob-
tain an orange precipitate. The orange precipitate was . 
washed .3 times with dist~ H20 and dissolved · in .J.O ml .of 
0.1 N KOH. The optical density of this ~olution was· ·read 
at 51.3 nm and the amount of DOAP was calculated from 11he 
calibration curve. 
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Figure . 58 
Effect of a single subcutaneous injection of 25 mg/kg 
8,8'-dioxo-6,6'-azopurine (DOAP) dissolved in 0,01 N NaOH 
on urine output of an adult male rat. After the injection, 
the rat was placed in a Holdge metabolic cage, and the u-
rine was collected on an automatic fraction collector for 
every 2 hr for a period of 24 hr. 
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Figure 59 
Effect of a single subcutaneous injection of 25 mg/kg 
8,8'-dioxo-6.6'-azopurine (DOAP) dissolv~d in 0~01 N NaOH 
on urine output of an adult male rat. After the injection, 
the rat was placed in a Holdge metabolic cage, and the u• 
rine was collected on an automatic fraction collecto.r for 
every 2 hr for a period of 7. days. 
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Figure 60 
Effect of 25 mg/kg 8,8'-dioxo-6,6'-azopurine {DOAP) 
on urinary excretion of xanthine and hypoxanthine in ail a-
dult male rat. To a silica cuvette of· i em pathlength, 500 
~1 of the urine, collected as described in Chapter III, 
Section J (a), and 1500 ~1 of M/15 glycin buffer, pH 9 • .3, 
25 Ill of 0.4 units/ml uricase was added and the reaction 
mixttire was incubated at room temperature for 15 min • • To 
this solution, 200 ~1 of 1. 5 N NaOH was added and after a · 
15 min interval, 200 ~1 of 1.6 N HCl, JOO ~1 of 0.6 M gly-
cylglycine buffer pH 8.2, and 25 ~1 of6.9 units/ml bovine 
milk xanthine oxidase was added. After an incubation peri-
od of 1 hr, 200 ~1 of 0.6 N NaOH, and .500 ~1 of 0.7 M gly-
cine buffer, pH 9.4 was added and optical density of this 
solution was read at 292 nm against a blank which was pre-
pared by using 25 ~1 of dist. H2o instead of 6.9 units/ml 
bovine milk xanthine oxidase. 
Then, 25 ~1 of o.l~ units/ml uricase was added · to the 
reaction mixture while 25~1 of dist. H2o was added to the 
blank. After incubating it at room temperature for 1 hr, 
the 6ptical density ·or the reaction mixture was read at 292 
. nm vs blank. The amount of uric acid was calculated from 
the 6 A292 nm as described in Chapter III, Section J (a). 
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EFFECT OF 25 mgJkg 8,8'-DIOX0-6,6'-AZOPURINE.(DOAP) 
ON URINARY EXCRETION OF XANTHINE AND HYPOXANTHINE 
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Figure 61 
Effect of 25 mg/kg 8,8'-dioxo-6,6'-azopurine (DOAP) 
on uric acid excretion in an adult male rat. 1.0 ml of the 
urine from the rat was diluted to 10 ml by adding 9.0 ml of 
dist. H2o. To 0. 5 m1 of this diluted urine, l. 0 ml of 0. 7 
glycine buffer, pH 9.4 and 5·7 ml of dist. H20 was added, 
Optical density of this.solution was read at 292 nm against 
dist. H2o. Then, 10 Ill of 0.4 units/ml uricase was added 
to it and the optical density of the final reaction mixture 
was read at 292 nm against dist. H2o. The change in opti-
cal density at 292 nm before and after adding the uricase 
was obtained and the amount of uric acid was calculated 
from a calibration curve. 
EFFECT OF 25 mgfkg a,a'-DIOX0-6,S-AZOPUR INE (DOAP) ON 
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Figure 62 
Calibration curve for uric a:cid analysis in adult 
male rat urine. Change in optical density at 292 nm pro-
duced bydegrading 5, 10, 20, JO, 40, and 50 llg of uric 
acid by 10 Ill of 0.4 units/ml uricase was obtained employ- . 
ing the same procedure as described for Figure 61. 
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Figure 63 
Effect of 25 mg/kg 8,8'-dioxo-6,6'-azopurine (DOAP) 
on urinary excretion of creatinine in an adult male rat. 
In a 50-:-ml Erlenrnyer flask containing L 0 ml of the rat u- · 
rine, 8.0 ml of 1/12 N H2so4 and 1.0 ml of 10% sodium tung~ 
state was added, the contents were mixed by gentle rotation 
and centrifuged at 600 X g for 10 min. 5.0 ml of the su-
pernatant was added to a tube marked "test" and 5.0 ml of 
dist. H20 to a tube marked "blank". 2.5 ml of freshly pre-
pared alkaline picrate reagent was added to both tubes and · 
they were incubated in a waterbath at 25°c for 1 hr.· Opti-
cal density of the reaction mixture was read vs blank at 
520 nm and the amount of creatinine in the urine was cal.-
culated from a calibration curve. 
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EFFECT OF 25 mgjkg a,a'-DIOX0-1»,6'-AZOPURINE (DOAP) 
ON URINARY EXCRETION OF CREATININE IN AN 
ADULT MALE RAT 
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Figure 64 
Calibration curve for creatinine analysis in adult 
male rat urine. 10, 20, JO, 40, 60, 80, and 100 j.lg . of 
creatinine from a stock solution were subjected to the 
same procedure as described for Figure 63 and the optical 
densities at 520 nni were recorded. 
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CALIBRATION CURVE FOR CREATININE ANALYSIS IN ADULT 
MALE RAT URINE 
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l'fl/rill of CREATININE 
Figure 64 . 
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Figure 65 
Uv spectra of an authentic sample of 8,8'-dioxo-6,6'-
hydrazopurine (DOHP) in 1 N HCl. 
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UV SPECTRUM OF · AUTHENTIC SAMPLE OF 
8,8'-DIOXO- 6,6'- HYDRAZOPURINE (DOHP), 
0.8 10 J19/ml in 1 . N HCI 
max. aba., nm 
298 
0 ~ 5 
..... 
u o.c · z 
• a:a · 
a: 
0 , 
Ill 0.3 c 
0·2 
WAVELENGTH, nm 
- ___ ____ .. --'-------
~----·---
Figure 65 
-276 
Figure 66 
Uv spectra of AG .50W-X8 chromatographic fraction 
no. 196 .obtained from urine of a rat subcutaneously in-
jected with 25 mg/kg 8,8'-dioxo-6,6'-azopurine (DOAP) dis-
solved in 0.01 N NaOH. 
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CHAPTER VIII 
CHARTS AND TABLES 
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Chart L SYNTHESIS OF OXOAZOPURINES 
Adenine (6 mg/ml in 1 N H2so4 , total vol. 2500 ml) 
KBr ( 120 ml of 15 rng/ml soln. 
in dist. H2o 
1 N KMno4 (800 rnl) 
30% H2o2 (50 ml added very 
· . slowly) 
Each added with one hour inter-
val while continuously stirring 
the reaction mixture. 
BRIGHT ORANGE SUSPENSION 
116 hr at 4°C 
BRIGHT ORANGE SUSPENSION 
1 600 X g/15 min 
BRIGHT ORANGE PRECIPITATE 
1. 
~sh with 4 N H2so4 , acetone, dry at 75 o 
BRIGHT ORANGE MICROCRYSTALS 
(DOAP) 
I 
SnCl /HCl , . 
· 7 5o 2C/20 min 
~ · 
I 0. 005 N NaOH 
60 hr at 40c 
.· i . 
TAN YELLOW PPT CHERRY RED PPT 
(DOHP) o. 5 N Na?H • (NaDOAXP) bubble a1r . · 
for 2 hr . 
dist. H2 0, C/16 hr 
,.... 
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Chart 2. A300 METHOD FOR AWEHYDE OXIDASE ACTIVITY 
a. CONTROL 
SAMPLE CELL 
1. 2.50 ml of 0.05 M potas-
sium phosphate buffer, 
pH 7.8 
{equilibrate at 25°C for 5 min 
in/min) . 
2. 0.25 ml of 0.06 M N1-meth-
ylnicotinamide chloride 
{equilibrate at 25°C for .5 min 
in/min) · · 
J. 0.25 ml of 5.04 mg pro-
tein/ml aldehyde oxidase 
suspension 
REFERENCE CELL . 
1'. 2.75 ml of 0.05 M potas- · 
sium phosphate buffer, 
pH 7.8 
using chart speed of 0.5 
using chart speed of 0.5 
)'. 0.25 ml of 5.04 mg pro-
tein/ml aldehyde oxidase 
· suspension 
{record A300 using chart speed of 2 in/min) 
b. TEST 
1. 2.25 ml of 0.05 M potas-
sium phosphate buffer, 
pH 7.8 
1' • 2.50 ml of 0.05 M potas-
sium phosphate . buff~r. 
pH 7.8 
(equilibrate at 25°C for 5 min using chart speed of 0.5 
in/min) 
2. 0~25 ml of 0.06 M N1-meth-
ylnicotinamide chloride 
(equilibrate at 25°C for 5 min using chart · speed of 0.5 
in/min). . 
J, 0. 25 ml of 2. 5 mg/ml NaAP 
in 0.05 M potassium phos-
phate buffer, pH 7.8 
J'. o. 25 ml of 2. 5 mg/ml NaAP 
in 0.05 M potassium phos-
phate buffer, pH 7.8 
(equilibrate at 25°C for 5 min using chart speed of 0.5 
in/min) · 
4. 0,25 ml O·f j.04 mg pro~ . 4 ·', 0.25 ml of 5,04 mg pro- .. 
tein/ml aldehyde oxidase · tein/ml aldehyde oxidase 
suspension . suspension 
(record A300 using chart speed of 2 in/min) 
The 0.05 M potassium phosphate buffer, pH 7.8 used in 
all the steps contained 0.005% EDTA 
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Chart J 
ENZYMATIC SYNTHESIS OF 
8,8'-DIOX0-6,6'-AZOPURINE MONOHYDRATE (DOAP) 
FROM 6, 6 '-AZOPURINE DIS ODIUM SALT ( NaAP) · 
(control) 
2 • .5 mg of NaAP in 10 ml of dist. H2o 
Yellow ppt 
Yellow ppt 
Yellow ppt 
+ 10 ml of 0.05 M potassium 
phosphate containing 0.005~ 
.EDTA, pH 7.8 · 
Incubate at room temp. for 
15 min 
+ 6.26 gm of solid (NH4 )2so4 (.50% saturation) 
8000 rmp/20 min at 4°c. 
dissolve in 25 ml of dist. 
H2o and add 2 ml of 5 N HCl 
8000 rmp/20 min at 4°C. 
dissolve in 2.5 ml of dist. 
H2o and add 2 ml of 5 N HCl 
8000 rmp/20 min at. 4°C. 
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Chart 4 
ENZYMATIC SYNTHESIS OF 
8,8'-DIOX0-6,6'-AZOPURINE MONOHYDRATE (DOAP) 
FROM 6,6'-AZOPURINE DISODIUM SALT (NaAP) 
(experimental system) 
2.5 mg of NaAP in 10 ml of dist. H2o 
Brown ppt 
1 
+ 7.5 ml of 0.05 M potassium 
phosphate containing 0,005% 
EDTA, pH 7.8 
+ 2.5 mlof s.o4 mg protein/ml 
of rabbit liver aldehyde oxi- _ 
dase 
Incubate at room temp. for 15 
min 
+ 6.26 gm of solid (NH4 ) 2so4 (50% saturation) 
8ooo rmp/20 min at 4°c. 
dissolve in 25 ml of dist. 
H2o and add 2 ml of 5 N HCl 
8000 rmp/20 min at 4°C. · 
Orange-Brown ppt 
Bright-Orange ppt 
dissolve in 25 ml of dist. 
H2o and add 2 ml .of 5 N HCl 
Sooo rmp/20 min at 4°C. 
Table 1. ELEMENTAL ANALYSIS DATA FOR DOAP 
I. At Room Temperature (c10H6N10o2.H 20) 
Anal. Calcd. % 
c1o 
H8 
NlO 
03 
37.98 . 
2.55 
44.29 
15.18 
Found % 
37.93 
2.56 
44.50 
14.90 
u. Fo 11 owing Drying At 105° For 1 Hour U~de~ Nitrogen 
Anal. Calcd. % Found % 
c1o 40.23 39.87 
H6 2.03 2.28 
NlO 46.97 46.53 
02 10.73 10.70 
( ClOH6N10°2) 
Difference 
-0.05% 
+0.01% 
+0.21% 
-0.28% 
Difference 
-0.41% 
+0.25% 
-0.44% 
-0.03% 
N 
00 
w 
....... 
Table 2: DETERMINATION OF THE EMPIRICAL FORt~ULA 0~ DOAP 
I. At Room Temperature · 
c = 38.25% t 12 = 3' 19 0.93 = 3.43 X 3 = 10.3 . 
H = 2.58% ~ 1 - . 2.58 ": 0.93 2.77 X 3 = 8.3 • 
N = 44.44% . 14 = 3.17 . 0.93 = 3.41 X 3 = 10.2 or C10H8Nl003 . 
0 = 14.80% L 16 = o ~ 93 . 0. 93 = 1. 00 X 3 = 3.0 . 
II. Following Drying At 100° c For 1 Hour Under Nitrogen 
c = 40.02% • 12 = 3.34 0.66 - 5.06 X 2 - 10.1 i' . . . 
H = 2.14% . = 2.14 ~ 0.66 = 3.24 X 2 = 6.4 or C10H6N10°2 . 
N = 46.2.0% 14 = 3.30 $- 0.66 = 5.00 X 2 = . 10.0 . 
0 = 10.60% 16 = 0.66 ~ 0.66 = 1. 00 X 2 = 2.0 . 
. . . . 
Table 3. D.ETERMINATION OF WATER OF CRYSTALLIZATION OF 
DOAP AT 100° C FOR 1 HOUR UNDER NITROGEN 
Anal • Ca 1 cd. % Sample Weight Loss Vaporized Water* 
Found % · Found % · 
5.69 5.26 5.41 
*Absorbed in magnesium perchlorate and the increase 
in weight of the drying agent measured. 
N 
OJ ' 
U1 
., 
Table 4. ELEMENTAL ANALYSIS DATA FOR DOHP 
I. At Room Temperature (C10H8N1002.H20) 
Anal. Calcd. % Found % Difference 
era 37.76 37.89 +0.13% 
HlO 3.14 2.89 -0.25% 
NlO 44.02 43.90 -0.12% 
03 15.08 15.31 +0.23% 
I I. Fo Tlowi ng Drying At 1000 C For i Hour Under Nitrogen (C 10H8N10o2) 
Anal. Calcd. % Found % Difference 
clO 40.02 39.82 -0.10% 
H, 
t\ 2.66 2.41 -0.25% 
NlO 46.65 46.36 -0.29% 
02 10.66 10.58 -0.08% 
, 
· Table .5; DETERMINATION OF THE EMPIRICAL FORt~ULA OF OOHP 
I. At Room Temperature ( C10H10N10°3) 
c = 37.89% \ 12 = 3.16 . -. 0.96 = 3.29 X 3 - 9.87 
H = 2. 89~~ •· 1 = · 2.89 . 0.96 = 3.01 X 3 = 9.03 .. -; 
N = 43.90% . 14 = 3.14 . 0.96 = 3.27 X 3 = 9.81 -.. . 
0 = 15.31% ! 16 - 0.96 . 0.96 = X 3 = 3.00 . . 
II. Following Oryi ng At 100° c For 1 Hour Under Nitrogen (C1oHaN1002) 
c = 39.82% . 12 = 3. 32 . 0.66 - · .5.03 X 2 = 10.06 . . 
H 2.41 % ! 1 . = 2.41 !. . 0.66 = 3.65 X 2 = 7.30 
N = 46.36% ! . 14 = 3.31 ! 0.66 = 5.02 . X 2 ;: 10.04 
0 = 10.58% .: 16 :;: . . 0.66 ! 0.66 . - 1 X 2 = 2.00 . . 
Table 6. ELEt,1ENTAL ANALYSIS DATA FOR NaDOAXP 
I. At Room Temperature (c10H3N1003Na3. 6H 20) 
Anal. Calcd. % 
c 24.59 
H 3.08 
N 28.68 
0 29 .. 50 
Na 14.13 
Anal. Calcd. Ol lo 
c · 31.59 
H 0.80 
N 36.84 
0 12.63 
Na 18.15 
.J 
Found % 
24.99 
3.07 
28.64 
28.69 
14.39 
Found % 
31.67 
1. 22 
36.65 
12.62 
18.37 
Difference 
+0.40% 
+0,01% 
-0.04% 
-0.82% 
+0. 26% 
Difference 
+0.08% 
+0.42% 
-0.19% 
-0 . 01% 
+0.22% 
N 
o::> 
o::> 
Table 7 . . DETERt1INATION OF THE EMPIRICAL FOR~1ULA OF NaDOAXP 
I. At Room Temperature (c10H3N10o3Na3.6H20) 
c = 24.99% . 12 = 2.08 . 0.63 3.30 3 = 9.90 . ';" = X 
H = 3.07% .! 1 = 3.07 :. 0.63 = 4.87 X 3 = 14.61 . . 
N = 28.64% 14 = 2.05 . 0.63 = 3.25 X 3 = 9.75 -. . 
0 = 28.69% :. 16 = 1.80 . 0.63 = 2.86 . X 3 = 8.58 · . . 
Na = 14.39% . 23 = 0.63 .: 0.63 ·- 1.00 X 3 = 3.00 .. . 
II. Following Drying At 165° C For 1 Hour Under Nitrogen ( ClOH3Nlo03Na3) 
c = 31.67% 12 = 2.64 0.79 = 3.34 X 3 = 10.02 .. . 
H = 1. 22% ! 1 = 1.22 . . 0.79 = 1. 54 X 3 = 4.62 
N = 36:65% .! 14 = 2.62 . -. 0.79 = 3.32 X 3 = 9.96 
0 = 12.62% . 16 = 0. 79 . 0.79 = 1.00 X 3 = 3.00 . . 
Na = 18.37%' .! 23 = 0.80 . . 0; 79 = 1.01 X 3 = ' 3.03 
N 
0::. 
\.0 
Table 8. OXIDATION OF 8,8'-DIOX0-6,6'-HYDRAZOPURINE (DOHP) 
IN abs. EtOH 
Time after · Color of 0.0. at 0.0. at 
addition of 10 AJg/ml 282 nm 442 nm 
abs. EtOH · so ln. 
· min. 
·4 yell ow 0.700 0.000 
17 yellow 0.685 0.000 
30 yellow 0.675 0.010 
43 yellow 0.660 0.015 
56 yellow 0.645 0.020 
69 yellow 0.625 0.030 
82 yellow 0.625 ·0.035 
95 ye 11 0\'1 . 0.600 ' 0.045 
108 yellow 0.575 0.060 . 
121 yellow 0.550 ·0.070 . 
151 golden-yellow 0.560 0.070 
181 golden-yellow 0.535 0.085 
241 golden-yellow 0.485 0.110 
361 golden-yellow 0.400 0.150 
601 golden-yellow 0. 285 0.225 
1441 golden-yellow 0.000 0.320 
1921 . go 1 den-ye 11 ow 0.000 0.330 
2881 ·. golden~yellow 0.000 0.330 
4291 . go1 den'-ye 11 ow 0.000 0.330 
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I 
· Compound . 
. (Mol. wt) 
OOAP .. 
(311.2) 
OOHP 
(318. 26) 
NaDOAXP 
(488.26) 
Tab Te 9. ULTRAVIOLET CHARACTERISTICS OF OXOAZOPURI NES 
Absorption Maxima and Molar Ext. Coe. X 103 . 
abs. EtOh 
230 (17 .1) 
302 (5.6) 
442 (11.5) 
490 (7.4) 
280 (22.2) 
245 (H.4) 
367 (2. 7) 
416 (4.0) 
490 (5.5) 
0.1 N KOH 
220 (25.2) 
245 (20. 7) . 
513 (16.3) 
220 (30.4) 
245 (22.4) 
513 (18.8) 
0.1 N HC1 
210 (34. 5) 
287 (17.8) 
0.05 M potassium 
phosphate 
215 (15.8) 
242 (14.3) 
345 ( 4.8) 
455 (9.0) . . 
Compound 
(Mol. wt) 
NaAP 
(319.2) 
HP 
(286.28) 
NaAXP 
(362.0) 
Table 10. ULTRAVIOLET CHARACTERISTICS OF AZOPURINES . 
Absorption ~laxima and r~olar Ext. Coe .. X 103 
abs. EtOH 
216 (21. 7) 
416 (9.9) 
211 (6.1) 
272 (4.3) 
345 (3.2) 
216 (21.5) 
416 (9.6) 
0.1 N KOH 
220 (14. 6) 
232 (15.6) 
407 (9.5) 
220 (15.7) 
232 (16.0) 
407 (9.9) 
0.1 N HCl 
210 (24.3) 
278 (22.6) 
338 (7.2) 
0.05 M potassium 
phosphate 
212 (17.8) 
392 (8.7) 
N 
1.0 
N 
· Table 11~ Rf VALUES OF OXOAZOPURINES 
Solvent System DOAP DOHP NaOOAXP NaAP HP NaAXP · 
abs. EtOH Pyridine Dist. H20 
67 20 13 0.17 0.19 0.16 0.25 0.24 . 0. 25 
pH 7.5 
n-Propanol Cone. NH3 
. Dist. H20 
60 30 10 0.27 0.28 0.29 0.50 
pH 12.0 
abs. EtOH 0.5 M Ammonium Acetate 
5 2 0.30 0.35 0. 77 0.77 
pH 7.40 
Table 12. PROTON CHEMICAL SHIFTS OF OXOAZOPURINES, AZOPURINES 
AND PURINE DERIVATIVES 
Compound c2-H c8-H amide imidazole hydrazo amino N9-H NrH N-H NH 2 
8,8 1 -Dioxo-6,6 1 - 8.96 12.22 12;84 
azopurine (DOAP) 
8,8 1 -Dioxo-6,6 1 - 8.34 10.42 11.88 8.92 
Hydrazopuri ne {DOHP) 
8, 8 1 - Di oxo- 6, 6 1 - 8.56 11. 78. 
azoxypuri ne (NaDOAXP) 
6,6 1 -Azopurine Di- 8.82 8.38 
sodium salt (Nal\P) 
6,6 1 -Bisadenine 8.52 8.52 13.42 10.04 
(HP) 
6,6 1 -Azoxypurine 9.08 8.64 
Di sodi urn sa 1t (NaAXP) 
Adenine 8.44 8.44 13.28 7.36 
(6-aminopurine) 
Hypoxanthine 8.43 8.28 12.88* 13.76 
(6-oxopurine) 
Xanthine 
{2,6-dioxopurine) 8.26 11. 20* 13.76 
11. 92# N 
~-
.j:::. 
* amide N1-H proton, # amide N3-H proton 
Table 13. INFRARED FREQUENCIES OF AZOPURINES AND OXOAZOPURINES 
Assignment DOAP NaAP DOHP HP NaDOAXP - NaAXP 
yNH(free) 3410m 3500sm 3200bm 3480m 
v NH (bonded) 3600- 3450- 3500- 3700- 3600-
220Gb 2200b 2200b 2600b 2200b 
NHYmax 2780 3000 2980 3010 
2660 2920 2840 2810 
2570 
YCH 3090m 3100m 3050m 3055m 
3040m 3030m 3040m 
vC=O 1760bs 1750bs 
JNH 1630vvsh 1655s 
N=N- 1590s 1535m l540m l530bm 
., C= C, enol 1640s 
(Continued on next page) 
Table 13. INFRARED FREQUENCIES OF AZOPURINES AND OXOAZOPURINES (contd.) . 
Assignment 
C=C/C=N 
ring modes 
Abbreviations: 
DOAP NaAP DOHP HP NaDOAXP NaAXP 
1590bm 1590m 1605s 1600s 1605w 
1565w 1570w 1580sh 
1460W 1540w 1540w 1545m 1550m 
1530w 
1465m 1380m 1460m 1440m 1450m 1480m 
1400w 1410w 1400m 1435m 1420m 
1380m 
1350w 1300w 1335m 1320m 1320w 
1295w 1270s 1280m 1270w* 1290* 
1250m 1250w 1260m 1250w 
1200bw 1230m 1230m !230m 1225w 
1170m 1160w 1150w l175w 
1130w 1150~/ . 1120~/ 1130w 1140w 
1085w 1100w llOOw 
1040w 1040w lOOOw 1050w 1040w 1045w 
1010w .· 985wsh 1000w 
950w 925wsh 930w 945w 950\'/ 
880w 900w 900w 870w 890w 900-910wd 
870w 875w 
810w 820w 845w 835\<'/ 815w 820w 
780W 790m 765w 770w 760w 700w 
735w 700b\v l.35w 700w 700w 
630w 615wsh 620w 640wsh 
s=strohg, m=medium, w=weak, sh=shoulder, b=broad 
d=doublet 
* This band .probably includes azoxy N-0 stretch 
· N 
1.0 
0'> 
Table 14. INFRARED FREQUENCIES OF OXOPURINES 
Assignments Adenine 2-0xoadenine 2,8-Dioxo Hypoxanthine xanthine Uric acid 
Sulfate adenine 
NH 3300m 3240w 3350s 3240w 
(free} :52 50s 
NH 3130m 3000b 3030s 3200b 3200b 3300b 
(bonded) 
.NH2 1720s 1660s (scissors) 
NH 
(deformation) 1660s 1725w 1710w* . 1720w 1715w 1720w 
N• 0 
NH3 + Stretch 3130m 
C=O 169os@(c2) 1715(c2) 1660~(C6 ) 1660cE6) 1600bs(E6) 
# 17 50s ( Cg) 1700s(~ 2 ) 1680bs(~ 2 ) 
l700bs(~8 ) 
CH 3095bs 2960bs 3030bs 3000bs 
ring modes 1590s 1590s 1610m 1570m 1650m 1580m 
"' (Continued on next page} ~. '""'-' 
. Table 14. INFRARED FREQUENCIES OF OXOPURINES (Continued) 
Assignments Adenine 2-0xaoadenine 2 ,8-Di oxo · Hypoxanthine Xanthine 
Sulfate adenine 
=C=C/C-N 1550w 1450s 1510m 1445m 1455m 
14955 1320m 1450m · 1410m 141Qm 
1405m 1270m 1380m I 350m 1370m 
13205 1200m I 340m !305m !325m 
12955 1160m 1210w 1265m I 250m 
I 240m 1120m 1160w .1205m l195m 
1145m 10705 1090m 1140m 1145s 
lllOm 965m lOOOw I 120m . lllOm 
920m 890w 950m 950m · · 1020m 
89Qm .· 820w 900m 880m 950m 
860w 790w . 850m 840sh 880w 
830w 710w 770m 780m 830m 
nom 730m 7.15m 750m 
700w 710ni 
Abbreviations: s= strong, m= medium, w::: weak,_ sh= shoulder, b= broad, d= doublet 
* Overlapping by c2 amide C=O 
# plus amide stretch 
@plus NH3+ 
Uric 
acid 
1340m 
1300m 
I 110m 
1020m 
980m 
860m 
765m 
N 
\.0 
co . 
Tab 1 e 15.. AG 50W-X8 COLUMN CHROt,1ATOGRAPHIC SEPARATION OF OXOPURI NES 
Peak tube No . abs. max. in HCl, nm Compound abs . max. of authentic 
compd., nm 
4 225, 282 Uric Acid 230, 282 
67 208, 228' 259 Xanthine 207' 227' 259 
87 207' 247 Hypoxanthine 207, 247 
103 215 Creatinine 215 
120 208, 232, 306 2,8-DOA . 208, 232, 305 
137. 211, 267, 280 8-0A 212, 267' 280 
180 . 208, 282 2-0A 208' 283 
224 208' 260 Adenine 207, 262 
284 210, 297 DOHP 210; 297 
.. 
Rat 
1 
2 
3 
4 
Table 16. RATS USED FOR IN VIVO INHIBITION OF XANTHINE OXIDASE AND t~ETABOLISM 
OF 8,8'-DIOX0-6,6 ' -AZO~URINE (DOAP) 
Age in days Weight in gm. mg of DOAP dissolved in 
ml of 0.01 N NaOH for a 
final dose of 25 mg/kg* 
llO 380 9.500 mg DOAP/6.3 ml 0.01 N NaOH 
68 210 . 5. 250 mg DOAP/3. 5 ml 0.01 N NaOH 
70 228 5.700 mg DOAP/3.8 ml 0.01 N NaOH 
63 235 . 5.875 mg DOAP/3.9 ml 0.01 N NaOH 
*The concentrat ion of DOAP in 0.01 N NaOH was 1.5 mg/ml . 
w 
0 
0 
Cone. of DOAP 
in 0.1 N KOH 
J.Jg/ml. 
2.5 
5.0 
10.0 
15.0 
20.0 
22.0 
Table 17. ANALYSIS OF DOAP IN RAT URINE: CALIBRATION CURVE FOR 
8,8'-DIOX0-6,6'-AZOPURINE (DOAP) IN 0.1 N KOH 
Optical Density at 513 nm. 
Expt. 1 Expt. 2 Expt. 3 Ex pt. 4 Average of E~pts. 
l ,2,3,4 
0.135 0.110 0.115 0.095 0.114 
0. 275 0.275 0.235 0.230 0.254 
0.560 0.470 0.475 0.450 0.489 
0.710 0. 740 0.710 0.760 0.730 
1.140 0.940 0.965 0.920 0.991 
1.100 1.150 1.110 1.120 1.120 
w 
0 
....,.. 
Table 18. EXCRETION OF 8,8'-DIOX0-6,6'-AZOPURINE (DOAP) AFTER A 
SINGLE SUBCUTANEOUS INJECTION OF 25 mg/kg in RAT URINE 
Hours after the 
injection of DOAP 
2 
4 
6 
8 
10 
12 
14 
16 
18 
20 
22 
24 
O.D. at 513 nm# 
0.225 + 0.0014 
0.990 + 0.0013 
1.130 + 0.0016 
0.880 + 0.0017 
0. 560 + 0. 0013 
0.670 + 0.0012 
0.315 + 0.0011 
0. 410 + 0. 0010 
0.510 + 0.0010 
0. 390 + 0. 0011 
0. 225 + 0. 0016 
0.045 + 0.0014 
..Ug/ml of DOAP 
4.5 
20.0 
20.8 
17.7 
11.3 
13.5 
6.3 
8.2 
10.3 
7.9 
4.5 
0.9 
g of DOAP excreted 
in 2 hour urine sample 
13.5 
60.0 
62.4 
53.1 
39.9 
40.5 
18.9 
24.6 
30.9 
23.7 
13.5 
2.7 
#An average of three experiments is listed with standard deviations. 
w 
0 
I') 
Table 19. EFFECT OF A SINGLE SUBCUTANEOUS INJECTION OF 25 mg/kg 8,8 1 -DIOX0-6~6 1 -AZOPURINE 
(DOAP) DISSOLVED IN 0.01 N NaOH ON URINE OUTPUT OF AN ADULT f•1ALE RAT 
Hours after the Urine volume, ml 
injection of DOAp 24 hr. before 24 hr. after · ' 24 Hr. 
0.01 N NaOH 0.1 N NaOH after DOAP. 
2 1.85 1. 50 3.25 
4 3.20 2.55 4.55 
6 2.30 2.30 5.30 
8 2.50 2.50 6.80 
10 2.80 1.80 8. 50 
12 2.50 2. 50. 8.90 
14 3.25 3.25 9.60 
16 5.45 5.25 10.80 
18 4.60 3.10 9.50 
20 1.10 1. 00 9.00 
22 0. 75 0.85 7.20 
24 0.70 0. 70 7.00 
w 
0 
w 
ml. 
Table 20. CALiBRATION CURVE FOR URIC ACID ANALYSIS IN ADULT MALE RAT URINE 
of std. soln.* pg of uric ml. of glycine ml. of di st. 
of uric acid· acid buffer# added H2o added 
0.1 5 1.0 6.1 
0.2 10 1.0 6.0 
0.4 20 1.0 5.8 
0.6 30 1.0 5.6 
0.8 40 1.0 5.4 
1.0 50 1.0 5.2 
*Standard solution of uric acid was purchased from Sigma Chemical Co., 
St. Louis, Mo., containing 0.05 mg of uric acid/ml. 
#0.7 M glycine buffer, pH 9.4. 
@ Average of three experiments. 
10 u1 of 0.4 units/ml of Uricase was used in all experiments. 
O.D. at 
292 nm@ 
0.050 
0.080 
0.165 
0.235 
0.335 
0.418 
w 
0 
.+::> 
Day 
1 
2 
3 
1 
2 
3 
' 1 
2 
3 
4 
5 
6 
7 
8 
Table 21. EFFECT OF 25 mg/kg 8,8'-DIOX0-6,6'-AZOPURINE (DOAP) ON URIC ACID 
EXCRETION IN AN ADULT MALE RAT URINE 
Urine val., ml. O.D. at 292 n~ of 
31.0 
29.4 
32.0 
0.5 ml. of urine 1.0 ml. of urine 
* sample sample 
0.0300 + 0.0014 
0.0375 + 0.0015 
0.0325 + 0.0013 
0.060 
0.075 
0.065 
a single subcutaneous injection of 0~01 N NaOH 
0.0225 + 0.0011 
0.0375 + 0.0010 
0.0300 + 0.0013 
0.055 
0.075 
0.060 
Uric Acid 
pg/ml . mg% 
of urine 
7.0 
8.5 
7.5 
7.0 
8.5 
7.0 
0. 70 
0.85 
0. 75 
0. 70 
0.85 
0.70 
a single subcutaneo~s injection of 25 mg/kg DOAP dissolved in 0.01 N NaOH 
90.4 
31.0 
42.0 
35.6 
31.2 
30.8 
29.3. 
30.1 
0.0100 + 0.0010 
0.0300+ 0.0014 
0.0200 + 0.0012 
0.0175 + 0.0010 
0.0225 + 0.0010 
0. 0300 + 0. 0011 
0.0250 + 0.0013 
0. 0375 + 0. 0013 . 
0.020 
0.060 
0.040 
0.035 
0.055 
0.060 
0.050 
0.075 
2.5 
7.0 
5.0 
4.5 
7.0 
7.0 
6.0 
8.5 
0.25 
0. 70 
0.50 
0.45 
0.70 
0. 70 
0.60 
0.85 
*an averag~ of thre~ experiments is listed with Standard Deviations 
w 
d 
(.]"1 
Day 
1 
2 
3 
1 
2 
3 
1 
2 
3 
4 
5 
6 
7 
8 
Table 22. EFFECT OF 25 mg/kg 8,8'-DIOX0-6,6'-AZOPURINE (DOAP) ON XANTHINE 
AND HYPOXANTHINE EXCRETION IN AN ADULT MALE RAT URINE 
Urine vol., ml. O.D. 292 nm * Uric Acid 
)Jg/ml mg% 
of urine 
31.0 0.018 + 0.0014 1.76 0.18 
2"9.4 o. 021 + 0. 0016 2.05 0. 20 
32.0 0.028 + 0.0013 2.74 0. 27 
a single subcutaneous injection of 0.01 N NaOH 
31.8 0. 021 + 0. 0014 2.05 0.20 
26.7 o. o23 I o.oo16 2.25 0.23 
27.3 0.020 + 0.0013 l. 95 0.19 
a single subcutaneous injection of 25 mg/kg DOAP dissolved in 0.01 N NaOH 
90.4 0.069 + 0.0013 6.74 0.67 
31.0 0.101 + 0.0016 9.87 0.99 
42.0 0.032 + 0.0014 3.13 0.31 
35.6 0.029 + 0.0015 2.83 0.28 
31.2 0.030+0.0011 2.93 0.29 
30.8 0. 021 + 0. 0016 2.05 0.20 
29.3 0.020 + 0.0013 1.95 0.19 
30.1 0.021 + 0.0012 2.05 0.21 
*an average of three experiments is listed with Standard Deviations. w 0 
0'\ 
Table 23; CALIBRATION CURVE FOR CREATININE ANALYSIS IN ADULT MALE RAT URINE. 
Tube no. ml of *stock ml of di st. 0.0. at 520 1'9 of creatinine 
·· sol n. · H20 nm vs blank per ml 
1 0.00 10 
2 0.10 9.9 0.040 10 
3 0. 20 9.8 0.060 20 
4 0.40 9.6 0.135 40 
5 0.60 9.4 0.210 60 
6 0.80 9.2 0.290 80 
7 1.00 9.0 0.365 100 
*The stock ~oln. of creatinine was 1.0 mg/ml in 0.1 N HC1. 
Table 24 . EFFECT OF 25 mg/kg 8,8 1 -DIOX0-6,6'-AZOPURINE (DOAP) ON CREATININE 
EXCRETION IN AN /l.DULT t-1ALE RAT URINE 
Day 
1 
2 
3 
1 
2 
3 
1 
2 
3 
4 
5 
6 
7 
8 
Urine vol., ml. 
2o.s 
25.2 
28.2 
0.200 + 0.0014 
0.210 + 0.0016 
0. 215 + 0. 0013 
Creatinine 
JUg/ml mg% 
55.0 
58.0 
60.0 
5.50 . 
5.80 
6.00 
a single subcutan~ous injeciion of 0. 01 N NaOH 
21 ~ 0 
22.8 · 
26.7 
0.230+ 0.0013 
0. 210 + 0. 0011 
0.190 :t 0.0012 
.. 63.5 
58.0 
52.5 
6.35 
5.80 
5.25 
a single subcutaneous injection of 25 mg/kg DOAP dissolved in 0.01 N NaOH 
.96.8 0.050 + 0.0010 13.5 1.35 
42.9 0.135 + 0.0014 37 . 0 3.70 
. 31.6 Q.175 + 0.0013 48.0 4.80 
45.6 0.120 + 0.0014 33.0 3.30 
21.3 0.230 + 0.0010 . 63.5 6.35 
28.2 0.210 + 0.0013 58.0 5.80 
26.3 0. 230 + 0. 0016 63.5 6.35 
25.0 0.220 + 0.0010 60.5 6.05 
*an average of three experiments is listed with Standard Deviations. 
w 
0 
co 
Table 25. DETERMINATION OF PROTEIN OF RABBIT LIVER ALDEHYDE OXIDASE. 
Dilution of A215 A225 ..6 0. D. pg protei n/ml. 
the stock soln. (A215-A225) in dil. soln. ( O.D. X 144) 
1 250 0.860 0.790 0.070 10.03 
1 500 0.550 0.490 0.060 3.64 
1 1000 0.385 0.350 0.035 5.04 
1 2000 0.280 0.260 0.020 2.88 
*pg protein/ml in diluted stock solution X dilution factor t 1000. 
Average of 5.04 mg protein/ml in the final stock solution of rabbit liver 
aldehyde oxidase. 
mg protein/ml 
of the stock 
soln. * 
2.52 
4.32 
5.04 
5.76 
Table 26. DETERf~INATION OF OPTIMAL SUBSTRATE CONCENTRJHION FOR RABBIT 
LIVER ALDEHYDE OXIDASE. 
. Substrate cone~ 
1·1 
3.33 X 10-4 
8. 33 X 10-4 
1. 66 X 10-3 
3.33 .X 10-3 
5.oo x ·10-3 
8. 33 X 10-3 
1. 66 X 10"" 2 
* N1-methylnicotinamide chloride 
Amt of aldehyde 
oxidase#, ).Jl 
100 
100 
100 
100 
100 
100 
· loa ·· 
# 5.04 mg protein/ml rabbit liver aldehyde oxidase. 
@ Change in optical density/min at 300 nm. 
Initial vrnlocity 
0.0./niin~ 
. 0. 010 
. 0.020 
0.030 
0. 035 . 
0.025 
0.200 
0.200 
w 
1-' . 
0 
Table 27. DETERMINATION OF OPTIMAL SUBSTRATE CONCENTRATION FOR RABBIT 
LIVER ALDEHYDE OXIDASE. 
Substrate Cone. * Amt of aldehyde 
M oxidase~ pl 
3.33 X 10-4 250 
1. 66 X lo- 3 250 
3.33 X 10-3 250 
5.00 X 1Q-3 250 
8.33 X 10-3 250 
1.66 X 10-2 250 
* N1-methylnicotinamide chloride 
# 5.04 mg protein/ml rabbit liver aldehyde oxidase 
@ Change in optical density/min at 300 nm. 
Initial volocity 
0.0./inin~ 
0.025 
0.055 
0.060 
0.060 
0.060 
0.055 
" 
Table 28. INHIBITION OF RABBIT LIVER ALDEHYDE OXJOASE BY 6,6•-AZOPURINE 
DISODIUM SALT (NaAP) AT 25°C: (I) 50AT pH 7.8 . 
Concentration of *NaAP · # 
ul of stock soln. FBC , 
0 0 
5 1.3 X 
10 2.6 X 
25 . 6.5 X 
50 1. 3 X 
100 2.6 X 
125 3.3 X 
0 0 
~I 
1o-6 
10-6 
10-6 
10"'"5 
1o-s 
10-5 
A300;min 
0.085 
0.055 
0.045 
0.025 
0.010 
0.005 
0.000 
0.085 
%! nhi bi ti on 
. 35.29 
47.05 
70.58 
88.23 
94.11 
5.0 X 1o-3 M Nl-methylnicotinamide chloride was used as substrate. 
*Stock solution of NaAP was prepared by dissolving 2.5 mg of NaAP in 10 
lill of dist. H2o 
# Final bath concentration w 
....... 
N 
Table 29. INHIBITION OF RABBIT LIVER ALDEHYDE OXIDASE BY 6,6'-AZOPURINE 
DISODIUM SALT (NaAP) AT 25°C: (I )50 AT pH 8. 2 
Concentration of NaAP 
Fsc#, ul of stock sol n* M 
0 0 
5 1. 3 X 10-6 
10 2.6 X 10-6 
25 6.4 x 1o-6 
.50 1.3 X lQ-5 
100 2.6 X 10-5 
125 3. 3 x 10- 5 
0 0 
A300;mi n 
0.085 
0.060 
0.055 
0.030 
0.010 
0.005 
0.000 
0.085 
%Inhibition 
29.41 
35.29 
64.71 
88.23 
94.12 
5.0 X 10-3 M N1-methylnic~tinamide chltiride was used as substrate · 
* Stock solution of NaAP was prepared by disso1ving 2.5 mg of NaAP in 10 ml 
of dist. H20 . . 
# Final bath concentration 
w 
I-' 
w 
· Table 30. INHIBITION OF RABBIT LIVER ALDEHYDE OXIDASE BY MENADIONE . 
AT 25oc: (l) SO AT pH 7. 8 
Concentration of)~enadione · # 
ul of stock soln. FBC, M 
0 0 
5 5. 3 X 10-8 
10 1. 0 X 10-7 
25 2. 6 X 10-7 . 
50 5. 3 X 10-7 
100 LOX 10-6 
0 · 0 
0.080 
0.047 
0.043 
0.027 
0.010 
0.000 
0.070 
5.0 X 10-3 M N1-methylnicotinamide chloride was used as substrate 
%Inhibition 
41.88 
46.88 
. 66.25 
87.50 
*Stock solution of t•lenadione was prepared by dissolving 2 mg of r~enadione Sodium 
Bisulfite into 200 mls of dist. H20 
# Fin~l bath concentration 
. . . . 
Table 31. INHIBITION OF RABBIT LIVER ALDEHYDE OXIDASE BY 8,8'-DIOX0-6~6'-AZO-
PURIN~ (DOAP) AT 25°C: (I) 50 At pH 8.2 
· Concentration of DOAP A300/min % Inhibition 
ul of stock soln * FBC#, M 
0 0.085 
100 u1 of 
0.005 N NaOH 0.085 
10 ~.3 X 10-6 0.080 5.88 
25 1. 3 x 1 o-5 0.075 11.76 
50 2.6 X 10-5 0.068 20.58 
100 5.3 X 10-5 0.065 23.53 
250 1.3Xlo-4 0.065 23.53 
500 u1 2.6 X 10-4 0.065 23.53 
0 0.085 
~.0 x 10-3 M N1-methylnicotinamide chloride was used as substrate 
* Stock solution of DOAP was prepared by dissolving 2 mg of DOAP in 4.0 ml of 
0.005 N NaOH 
# Final bath concentration 
Table 32. INHIBITION OF RABBIT LIVER ALDEHYDE OXIDASE BY 6,6'·AZOPURINE 
DISODIUM SALT (NaAP) AT pH 7.8, 25°C: LINEWEAVER-BURK PLOT 
1 ~ubstrQte . l X 10-l at Inhibitor (NaAP) Concentration (N ~methy n1cot1nam1de v . 
.. chloride) 
Concentration Control k x lo-2 (No i nhi biti on) 2. 6 X 10-6 M 6.5 X 10-6 M 1.3 X10-S M 
20 2.50 3,64 5.00 6.67 
10 2.00 2.22 3.33 4.00 
4 1 .82 1.82 1. 90 2.00 
2 1.67 1. 54 1.67 l. 74 
1 1. 54 1.43 1. 54 1. 54 
· . w 
........ 
(j) 
, 
Table 33. INHIBITION OF RABBIT LIVER ALDEHYDE OXIDASE BY 6,6'-AZOPURINE 
DISODIUM SALT (NaAP) AT pH 7.8, 25°C: DIXON PLOT 
· Substrate (Nl-methylnicotinamide 
chloride) 
Cone., M 
5.0 X 10-4 
2. 5 X 10-3 
1 X lo-1 at Inhibitor (NaAP) Concentration 
-
v 
2.6 X 10-6 M 6.5 X lo-6 M 1.3 X 10-5 M 
3.55 5.05 6.68 
2.42 3.17 3.90 
I· 
Table 34. INHIBITION OF RABBIT LIVER ALDEHYDE OXIDASE BY MENADIONE 
. 0 AT pH 7.8,25 C: LINEWEAVER-BURK PLOT 
· Substrate · 1 x 1 o-1 M at Inhibitor (Menadione) (Nl-methylnicotinamide - Concentration v 
chloride) 
Concentration 
1 Control 
l.O X 10-7 M 2.6 X 10-7 M M X 10-2 (No inhibition) 
20 2.50 3.33 8.00 
10 . 2.00' 2.86 6.66 
4 1.81 2.50 5.71 
2 1.66 2.35 5.55 
l 1. 54 2.22 5.00 
Table 35. IDENTIFICATION OF THE PRODUCT OF ENZYMATIC OXIDATION 
OF 6,6'-AZOPURINE DISODIUM SALT (NaAP} BY RABBIT 
LIVER ALDEHYDE OXIDASE 
Solvent System Rf values 
DOAP ppt. 1 ppt. 2 ppt. 3 NaAP 
abs. EtOH Pyridine Dist. H20 
67 20 13 0.165 0.162 0.165 0.165 0.256 
n-Propanol Cone. NH3 Dist. H20 
60 30 10 0.357 0.363 0.370 0.370 0.593 
abs. EtOH 0. 5 r'1 Ammon i urn Acetate 
5:2 0.085 0.091 0.085 0.093 0.399 
ppt. 4 
0.256 
0. 585 
Precipitates l, 2, and 3 were the final orange precipitates obtained from the brown-orange 
DOAP-protein complex, precipitated by using 50% ammonium sulfate saturation, incubation in 
boiling water-bath for 10 min, and by adding 5 N HC1 respectively. Precipitate 4 was obtained 
from the control system (Ref. Chart 3) 
w 
....... 
1..0 
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